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 Abstract 
Hydrogen bonds are the most utilized non-covalent interactions in biological 
systems, due to their directionality, stability, reversibility and diversity. The weak 
strength of hydrogen-bond can be modified by combining several hydrogen bonds in the 
same unit, like in the melamine∙cyanuric/barbituric acid rosette-type system.  
Arene ruthenium metalla-assemblies have showed a great biological potential. 
Inspired by the combination of hydrogen bonding and metal complexation from the 
group of de Mendoza, we have recently prepared a series of hydrogen-bonded metalla-
assemblies. Therefore, to further investigate hydrogen-bonded metalla-assemblies, we 
used the melamine/barbituric rosette-type system with piano-stool complexes or 
dinuclear metalla-clips. The introduction of a pyridyl group on the barbituric acid 
moiety or the melamine moiety allows coordination of metals at the periphery of the 
rosette.  
New rosette-type metalla-assemblies have been prepared and characterized. 
Neutral and cationic trinuclear rosette-type metalla-assemblies have been synthesized, 
as well as hetero-hexanuclear rosette-type metalla-assemblies. Coordination of 
dinuclear metalla-clips has produced cationic hexanuclear metalla-assemblies. Overall, 
rosette-type assemblies with piano-stool complexes offer great opportunities in the field 
of supramolecular chemistry. 
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Chapter 1 
Introduction 
 
 
 
 
 
1.1  Hydrogen bonding 
1.1.1  Definition 
Hydrogen bonds are the most important interactions in supramolecular chemistry, 
and it is widely used in chemical, biological and physical science. The term ‘‘hydrogen 
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bond’’ was first mentioned by Bernal in 1935,[1] followed by Huggins in 1936.[2] The 
first definition was given by Pauling in 1939,
[3]
 only then the hydrogen-bond theory 
started to display an important role in the understanding of some natural substances, 
such as water, proteins, sugars and so on. Since the 1970s, many researchers have 
changed their focusing field from theoretical chemistry to biochemistry and materials 
science.
[4-5]
 And in 1997, the IUPAC defined hydrogen bonds in the ‘‘Compendium of 
Chemical Terminology’’.[6] Then the definition of hydrogen bonds was updated and 
detailed in 2011. The new definition says: ‘The hydrogen bond is an attractive 
interaction between a hydrogen atom from a molecule or a molecular fragment X-H in 
which X is more electronegative than H, and an atom or a group of atoms in the same 
or a different molecule, in which there is evidence of bond formation.’[7] Until now, 
there are almost 100 years of history about ‘‘hydrogen bond’’ interactions, but it is still 
a growing research area. 
The hydrogen-bonded system generally contains three parts (Figure 1). 
Hydrogen atom is necessary and it connects to an atom D (donor) by a covalent bond 
and is attracted at the same time by another atom A (acceptor). The dipole-dipole 
interaction between the hydrogen atom and atom A is defined as ‘‘Hydrogen 
bonding’’.[8] Atoms D and A are electronegative atoms, their electronegativity is larger 
than that of hydrogen. Examples are C, N, O, S and Cl with electronegativity of 
respectively C: 2.55, H: 2.20, N: 3.04, O: 3.44, S: 2.58, Cl: 3.16.
[9]
 In such systems, 
atom D can be considered as the ‘‘donor’’, due to its strong electronegativity, the 
electrons around the hydrogen atom are pulled towards D, giving a partially negative 
charge to atom D (δ-) and a partially positive charge to the hydrogen atom (δ+).[10] 
Generally, atom A is an atom or an anion, or a fragment (A-B), with a lone pair of 
electrons. This lone pair attracts the hydrogen atom, therefore atom A can be considered 
as the ‘‘acceptor’’.[7] Therefore hydrogen-bonded systems are generally expressed as D-
H∙∙∙A systems. 
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Figure 1: Components of a hydrogen-bonded system 
 
1.1.2  Properties and characteristics 
Hydrogen bonds have special properties in comparison with other non-covalent 
interactions, such as directionality, reversibility, stability and diversity. Several 
characteristics of hydrogen bonds will now be introduced. 
The orientation of hydrogen bonds is defined from the hydrogen-bond donor 
towards the hydrogen-bond acceptor, so it can be determined for each hydrogen-bond 
donor/acceptor pairs. Another important factor is the D-H∙∙∙A angle. This angle is 
usually equal or close to 180°, and should preferably be more than 110°. For example, 
the hydrogen-bond angle of the hydrogen fluoride dimer is 171.21° (Figure 2).
[7]
 
 
Figure 2: Representation of hydrogen bond in the hydrogen fluoride dimer 
 
 Hydrogen bonds are much weaker than other non-covalent interactions, except 
for ‘van der Waals’ interactions. Furthermore, covalent bonds are almost ten times 
stronger than hydrogen bonds.
[11]
 So the hydrogen bond has been defined as a relatively 
weak interaction, but it has a wide range of interaction strengths. Depending on various 
D :A H 
Hydrogen-bond 
donor 
Hydrogen-bond 
acceptor 
Covalent  
bond 
Hydrogen  
bonding 
δ- δ+ 
Electronegative  
atom 
Electronegative  
 atom 
Electron  
lone pair 
B 
F H 
F 
H 
171.21° 
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strengths, a classification of hydrogen bonds was proposed by Jeffrey.
[12]
 This 
classification can help us to analyze hydrogen bonds qualitatively in different structures. 
 Hydrogen bonds were divided into three types by Jeffrey (Table 1), a strong 
interaction with a strength of 14 – 40 kcal mol-1, a moderate interaction with a strength 
of 4 – 15 kcal mol-1 and a weak interaction with a strength of less than 4 kcal mol-1. The 
strong hydrogen bond is similar to a covalent bond; its bond length is close to the bond 
length of DH. The shape of strong hydrogen bonds is almost linear, for example the 
[F∙∙∙H∙∙∙F]- has a strength of 38.6 kcal mol-1 with a D-H∙∙∙A angle of 171.21°.[13] This 
type of hydrogen bonds is usually formed between a strong acid and a good hydrogen-
bond acceptor, or a strong base and a good hydrogen-bond donor. Moderate hydrogen 
bonds form between neutral hydrogen-bond donor and neutral hydrogen-bond acceptor 
via electron lone pairs.
[9]
 Hydrogen bonds formed by acids, alcohols, phenols and 
hydrates in biological molecules show moderate interaction. The bond length of 
moderate hydrogen bonds is longer than that of D-H, and their shape is slightly bent, 
like the [O-H∙∙∙O=C], and [O-H∙∙∙O-H].[14] Then weak hydrogen bonds are electrostatic, 
with a bond length two or three times longer than that of D-H. The shape of weak 
hydrogen bonds is non-linear. Normally, weak hydrogen bonds can form between weak 
hydrogen-bond donor and strong hydrogen-bond acceptor (C-H∙∙∙O=C), strong 
hydrogen-bond donor and weak hydrogen-bond acceptor (O-H∙∙∙C=C), or weak 
hydrogen-bond donor and weak hydrogen-bond acceptor (C≡C-H∙∙∙C≡C). These weak 
hydrogen bonds always play a role of stabilizing the molecular structures. 
 From another point of view, we can observe that the stronger the hydrogen bond 
is, the shorter the distance between hydrogen atom and hydrogen-bond acceptor are, and 
also that the shape of hydrogen bonds is closer to linear. Through this rule, we can 
better characterize hydrogen bonds.
[12]
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 Strong Moderate Weak 
D-H∙∙∙A 
interaction 
Mainly covalent 
Mainly 
electrostatic 
Electrostatic 
Bond 
lengths 
dDH ≈ dHA dDH < dHA dDH << dHA 
dHA (Å ) 1.2 – 1.5 1.5 – 2.2 2.2 – 3.2 
dDA (Å ) 2.2 – 2.5 2.5 – 3.2 3.2 – 4.0 
Bond angles 
[°] 
175 – 180 130 – 180 90 – 150 
Bond energy 
(kcal mol
-1
) 
14 – 40 4 – 15 < 4 
1
H NMR 
chemical 
shift 
downfield 
(ppm) 
14 – 22 < 14 – 
Examples 
 Gas-phase dimers 
with strong acids 
or strong bases 
 Acid salts 
 Proton sponges 
 Pseudohydrates 
 HF complexes 
 Acids 
 Alcohols 
 Phenols 
 Hydrates 
 All 
biological 
molecules 
 Gas-phase dimers 
with weak acids or 
weak bases 
 Minor 
components of 3-
center bonds 
 C – H∙∙∙O/N bonds 
 O/N – H∙∙∙π bonds 
Table 1: Classification and properties of hydrogen bonds 
 
 Solvent is a factor that cannot be ignored in any interacting systems, especially 
in hydrogen-bonded systems. The hydrogen-bonding interaction strongly depends on 
the solvent. In other words, the strength of hydrogen bonds will be influenced in protic 
and polar solvents such as water. Hydrogen bonds are easy to break in these solvents. 
Hunter’s group studied a hydrogen-bonded system between perfluoro-tert-butyl alcohol 
and tri-n-butylphosphine oxide, and its association constants in different solvents were 
published (Figure 3).
[15]
 Results showed that their association constants in carbon 
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tetrachloride and cyclohexane were better than those in other polar solvents, because of 
limited competitions with hydrogen bonds for nonpolar solvents. 
 
 
 
 
 
 
 
Figure 3: Association constants in different solvents of the hydrogen-bonded system perfluoro-
tert-butyl alcohol and tri-n-butylphosphine oxide
[15]
 
 
Therefore, most hydrogen-bonded systems are analyzed in chloroform, toluene 
and cyclohexane.
[16]
 However, the poor solubility of some hydrogen-bonded systems in 
these solvents can be problematic. In 2008, the strength of hydrogen-bonded assemblies 
was increased by Rehm and Schmuck, through combinations with other interactions 
such as hydrophobic contacts, metal-ligand interactions or ion-pair formations,
[17]
 thus 
offering the possibility to use other solvents to study hydrogen-bonded systems.  
 As we know, hydrogen bonds are relatively weak interactions, the most direct 
method to increase its strength is the combination of several hydrogen bonds together.
[18]
 
Therefore, a wide range of double, triple and quadruple hydrogen-bonded systems has 
been synthesized and studied. The cooperativity gives a much stronger system than 
single hydrogen bond.
[10]
  
 The strength of the single hydrogen bond depends on the basicity of the 
hydrogen-bond donor and the acidity of the hydrogen-bond acceptor.
[19]
 However, for 
multi-hydrogen-bonded systems, the strength can be increased by multiplying hydrogen 
bonds.
[20]
 Some examples are listed in Figure 4, we can see that UPy dimer with four 
Solvents 
Association constants 
(Ka in M
-1
) 
DMSO 6.8 × 10
-1
 
Acetonitrile 1.6 × 10
2
 
THF 2.4 × 10
2
 
Nitromethane 1.5 × 10
3
 
CHCl3 2.7 × 10
3
 
CCl4 7.6 × 10
4
 
Cyclohexane >10
5
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hydrogen bonds is more stable than G-C with three hydrogen bonds, and G-C is more 
stable than A-T with two hydrogen bonds. 
 
             A-T                                              G-C                                           Upy dimer 
         Ka = 10
2
 M
-1
                           Ka = 10
4 – 105 M-1                              Ka > 10
6
 M
-1
                       
Figure 4: Multi-hydrogen-bonded systems and their association constants 
 
The number of hydrogen bonds is not the unique factor affecting the strength of 
multi-hydrogen-bonded systems. Intramolecular hydrogen bonds, preorganizations, 
secondary interactions, tautomerizations and electronic substituent effects cannot be 
ignored. 
In recent years, scientists are more attracted by triple and quadruple hydrogen-
bonded systems, because they are good linkers for constructing supramolecular 
assemblies. Secondary interactions exist almost in all triple and quadruple hydrogen-
bonded systems. Therefore we need to study these secondary interactions. 
Secondary electrostatic interactions were identified by the group of Jorgensen in 
1990.
[21]
 Due to partial charges on adjacent atoms, attractions and repulsions occur and 
have an effect on the stability of the multi-hydrogen-bonded system.
[22]
 The strength of 
a multi-hydrogen-bonded system will be stronger, if there is more attractive secondary 
electrostatic interactions. On the contrary, the higher the number of secondary 
repulsions is, the weaker the strength will be. Thus DDD-AAA array with only 
attractive interactions is more stable than the ADA-DAD and AAD-DDA arrays (Figure 
5).
[23]
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           1.5 × 10
6
                     1.4 × 10
4
                      1.3 × 10
2
 
Figure 5: Arrangements of triple hydrogen-bonded systems and their predicted stability 
constants (in M
-1
) in chloroform 
  
The same rule can be applied in quadruple hydrogen-bonded systems. In six 
quadruple hydrogen-bonded dimers, four of them are complementary arrays and two of 
them are self-complementary arrays (Figure 6). Through studies of multi-hydrogen-
bonded systems, Schneider predicted that the primary interaction increases the stability 
by -8.0 kJ mol
-1
, the attractive secondary interaction gives -2.9 kJ mol
-1
 and the 
repulsive secondary interaction weakened the system by +2.9 kJ mol
-1
.
[23]
 
 
 
 
 
 
 
 
 
 
 
 
 
D      D      D 
A      A      A 
D      D      A 
A      A      D 
D      A      D 
A      D      A 
Attractive secondary 
interactions 
Repulsive secondary 
interactions 
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Complementary Arrays: 
           
         3.9 × 10
8
                    3.6 × 10
6
                    3.3 × 10
4
                    3.3 × 10
4 
Self-Complementary Arrays: 
                                      
                         3.6 × 10
6
                            3.1 × 10
2 
Figure 6: Arrangements of quadruple hydrogen-bonded systems and their predicted stability 
constants (in M
-1
) in chloroform
[18]
 
 
1.1.3  Hydrogen-bonded complexes in biological chemistry 
The idea of exploiting hydrogen bonds in supramolecular chemistry comes from 
nature. In nature, the most evident example is water (Figure 7). The oxygen atom in a 
water molecule provides two lone pairs of electrons that can form two hydrogen bonds 
with other water molecules. Therefore, four hydrogen bonds are obtained for each water 
molecule.  
The crystal structure of ice is affected by hydrogen bonds. Because of cavities in 
the open hexagonal lattice of ice, the density of ice is less than the density of water. 
That is the reason why ice always floats on liquid water. 
The boiling point of water is also affected by hydrogen bonds. As we all know, 
the boiling point of water is 100°C. It is higher than the boiling point of fluorhydric acid 
which has only two hydrogen bonds within one molecule of fluorhydric acid. To reach 
the gas state, they need to break their hydrogen bonds. Therefore they have relatively 
D    D    D    D      
A    A    A    A 
D    D    D    A      
A    A    A    D 
D    D    A    D      
A    A    D    A 
D    A    A    D      
A    D    D    A 
D    D    A    A      
A    A    D    D 
A    D    A    D      
D    A    D    A 
Attractive secondary 
interactions 
Repulsive secondary 
interactions 
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high boiling points compared to similar molecules without hydrogen bonds, such as 
hydrogen sulfide and methane.
[24]
  
 
Figure 7: Tetrahedrally-placed hydrogen bonds in water molecules 
 
 When we mention hydrogen bonds, we have to mention DNA and proteins 
(Figure 8).
[25]
 Two strands of DNA are held together by hydrogen bonds and π-π 
stacking interactions, thus giving a stable double helical structure of DNA. Hydrogen 
bonds are observed between either adenine and thymine, or guanine and cytosine, which 
are the four basic components of DNA. These mutually complementary hydrogen-
bonded pairs are called Watson-Crick base pairs, and were first identified in 1953.
[26]
 
The G-C pair with three hydrogen bonds is more stable than the A-T pair with only two 
hydrogen bonds, as mentioned previously. The mainly used hydrogen bond is N-
H∙∙∙O/N with a length of about 2.8 – 2.9 Å. In total, the G-C pair has the same length as 
the A-T pair. Therefore, they form a perfect double helix self-assembly.
[27]
 
                          
Figure 8: The DNA double helix, G-C and A-T pairs 
 
2.84 Å 
2.84 Å 
2.92 Å 
2.82 Å 
2.91 Å 
10.85 Å 
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The first structure of a protein was published by the group of Pauling in 1951 
(Figure 9).
[28]
 In the protein secondary structures, the most basic structure motifs are α 
helices and β sheets. They are constituted by repeating N-H∙∙∙O=C hydrogen bonds.[29] 
                                  
                     α helix                                          β sheets  
Figure 9 : Structures of α helix[30] and β sheets 
 
In addition, the interesting structure of G-quadruplex was detected with 
crystallographic methods by the group of Gellert in 1962 (Figure 10).
[31]
 Four guanines 
are associated through eight hydrogen bonds to form a square planar structure called 
quartet of guanines.
[32]
 Each guanine possesses two hydrogen-bond donors and two 
hydrogen-bond acceptors, thus they can link each other in a tetrameric way. The 
cooperativity improves an average energy for hydrogen bonds from 0.22 to 0.42 eV in 
G-quartet.
[33]
  Furthermore, the presence of a cation like potassium in the middle can 
stabilize this structure.
[34]
 
In fact, G-rich repetitive sequences do not exist as quartet of guanines, they exist 
in biological systems as a more complicated structure. Three quartets of guanines 
superimposed from top to bottom to form the G-quadruplex by π-π stacking interactions. 
These stacked tetrads align themselves to generate a right-handed helical twist. These 
G-rich repetitive sequences are mainly located at the end of chromosomes and a protein, 
with a reverse transcriptase activity.
[35]
 Its formation can inhibit telomerase activity of 
cancer cells. 
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Figure 10: Structure of G-quadruplex
[35]
 
 
1.1.4  Hydrogen-bonded complexes in synthetic chemistry 
Inspired from biomolecules, novel designs of hydrogen-bonded assemblies can 
give numbers of novel applications. In the 1980s and the 1990s, a wide range of 
hydrogen-bonded assemblies was synthesized through designing multi-hydrogen-
bonded modules. Heterocycles containing nitrogen and cycles with nitrogen functional 
groups were mainly used to design hydrogen-bonded modules, for example, compounds 
based on amides,
[36-37]
 ureas,
[38-39]
 imides,
[40-41]
 and so on.  
Triple hydrogen-bonded systems can be formed between pyridine-2,6-
diyldiacetamide and uracil (Scheme 1). On this basis, tartaric acid linked bidentate 
derivative 1 and uracil bidentate derivative 2 were synthesized by Lehn’s group.[42] The 
spontaneous association between these two complementary units promoted the 
formation of a polymolecular entity 3. Liquid crystalline properties were shown by 
polymer 3, but not for compounds 1 or 2 alone.
[43]
  
 
Quartet of guanines 
=
 
Three quartets of 
guanines 
= G-quadruplex 
G-quadruplex 
DNA 
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Scheme 1: Self-assembly of the poly-supramolecular species 3 
 
In 1988, a receptor of barbiturates including two 2,6-diamidopyridine units was 
synthesized by the group of Hamilton (Figure 11).
[44]
 Two triple hydrogen-bonded 
systems were incorporated in this receptor, thus the selectivity for the barbiturate family 
of drugs was increased. The binding strength between the receptor and the substrate 
reached up to 10
5
 M
-1
.
[45]
 Hamilton’s receptor is a successful example in supramolecular 
chemistry, and has extensive applications in the domain of supramolecular polymers. In 
summary, the combination of several hydrogen-bonded systems in one molecule makes 
the whole system more stable, and supplies the lack of strengths for ADA-DAD arrays. 
This structure will be introduced in more detail later. 
 
Figure 11: Hydrogen bonds between Hamilton’s receptors and barbital 
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In 2008, 5-membered heterocycles were used to replace 6-membered rings for 
the formation of DDA arrays by the group of Hisamatsu
[46]
 and the group of Wilson 
(Figure 12).
[47]
 This replacement avoids influences from intramolecular hydrogen-
bonded interactions on the formation of compounds containing DDA-AAD arrays. Then, 
the group of Wilson found that the stability of hydrogen-bonded compounds was 
modified by changing the substituents in each array. The stability of hydrogen-bonded 
compounds could reach up to 8 × 10
4
 M
-1
.
[48]
 
                                                            Ka = (1.9 ± 0.8) × 10
3
 M
-1
     (86 ± 34) × 10
3
 M
-1 
Figure 12: DDA-AAD hydrogen-bonded systems and their association constants 
 
The DDD-AAA hydrogen-bonded system is the most stable one, but their 
complicated structures are difficult to synthesize. Some examples are known (Figure 
13):
[49-51]
 among them, the most stable one was synthesized by the group of Leigh 
through protonated diaminopyridine as DDD arrays. The stability constant of this 
compound reached 3 × 10
10
 M
-1
.
[52]
 
 
         Ka > 10
5
 M
-1
              Ka = 2 × 10
7
 M
-1
      Ka = 2.4 × 10
4
 M
-1
    Ka = 3 × 10
10
 M
-1
 
Figure 13: DDD-AAA hydrogen-bonded systems and their association constants 
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Six combinations of quadruple hydrogen-bonded systems can be designed. 
Among them, DDDD-AAAA, DDDA-AAAD and DDAD-AADA arrays have been 
rarely published, due to their synthetic difficulties and scarce applications.  
The DADA-ADAD hydrogen-bonded system is considered as the least stable 
system, because of six additional repulsions according to Jorgensen’s theory of 
secondary interactions. A series of DADA-ADAD hydrogen-bonded systems was 
synthesized by the group of Meijer. When they designed their hydrogen-bonded system, 
they found that two amides with the trans configuration were replaced by amides with 
cis configuration in compound 6, because of electrostatic repulsions between carbonyl 
groups and nitrogen atoms in the triazine ring (Scheme 2). Thus only dimer 7 was found 
and analyzed, and its dimeric constant was only 37 M
-1
.
[53]
 
 
Scheme 2: Conformational equilibrium of diacylated 2,4-diaminotriazines 6 and the dimer 7 
with additional repulsive electrostatic interactions 
 
Subsequently, an amide group was removed to form a DADA array, see 
compound 8 (Figure 14). An intramolecular hydrogen-bonding interaction was used to 
preorganize arrays in dimers 9 and 10, thus their dimeric constants were significantly 
improved.
[54]
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          R = Ar(OC12H25)3             R = Ar(OC12H25)3 
              Kd = 530 M
-1
                  Kd = 2 × 10
4
 M
-1
                  Kd = 2 × 10
5
 M
-1
 
Figure 14: Quadruple hydrogen-bonded systems synthesized by the group of Meijer 
 
In the case of the deazapterin (DeAP) 11 hydrogen-bonded system, the group of 
Zimmerman found that the presence of 2,7-diamido-1,8-naphthyridines (14) broke the 
dimeric system of DeAP and formed new DAAD-ADDA systems with 14 (Figure 
15).
[55]
 The group of Zimmerman developed a series of DAAD-ADDA systems based 
on 14. For example, the system formed between butylurea of guanosine (UG) 12 which 
used imidazole in place of the pyridine ring in DeAP 11
[56-57]
 and ureido-7-
deazaguanine (DeUG) 13 which used pyrrole in place of the pyridine ring in DeAP 
11.
[58]
 When UG and DeUG are alone, their dimeric constants are small, 230 M
-1
 for 
UG 12 and 880 M
-1
 for DeUG 13. However, they can form stable heterodimers with 
DAN 14, their association constants can reach 3 × 10
8
 M
-1
 for 12-14 dimer and 1.9 × 
10
8
 M
-1
 for 13-14 dimer. The structure of 13-14 dimer was confirmed by X-ray 
spectroscopy and showed a zipper-like hydrogen-bonded assembly.
[59]
 
 
Figure 15: The DeAP 11, quadruple hydrogen-bonded heterodimers based on UG 12, DeUG 13 
and DAN 14 
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Recently, the DDAA-AADD array is the most widely developed system in all 
quadruple hydrogen-bonded systems. This array has only one secondary repulsion, thus 
it has a relatively stable structure, and involves a relatively simple synthesis. In 
numerous DDAA-AADD arrays, the UPy (ureidopyrimidinone) dimer is the most 
successful one (Figure 16). The intramolecular hydrogen-bonded interaction is used to 
fix and form favorable dimers. Therefore, the dimeric constant of UPy is more than 10
7
 
M
-1
.
[60]
 Different substituents were added and thereby improved solubility and 
functionality to the dimeric systems.
[39, 61]
 UPy systems were widely used in 
supramolecular and material sciences, due to their excellent performance.
[62]
 
 
                 Kd > 10
7
 M
-1
 
Figure 16: UPy dimers with different substituents 
 
1.1.5  Combinations of hydrogen bonds and metal 
coordinations 
Metal-ligand and hydrogen bonds are two effective methods to establish 
supramolecular architectures and to control molecular self-assemblies.
[63]
 The 
combination of hydrogen bonds and metal coordinations was already demonstrated and 
used in the 1990s.
[64-66]
 
The UPy dimer was also used to form supramolecular structures with metal 
coordinations by the genius idea from the group of De Mendoza (Figure 17).
[67]
 Square 
planar cis-coordinated Pd(II) species were chosen for the formation of neutral cyclic 
arrangements based on the pioneer work of Fujita and Stang.
[68-69]
 Upon mixing 
equimolecular amounts of Pd(II) complexes and UPy dimers with two coordinated sites, 
neutral molecular squares and triangles were formed. This work reminds us that 
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structural changes, steric factors and solubility issues need to be considered for the 
design of molecular architectures. 
 
 
Figure 17: Structures of Pd (II) cyclic aggregates: propeller-shaped triangle, propeller-shaped 
square, tubular-shaped tetramer
[67]  
 
The UPy dimer also serves an important role in the formation of supramolecular 
polymers. A fast and easy synthesis was used to establish complicated structures by the 
group of Stang, where bis (phosphine) Pt(II) rhomboidal or hexagonal metallacycles 
were connected by UPy dimers to form linear chains or cross-linked supramolecular 
polymers (Figure 18).
[70]
 In this synthesis, the number of steps was reduced due to the 
contribution of hydrogen-bonded interactions.
[71]
 
 
Figure 18: Representations of the linear supramolecular polyrhomboid and the cross-linked 
supramolecular hexagonal network
[70]
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Thus 2-ureido-4-[1H]-pyrimidinone (UPy) being the most popular, this scaffold 
was chosen by our team to design arene ruthenium metalla-assemblies (Figure 19). 
Several cationic arene ruthenium cages were synthesized, characterized and investigated 
by rotating frame overhauser effect NMR measurements.
[72]
 The arene ruthenium 
rectangles remained stable in solution owing to the DDAA hydrogen-bonded array of 
ureido-pyrimidone dimers. These successful examples demonstrate that even 
monodentate ligands can be considered as scaffold for designing supramolecular 
assemblies.
[73]
  
 
Figure 19: Structures of synthesized cationic arene ruthenium cages  
 
1.1.6  Melamine•cyanuric/barbituric acid self-assemblies 
The melamine∙cyanuric acid (M∙CA) lattice was formed by the reaction between 
melamine with DAD hydrogen-bonded arrays and cyanuric acid with ADA hydrogen-
bonded arrays.
[74]
 These two components were mixed in a 1:1 ratio leading to a stable, 
insoluble complex (Figure 20).
[75]
 Three types of aggregates are contained in this lattice: 
cyclic rosettes,
[76-77]
 linear tapes
[78-79]
 and crinkled tapes.
[80]
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Figure 20: Structure of melamine∙cyanuric acid lattice 
 
The melamine∙cyanuric acid/barbituric acid (M∙CA/BA) pair was widely 
investigated by the group of Whitesides.
[75, 81-82]
 Two concepts were demonstrated for 
the preferential formation of cyclic rosettes (Figure 21).
[83]
 The covalent preorganization 
concept connected three melamines by a central ‘hub’ spacer and formed a cap upon the 
rosette.
[75]
 The peripheral crowding concept used melamines with sterically bulky 
substituents as walls to promote the formation of single rosette.
[76]
 The most widely 
used substituent is tert-butylphenyl that provides favorable steric interaction to form 
rosette structures.
[84]
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Figure 21: Rosette structures forming selectively by covalent preorganization or by peripheral 
crowding 
 
In 2001, a theoretical model for the self-assembly of melamine and 
cyanuric/barbituric acid derivatives into rosettes and tapes was reported by the group of 
Timmerman.
[85]
 All possible stereoisomeric tape structures were considered for the 
calculations. Their studies showed that the internal energy of the rosette structure was 
affected sensitively through changes in parameters, thus impacting the tape/rosette ratio. 
After the investigation of these calculations, the concept of peripheral crowding was 
questioned and the concentration ratio was suggested to be the key element.
[86]
 
The tape-like structures possess undefined shape and size, and limited solubility. 
However, these disadvantages do not exist for rosette motifs. Therefore, rosettes are 
more attractive than tape-like structures for scientists in the field.
[10]
 The six-membered 
rosette with complementary hydrogen-bonded pairs can be formed between heterocyclic 
motifs M and CA/BA, which is hold together by 18 hydrogen bonds through 
complementary centrosymmetric ADA-DAD hydrogen-bonded arrays. M∙CA/BA 
rosettes were extensively studied by the groups of Whitesides,
[83]
 Timmerman
[10]
 and 
Yagai.
[87]
  
One of the most well-known rosette was the one formed between N,N’-bis(4-
tert-butylphenyl) melamine (ME) and barbital (BA) that was synthesized by the group 
of Whitesides in 1994 (Scheme 3).
[80]
 One equivalent of ME was mixed with one 
equivalent of BA in chloroform, to form the rosette (ME)3∙(BA)3. In this system, 
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concentrations of both reactants need to be higher than 4 mM, if not, the disassembly of 
rosette (ME)3∙(BA)3 will occur in solution. Similar observations were made for another 
hydrogen-bonded trimer synthesized by the group of Zimmerman in 1992.
[88]
 Rosette 
(ME)3∙(BA)3 demonstrated a better solubility than each reactant in chloroform which is 
a nonpolar and aprotic solvent. The self-assembly of (M)3∙(CA/BA)3, which is led by 
polar hydrogen bonds, prefers the formation of soluble rosettes over insoluble tapes. 
 
Scheme 3: Self-assembly of rosette (ME)3∙(BA)3 
 
A series of analytic methods was used by the group of Whitesides to comfirm 
the structure of the rosette. 
1
H NMR is the most direct method, signals of hydrogen 
bonds can be observed in the spectrum. Vapor pressure osmometry (VPO) can be used 
to predict the average molecular weight of the rosettes.
[89]
 Another method to determine 
the molecular weight of rosettes is gel permeation chromatographic (GPC). But this 
method was unsuccessful for the molecular weight determination of rosette 
(ME)3∙(BA)3, because of its good thermodynamic stability.
[80]
 Crystals of rosette 
(ME)3∙(BA)3 were obtained through slow evaporation of a solution containing ME/BA 
(1:1) in isopropyl alcohol/toluene (1:1), and the X-ray structure was determined (Figure 
22). 
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Figure 22: X-ray crystal structure and packing structure of (ME)3∙(BA)3 rosette 
[80]
 
 
In 1997, four aggregates based on (M)3∙(CA)3 rosettes were synthesized and 
characterized by the group of Whitesides (Figure 23).
[90]
 Zinc tetraphenyl porphyrin 
units (ZnTPP) were added at the periphery of the rosettes by coordination to the 
imidazole groups. Aggregates with ZnTPP were demonstrated to be more stable than 
aggregates with free imidazole groups. 
 
Figure 23: Structures of aggregates with free imidazoles or ZnTPP
[90]
 
 
In the same year, the metalla-dendrimer associated with (M)3∙(BA)3 was 
constructed by the group of Reinhoudt (Figure 24).
[91]
 2-D NOESY experiments were 
used to confirm the structure of the rosette, strong cross signals were found between the 
three hydrogen bonds in the rosette. This was the first nanosized assembly formed by 
the combination of hydrogen bonds and metal coordinations. 
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Figure 24: Structure of the discrete rosette with palladium coordination
[91]
  
 
In 2004, gold atoms were inserted into the double rosette structure through 
phosphane addition at the periphery of the melamine unit (Figure 25).
[92]
 Six Au(I)Cl 
moieties were incorporated into hydrogen-bonded rosette assemblies. This rosette was 
extremely stable in the solid state. 
 
Figure 25: Structure of double rosettes containing six Au(I) atoms
[92]
 
 
In the same year, free porphyrin and Zn(II) porphyrin derivatives were prepared 
by the group of Li (Figure 26).
[93]
 The presence of large porphyrins stabilized the 
rosettes. Therefore, these porphyrin rosettes were found to be more stable than the 
rosette initially synthesized by the group of Whitesides. The results show that rosette 
(M)3∙(CA/BA)3 can be used to generate supramolecular receptors by binding large 
molecules at the periphery. 
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Figure 26: Structures of rosettes with porphyrins
[93]
  
 
Three strategies were used to add Zn(II) porphyrins around rosettes. The first 
one was by connecting the porphyrin to the CA structure (Figure 27). The second 
method used the coordination of Zn(II) over the melamine or BA unit through the 
addition of pyridines. These ideas are extremely useful for our design of hydrogen-
bonded metalla-assemblies. 
 
 Figure 27: Key molecules for the coordination of Zn(II) porphyrins to (ME)3∙(BA)3 rosettes 
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All above mentioned examples show the feasibility of the combination between 
(M)3∙(CA/BA)3 rosettes and metal coordinations. 
Stimuli-responsive properties were found for several (M)3∙(CA/BA)3 rosettes 
with π-conjugated systems, due to the possibility of dynamically rearranging hydrogen-
bonded patterns.
[87]
  
Photoswitching properties were first found in the M∙BA assembly by the group 
of Kitamura in 2003 (Scheme 4).
[94]
 The isomerization of azobenzenes through UV-
irradiation suppressed transformation from soluble cyclic rosette into insoluble tape-like 
polymers. Owing to the thermodynamic stability of rosette 15 in solution, the stability 
was further increased upon the photoisomerization of the azobenzene groups. 
 
Scheme 4: Transformation of rosette 15 by UV-irradiation
[94]
 
 
Soon after, a more complicated rosette 16 with azobenzenes accompanying the E 
→ Z isomerization through photoirradiation was synthesized by the same group (Figure 
28).
[95]
 This rosette 16 is stable in chloroform, toluene and methylcyclohexane. 
15 
Chapter 1 Introduction 
27 
 
Figure 28: Structure of rosette 16 
 
Another disk-shaped aggregate with azobenzene was investigated by the same 
group in 2005 (Scheme 5).
[96]
 The columnar aggregate of rosette 17 in cyclohexane was 
dissociated and reformed through trans-cis isomerization by UV-irradiation of the 
azobenzene group. 
 
Scheme 5: Formation of aggregates on the basis of rosette 17
[96]
 
 
Heating-induced rosette-type assembly was explored by the group of Yagai in 
2012 (Figure 29).
[97]
 Perylene 3,4,9,10-tetracarboxylic acid bisimide (PBI) was added to 
the cyanuric acid part for the formation of rosette 18. The transformation from columnar 
assemblies of rosettes to lamellar assemblies of linear tapes occurred by increasing the 
temperature. 
 
17 
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Figure 29: Thermoresponsive aggregates of rosette 18
[97]
 
 
These stimuli-responsive self-assemblies mentioned above can be used for the 
design of smart nanomaterials. 
Rosette 19 was formed by a collaborative work of Yagai and Ajayaghosh 
(Scheme 6).
[98]
 A self-organisation in aliphatic solvent between the melamine-derivative 
20 with the substituent oligo(p-phenyleneethynylene) (OPE) and cyanurate 21 provides 
the desired rosette 19. Toroidal nanoobjects were detected by atomic force microscopy 
(AFM). This rosette system may possibly be used for the design of artificial light-
harvesting nanodevices. 
 
Scheme 6: Formation of rosette 19
[98]
 
 
Rosette 19 
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1.2  Supramolecular chemistry 
1.2.1  General introduction 
In 1987, Jean-Marie Lehn, Donald J. Cram and Charles J. Pedersen won the 
Nobel Prize in chemistry for their contributions in supramolecular chemistry. Since this 
Nobel Prize, the field of supramolecular chemistry has become more and more widely 
investigated and applied.
[99]
 In 2016, James Fraser Stoddart, Bernard L. Feringa and 
Jean-Pierre Sauvage were awarded the Nobel Prize in Chemistry for molecular 
machines based on supramolecular chemistry.
[100]
 And after nearly thirty years of 
development, supramolecular chemistry has now evolved to supramolecular science. 
This interdisciplinary science covers chemical, physical, biological and material 
areas.
[101] 
A definition of supramolecular chemistry was provided by Lehn in the book 
“Supramolecular chemistry-concepts and perspectives”: ‘Beyond molecular chemistry 
based on the covalent bond there lies the field of supramolecular chemistry, whose goal 
it is to gain control over the intermolecular bond.’ This means that the supramolecular 
chemistry based on molecular interactions is focused on the synthesis of complicated 
system associating two or more molecules, owing to its highest efficiency and 
selectivity.
[102]
 
 
1.2.2  Tools of supramolecular chemistry 
Molecules that are held together by non-covalent interactions are called 
supramolecules. Non-covalent interactions are normally weaker than covalent 
interactions (250 – 800 kJ mol-1), but their cooperativities can help them to form stable 
supramolecular complexes. A list of non-covalent interactions is provided in Table 2 
with their relative strengths.
[103-104]
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Interaction Strength (kJ mol
-1
) 
Ion - ion 200 – 300 
Ion - dipole 50 – 200 
Dipole – dipole 5 – 50 
Hydrogen bonding 4 – 120 
Cation - π 5 – 80 
π - π 0 – 50 
Van der Waals < 5 
Hydrophobic < 50 
Coordination bonding 50 – 150 
Table 2: Summary of supramolecular interactions 
 
1.2.3  Categories of supramolecular chemistry 
Supramolecular chemistry can be divided in two categories: host-guest 
chemistry and self-assembly.
[104]
 
 The concept of ‘host-guest chemistry’ was first proposed by Cram in 1974, 
while investigating enzymatic systems.
[105]
 The substrate selectivity of enzymes can be 
simulated to design complexes composed of organic compounds. To design host-guest 
systems, matching sizes, shapes and electronic properties that can provide strong 
bindings between hosts and guests are crucial.
[106]
 
 Some common supramolecular host molecules have been found since 1967. A 
series of crown ethers was synthesized by the group of Pedersen and their cavity size 
was controlled by the number of repetitive motifs (Figure 30).
[107-108]
 Then cryptands 
were synthesized by the group of Lehn in 1969.
[109-110]
 Spheroids were synthesized and 
investigated by the group of Cram.
[111] 
Soon after, complexation rates and equilibria 
were investigated between host molecules and ions.
[112]
 
 
Chapter 1 Introduction 
31 
 
  Crown ether              Cryptand                      Spheroid                        Calixarene 
Figure 30: Typical supramolecular host molecules 
 
Obviously, supramolecular interactions can be used in host-guest systems. For 
example, Van der Waals interactions can be increased by extending the contact surface 
between the host and the guest. Acceptors or donors of hydrogen bonds can be inserted 
into host molecules, and guest molecules can be attracted by adding complementary 
sites (Scheme 7). Ion dipole interactions were the first interactions used in host-guest 
systems.
[108]
 The electrostatic interaction between two ions can also be used in such 
system. Additionally, combinations of several interactions are common to obtain stable 
complexes.  
 
Scheme 7: Supramolecular interactions used in host-guest systems
[113]
 
 
Receptor Substrate Complex 
Receptor Substrate Complex Receptor Substrate Complex 
Receptor Substrate Complex Receptor Substrate Complex 
Receptor Substrate Complex Hydrogen bonding 
Van der Waals 
Electrostatic 
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Self-assembly was first defined as the convergent process from which a 
supramolecular species forms spontaneously from its components.
[114]
 Then self-
assembly was redefined by the group of Steed in 2009 “as the spontaneous and 
reversible association of molecules or ions to form larger, more complex 
supramolecular entities according to the intrinsic information contained in the 
molecules themselves”.[9] But self-asembly is not only confined to supramolecular 
chemistry, it is ubiquitous throughout life. 
The first self-assembling macrocycle formed upon coordination chemistry was 
reported by the group of Maverick in 1984 (Figure 31).
[115]
 This work showed how 
simple self-assemblies can be formed when using metal coordinations. Soon after, 
another macrocycle was synthesized by the same group.
[116]
 
 
Figure 31: Self-assemblies synthesized by the group of Maverick 
 
Then Saalfrank’s tetrahedral iron-malonate assembly was published in 1993 
(Figure 32).
[117]
 Pyridyl ligands were used as skeletons for most of this study. For 
example, Lehn’s cylindrical box was based on copper (I) and coordination of 2,2’-
bipyridine.
[118]
 Fujita and Ogura’s square box was based on palladium (II) and 
coordination of 4,4’-bipyridine,[119] which can be extended into cubes. A 
supramolecular cube was formed through the combination of eight octahedral metal 
‘corners’ and twelve ligand ‘edges’ by the group of Thomas in 1998.[120] Thus, the 
brilliant value of self-assemblies was demonstrated for the formation of large complexes. 
 
Figure 32: Self-assemblies with different sizes and shapes
[121]
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Multiple hydrogen-bonding interactions have been demonstrated to be useful for 
the formation of closed self-assembled spherical molecules or capsules.
[122]
 Reversible 
dimerization was used for the formation of bowl-shaped molecules through the presence 
of hydrogen bonds. A relatively large bowl-shaped molecule was synthesized by the 
group of Rebek in 1996 (Figure 33).
[123]
 Glycoluril units were used to provide two 
donors and two acceptors groups for self-complementary structures. When three 
glycoluril units were attached to a triphenylene core, two molecules could be assembled 
by twelve hydrogen bonds, thus forming a large capsule (22). Some aromatic guests like 
cyclohexane were encapsulated in the cavity of this bowl-shaped capsule. 
 
Figure 33: Structure of a bowl-shaped assembly 22
[123]
 
 
Self-assembling capsules were defined by the group of Rebek in 1997 ‘‘as 
receptors with enclosed cavities that are formed by the reversible noncovalent 
interaction of two or more, not necessarily identical, subunits’’.[124] Utilizations of non-
covalent reversible interactions can offer opportunities for ‘catch-and-release’ of a guest 
to control drug delivery or reactivity.
[125]
 Therefore, a series of capsules was self-
assembled through hydrogen bonds. 
One common example is capsules formed by calixarenes. A self-assembling 
heterodimeric system was reported by the group of Reinhoudt (Figure 34). The 
tetrasubstituted calixarene with pyridyl groups and the other calixarene with carboxylic 
acid groups were combined through four hydrogen bonds.
[126]
 
+ 
22 
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Figure 34: Structure of calixarenes based capsule 
 
 Another example was the supramolecular capsule constructed by resorcinarene-
based cavitands functionalized with acetamido groups, which was reported by the group 
of Aakeroy in 2011 (Figure 35).
[127]
 In this case, chelating effects at the cavitands were 
created to avoid the formation of co-products from polymerization. Two c-pentyltetra(2-
acetamidopyridyl-5-ethynyl) cavitands were held together by three self-complementary 
NH∙∙∙O=C hydrogen bonds to give this capsule. In their investigation, three ethanol 
molecules, two methanol, and one toluene were trapped in the cavity of this capsule. 
 
Figure 35: Assembly of two cavitands and crystal structures of a resorcinarene-based capsule
[127]
 
 
1.3  Coordination chemistry 
1.3.1  Element ruthenium 
Ruthenium, derived from the latinised name of Russia, was discovered by Karl 
Karlovitch Klaus in 1844. It was the last ‘platinum metal’ to be discovered.[128] 
Ruthenium is a rare transition metal, it is only the 74th most abundant metal on Earth. 
and/or 2 
Discrete capsules Polymeric species 
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Ruthenium has the symbol Ru, molecular weight 101.07 g/mol,
[129]
 and atomic number 
44. It is in group 8 and period 5 in the periodic table with its electronic configuration 
[Kr] 4d
7
 5s
1
.
[130]
 Ruthenium has a wide range of oxidation states from -II {[Ru(CO)4]
2-
} 
to +VIII (RuO4).
[131]
 Principal oxidation states for ruthenium are +II and +III. 
Ruthenium (III) is the best-known oxidation state, and its complexes are generally 
octahedral {[Ru(H2O)6]
3+
} and distorted tetrahedral [Ru2(CH2SiMe3)6]. Ru(II) is the 
second most common oxidation state. It forms complexes with ligands based on group 
15 or 16 elements. Ru(II) complexes are normally octahedral {[Ru(bpy)3]
2+
}, pseudo-
tetrahedral [(arene)RuCl2(PPh3)] and trigonal bipyramidal [RuHCl(PPh3)3], apart from 
complexes like [RuCl2(PPh3)3], which are square pyramidal because of their 
stereochemically blocked coordination positions.
[132]
 Ruthenium containing complexes 
have potential applications in catalytic chemistry, biology and medicine. 
 
1.3.2  Mononuclear arene ruthenium complexes 
Mononuclear arene ruthenium complexes with a piano-stool structure are the 
most studied complexes in the large family of ruthenium (Figure 36), 
[133]
 they possess 
potential biological applications. In this type of complexes, the arene can be considered 
as the seat of the piano-stool and the other three ligands as the legs. Because arenes are 
able to occupy three coordination sites, the three remaining sites are available for 
different ligands.
[134]
 Because of their structural similarity, this type of complexes can 
also be called half-sandwich complexes. In such complexes, the arenes prevent 
oxidation from Ru(II) to Ru(III). Furthermore, arenes with extended ring systems can 
potentially interact with DNA.
[135]
 The other coordination sites can be used to introduce 
desired properties.
[133]
 Normally, ligands with N-, O-, S-, or P-donor groups are easily 
introduced, labilities of these ligands offer more possibilities in self-assemblies
[136]
 and 
catalytic processes.
[137]
 In particular, chelate ligands can increase the stability of the 
complexes and modulate the electronic properties of the metal center.
[138]
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Figure 36: Piano-stool and the typical structure of mononuclear arene ruthenium complexes 
 
The first arene ruthenium complex [(η6-mesitylene]2Ru](BPh4)2 was synthesized 
by Fischer and Böttcher in 1957 through a redox reaction from RuCl3 and Al.
[139]
 In 
1967, the synthesis of [(η6-C6H6)RuCl2]x was reported by Winkhaus and Singer. This 
polymeric complex was obtained from RuCl3∙nH2O (Scheme 8), the most common 
precursor in the synthesis of arene ruthenium complexes. [(η6-C6H6)RuCl2]x is a red 
powder, poorly defined chemically but very versatile synthesized.
[140-141]
 Subsequently, 
a dimeric structure was suggested by Zelonka and Baird.
[142]
 Soon after, a series of 
brown, diamagnetic complexes with the general formula [(η6-arene)RuCl2] were 
prepared through methanolic or ethanolic RuCl3 with the appropriate cyclohexa-1,3-
diene or cyclohexa-1,4-diene. The para-cymene complex was demonstrated by 
osmometry to be dimeric in chloroform.
[143]
 Eventually, Bennett confirmed the dimeric 
structure of [(η6-C6H6)Ru(μ-Cl)Cl]2 in 1974, where two Ru(II) are linked by two 
chloride bridges (Scheme 8).
[144]
 
 
Scheme 8: Synthesis and structure of benzene ruthenium complex 
 
Meanwhile the most common procedure to prepare standard dimeric arene 
ruthenium complexes with chloride bridges was found by the same group. The reaction 
between RuCl3∙nH2O and a cyclohexadiene derivative in EtOH/H2O can give different 
arene ruthenium complexes.
[144]
 Another procedure implies arene exchange, a method 
that can be used to synthesize ruthenium complexes with electronically rich arenes.
[145]
 
Starting from dinuclear arene ruthenium complexes, the electronically rich arenes can 
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replace the original arenes at high temperature to form the desired arene ruthenium 
dimers (Scheme 9). 
 
Scheme 9: Methods to synthesize chloro-bridged arene ruthenium complexes 
 
A wide range of half-sandwich piano-stool complexes was synthesized using 
dinuclear chloride-bridged arene ruthenium complexes [(η6-arene)Ru(μ-Cl)Cl]2 as the 
reactant (Scheme 10). Because of the easy cleavage of the chloride bridges, especially 
in coordinating solvents, solvated monomeric derivatives can be formed.
[146]
 
 
Scheme 10: Methods to synthesize half-sandwich piano-stool complexes 
 
The biological potential of arene ruthenium complexes has been extensively 
investigated by the groups of Dyson
[147]
 and Sadler.
[148-149]
 In their early studies, 
RAPTA-C and RM175 were considered as promising compounds for anticancer 
applications.
[149]
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The RAPTA family is characterized by their half-sandwich piano-stool structure 
(Figure 37). Their unique properties are obtained by the coordination of the 
monodentate PTA (1,3,5-triaza-7-phosphaadamantane) ligand. PTA is an hydrophilic 
ligand, thus water solubility can be increased.
[150]
 The first RAPTA complex was 
[Ru(cym)Cl2(PTA)] abbreviated as RAPTA-C.
[151]
 Although a poor anticancer activity 
was observed in vitro, an in vivo study showed promising antimetastatic activities.
[152]
 
The number and weight of solid lung metastases were reduced in mice bearing the MCa 
mammary carcinoma. Then several new RAPTA complexes were reported and 
investigated for anticancer activities in vitro.
[153]
 Further studies of RAPTA-C showed 
anti-tumor activities in human ovarian and colorectal carcinomas, where an inhibition of 
angiogenesis was observed.
[154-155]
  
 
Figure 37: Structures of RAPTA complexes 
 
 The half-sandwich arene ruthenium complexes, abbreviated as RM or HC, have 
been synthesized by the group of Sadler in 2001
[156]
 (Figure 38), and their biological 
properties investigated by the same group in 2002.
[157]
 This type of arene ruthenium 
complexes is bonded by a chelate diamine ligand and a labile ligand.
[158]
 RM175 and 
HC29 have both shown good activities in vitro in human ovarian cancer cells, which is 
comparable to carboplatin. In this family, the most active complex is HC11, which 
allows an activity comparable to cisplatin. During their investigations, the presence of a 
stable ligand (chelate), a more hydrophobic arene ligand (possibly to enhance cellular 
penetration) and a labile ligand, were identified as necessary components to design 
active anticancer complexes.
[157]
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Figure 38: Structures of arene ruthenium complexes with chelate diamine ligands 
 
1.3.3  Dinuclear arene ruthenium clips 
 Dinuclear arene ruthenium clips bridged by OO∩OO or ON∩NO have been 
widely used by our group to construct more complicated supramolecular structures, 
such as metalla-rectangles, metalla-prisms and metalla-cubes. Since the first OO∩OO 
clip and its arene ruthenium metalla-rectangle was synthesized by Süss-Fink in 1997 
(Scheme 11),
[159]
 our group developed metalla-cages via the strategy used in this paper. 
The activation of metalla-clips can be achieved by adding silver triflate, thus the 
chloride ligands are abstracted to form silver chloride, which is then removed by 
filtration. The dicationic intermediate with coordinations of solvent molecules can 
easily react with pyridyl-based ligands.
[160]
 One of the dicationic intermediates with 
coordinations of methanol has been isolated and characterized.
[161]
  
 
Scheme 11: Synthesis of arene ruthenium metalla-rectangle [(cym)4Ru4(C2O4)2(bpy)2](4CF3SO3) 
 
 The general synthetic method to prepare arene ruthenium clips uses chloride-
bridged arene ruthenium complex [(η6-arene)Ru(μ-Cl)Cl]2 as starting materials. The 
activation of this complex is performed by cleavage of two chloride bridges, and one 
equivalent of the desired quinone ligand can replace two chloride bridges (Scheme 12). 
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Quinones with a weak reactivity need the addition of sodium acetate to react. Another 
type of bridges is ON∩NO bridges, which can be synthesized with the same reactant 
and desired ON∩NO ligands in the presence of weak bases [diisopropylethylamine 
(DIPEA) or NEt3].  
 
Scheme 12: Method to synthesize arene ruthenium clips with OO∩OO or ON∩NO bridges 
 
 Another type of clips with two carboxylic acid bridges was synthesized by the 
group of Severin in 2010 (Scheme 13).
[162]
 Their synthesis is similar to ours with the 
same reactant and the presences of two equivalents of the desired carboxylic acid 
ligands and silver acetate. 
 
Scheme 13: Method to synthesize arene ruthenium clips with carboxylic acid bridges 
 
 Several OO∩OO bridged arene ruthenium clips have been used in our group[160], 
such as [Ru2(η
6
-arene)2(oxalato)Cl2],
[159]
 [Ru2(η
6
-arene)2(dhbq)Cl2] (dhbq: 2,5-
dihydroxy-1,4-benzoquinonato),
[163]
 [Ru2(η
6
-arene)2(dchq)Cl2] (dchq: 2,5-dichloro-1,4-
benzoquinonato),
[164]
 [Ru2(η
6
-arene)2(dhnq)Cl2] (dhnq: 5,8-dihydroxy-1,4-
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naphthoquinonato),
[165]
 [Ru2(η
6
-arene)2(dhaq)Cl2] (dhaq: 9,10-dihydroxy-1,4-
anthraquinonato),
[166]
 and [Ru2(η
6
-arene)2(dhtq)Cl2] (dhtq: 6,11-dihydroxynaphthacene-
5,12-dionato).
[167]
 To increase the size of the assembly and to encapsulate various ‘guest’ 
compounds, arene ruthenium clips possess different lengths (Figure 39). 
 
Figure 39: OO∩OO bridged dinuclear arene ruthenium clips 
 
 The ON∩NO derivatives show similar properties,[168] but offer more synthetic 
possibilities to insert functional groups. Some arene ruthenium cationic cages formed by 
these clips showed great selectivity for cancerous cells.
[169]
 Thus developments of this 
type of clips are necessary for biological optimization.
[169]
 Some ON∩NO arene 
ruthenium clips were synthesized by our group and others, such as [Ru2(cym)2(μ-L)Cl2] 
[H2L: diethyl-1,2-diazenedicarboxylate, N,N’-bis(2-hydroxyethyl)oxamide, N,N’-
bisethanediamide,
[169]
 dihexyloxalamide or dioctyloxalamide]
[170]
 (Figure 40). 
 
Figure 40: ON∩NO bridged dinuclear arene ruthenium clips 
 
3.7 Å 
5.5 Å 
7.9 Å 8.4 Å 
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 Dicarboxylate-bridged ruthenium clips opened a new domain for the synthesis of 
arene ruthenium cages (Figure 41). They can be used to synthesize neutral arene 
ruthenium cages and offer access to more complex molecular architectures.
[171]
 The 
dicarboxylate spacers were chosen owing to the lability of the carboxylate donor groups 
and their flexible coordination geometries.
[172]
 Furthermore, one of them prepared from 
3,6-dimethoxynaphtalene-2,7-dicarboxylic acid can reach a length of  10.9 Å and its 
metalla-prism can encapsulate two coronene molecules.
[162]
 
 
Figure 41: Dicarboxylate-bridged dinuclear arene ruthenium clips 
 
1.3.4  Multinuclear arene ruthenium complexes 
 From dinuclear arene ruthenium clips, different metalla-rectangles, metalla-
prisms and metalla-cubes can be synthesized through metal-ligand coordinations. 
Coordination-driven supramolecular complexes were principally pioneered by the 
groups of Fujita
[136]
 and Stang.
[173]
 The Pd(II) square complexes were quantitatively 
synthesized by the group of Fujita in 1990.
[119]
 The geometry of transition metal centers 
and the rigidity of electron-rich organic ligands are two important features to design this 
type of supramolecular metalla-cages.
[174]
 It took five years, to extend 2D 
supramolecular structures to 3D structures.
[175]
 These Pd(II) M6L4 octahedral 3D 
structures showed high solubility in water, strong bindings with ‘guest’ molecules 
through hydrophobic interactions, and large cavities,
[136]
 which inspired many groups, 
including ours. 
 The desired 2D and 3D supramolecular assemblies are obtained by combining 
the appropriate building blocks. Different pyridyl spacers, which were widely used by 
the groups of Fujita
[176]
 and Stang
[177-178]
 to form Pd(II) or Pt(II) metalla-assemblies, 
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were chosen by our group for the design of arene-ruthenium metalla-cages (Table 3). 
Pyridyl spacers play a crucial role to determine the geometry of the arene ruthenium 
metalla-assembly. For example, linear bipyridyl ligands have two coordination sites at a 
180° angle, thus arene ruthenium rectangles are formed by the combination of two 
bipyridyl ligands with two arene ruthenium clips. A wide range of multinuclear arene 
ruthenium cages was reported by our group.
[179]
 
Arene Ruthenium 
Clips 
Spacer ligands 
Metalla-cages 
Structures Angle 
 
      
 
 
 
180° 
 
Metalla-rectangle 
 
120° 
 
Metalla-prism 
 
90° 
Metalla-cube 
Table 3: Strategies for syntheses of metalla-cages from arene ruthenium clips with spacer 
ligands 
 
 A series of metalla-rectangles with the general formula [Ru4(η
6
-
arene)4(OO∩OO)2(N∩N)2](CF3SO3)4 (η
6
-arene = para-cymene, hmb; OO∩OO = dobq, 
dClobq; N∩N = pyrazine (pyr), 4-4’-bipyridine (bpy), 1,2-bis(4-pyridyl)ethylene (bpe)) 
was synthesized by our group.
[180]
 Their anticancer activities were tested against the 
A2780 ovarian cancer cell line. The metalla-rectangle 
Ru 
Ru 
Ru 
Ru 
Ru 
Ru 
Ru 
Ru 
Ru 
Ru 
Ru 
Ru 
Ru 
Ru 
Ru 
Ru 
Ru 
Ru 
Ru 
Ru 
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[Ru4(hmb)4(dobq)2(bpe)2](CF3SO3)4 showed the best activity (Figure 42). Importantly, 
these metalla-rectangles showed good selectivity towards tumor cells over normal cells. 
In addition, the formation mechanisms of such metalla-rectangles were also 
investigated.
[181]
 
 
Figure 42: Structure of metalla-rectangle [Ru4(hmb)4(dobq)2(bpe)2](CF3SO3)4 
 
 The first arene ruthenium metalla-prism synthesized by our group was the 
oxalato-bridged para-cymene ruthenium prism.
[182]
 Then the chloro-bridged para-
cymene ruthenium prism was synthesized.
[183]
 But no guest molecule could be 
encapsulated in these two prisms, because of a limited length between the two tpt panels. 
To overcome this limitation, the dobq-bridged para-cymene ruthenium prism was 
synthesized and showed good ability for encapsulations.
[184]
 A series of encapsulations 
was achieved,
[185]
 and the encapsulation was realized during the synthesis of the prism. 
 A ‘‘Trojan horse’’ strategy was suggested for cancer treatment, as non water 
soluble drugs were encapsulated in the hydrophobic cavity of the metalla-prisms for 
transport and release into cancer cells (Scheme 14).
[186]
 Metalla-prisms were isolated as 
trifluoromethanesulonate salts, thus presenting good solubility in water. 
[187-188]
  
In their biological tests, the cytotoxicity of the prism was increased after 
encapsulations of complexes [Pt(acac)2], [Pd(acac)2] or pyrenyl derivatives. And highly 
cytotoxic systems were obtained through changing functional groups at the edge of the 
pyrenyl compounds.
[189]
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Scheme 14: Synthesis of the dobq-bridged para-cymene ruthenium prism with encapsulations of 
pyrenyl derivatives or complexes 
 
Arene ruthenium metalla-cubes, larger than metalla-prisms, were synthesized to 
increase the size of the metalla-assemblies. The metalla-cube 
[Ru8(cym)(dhnq)4(tpvb)2](CF3SO3)8 (tpvb: 1,2,4,5-tetrakis[2-(4-pyridyl)vinylbenzene]) 
can be used to encapsulate porphin, a photosensitizer (Figure 43).
[190]
 This system 
showed hypochromism properties towards the photosensitizer inside the cavity. Thus 
the phototoxic effect can be hidden during encapsulation.
[191]
 
 
Figure 43: Encapsulated porphin in the cavity of metalla-cube 
[Ru8(cym)(dhnq)4(tpvb)2](CF3SO3)8 
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1.3.5  Cyclopentadienyl rhodium/iridium complexes 
 Rhodium and iridium are both rare elements, they are members of the ‘Platinum-
group metals’ with ruthenium, palladium, osmium and platinum, owing to their similar 
chemical and physical properties.
[192]
 Rhodium has the symbol Rh, molecular weight 
102.91 g/mol, and atomic number 45. It is in group 9 and period 5 of the periodic table 
with the electronic configuration [Kr] 4d
8
 5s
1
. Iridium has the symbol Ir, molecular 
weight 192.22 g/mol, and atomic number 77. It is also in group 9 but in the next period 
6 of the periodic table with the electronic configuration [Xe] 4f
14 
5d
7 
6s
2
. Rhodium and 
Iridium have a wide range of oxidation states from -III ([M(CO)3]
3-
) to +VI ([MF6]).
[132]
 
In my thesis, only complexes with Rh(III) and Ir(III) were synthesized. 
 The chemistry of cyclopentadienyl rhodium/iridium complexes is similar to that 
of arene ruthenium complexes.
[193]
 The most common cyclopentadienyl derivative is the 
1,2,3,4,5-pentamethylcyclopentadiene (Cp*) rhodium/iridium complexes. In these 
complexes, the rhodium and the iridium possess six coordination sites, three of them are 
occupied by the cyclopentadienyl derivative. The other three coordination sites can be 
coordinated by ligands of various properties.
[194]
 
 Like the synthesis of mononuclear arene ruthenium complexes, mononuclear 
cyclopentadienyl rhodium/iridium complexes are obtained from the dinuclear chloride-
bridged cyclopentadienyl rhodium/iridium complexes [(Cp*)M(μ-Cl)Cl]2 (M = Rh or Ir) 
(Scheme 15). As mentioned previously, the pentamethylcyclopentadienyl derivative 
was selected owing to its good stability. The dinuclear chloride-bridged 
pentamethylcyclopentadienyl rhodium/iridium complexes [(Cp*)M(μ-Cl)Cl]2 (M = Rh 
or Ir) are easy to prepare and give high yields and pure products.
[195]
  
 
Scheme 15: Synthesis of mononuclear pentamethylcyclopentadienyl rhodium/iridium 
complexes 
 
 Rhodium (III) and iridium (III) complexes have showed relatively inert 
anticancer activities, until a bioactive iridium (III) complex [(Cp*)Ir(ppy)Cl] (ppy: 2-
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phenylpyridine) was reported by the group of Sadler in 2011 (Figure 44).
[196]
 This 
complex with a C,N-bidentate ligand showed significant cytotoxicity towards A2780 
cell line, owing to its strong nucleobase binding ability and high hydrophobicity.
[197]
 
Later on, one iridium complex with a N,O-bidentate ligand (ketoiminate) was 
synthesized and showed activity comparable to cisplatin against HT-29 and MCF 7 cell 
lines. Another iridium (III) complex with an O,O-bidentate ligand (2-hydroxy-1,4-
napthoquinone) was synthesized by the group of McGowan. This complex showed 
more anticancer properties than that of the reactants.
[198]
 For mononuclear 
cyclopentadienyl rhodium complexes, the neutral complex [(Cp*)Rh(pmp)Cl] (pmp: 2-
[(propylimino)methyl]phenol) was synthesized by the group of Smith in 2013. It 
showed only moderate cytotoxicity.
[199]
 
 
Figure 44: Structures of pentamethylcyclopentadienyl iridium and rhodium complexes 
 
 Dinuclear cyclopentadienyl rhodium/iridium clips bridged by OO∩OO ligands 
have been used by our group to construct metalla-assemblies. Their preparations are 
similar to those of arene ruthenium complexes bridged by OO∩OO ligands. From 
[(Cp*)M(μ-Cl)Cl]2 (M = Rh or Ir), the corresponding OO∩OO ligands can be 
introduced to obtain rhodium/iridium clips (Scheme 16). The activation of 
rhodium/iridium clips can be achieved by adding silver triflate. The dicationic 
intermediate obtained can be used for the formation of metalla-cages. 
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Scheme 16: Synthesis of pentamethylcyclopentadienyl rhodium/iridium clips with OO∩OO 
bridges 
 
 Because of moderate anti-cancer activities of rhodium and iridium complexes, 
our group has tried to increase their antiproliferative activities by preparing a range of 
thiolato-bridged dinuclear pentamethylcyclopentadienyl rhodium/iridium complexes 
(Figure 45).
[194, 200]
 Both neutral thiolato-bridged rhodium/iridium complexes and 
cationic thiolato-bridged rhodium/iridium complexes showed good antiproliferative 
activities and cytotoxicity in the nanomolar range. The cytotoxicity of these complexes 
was strongly affected by the substituents connected to the thiolato-bridges. However, 
their poor selectivity was problematic. 
 
Figure 45: Structures of thiolato-bridged pentamethylcyclopentadienyl rhodium/iridium 
complexes 
 
 After the successful synthesis of arene ruthenium metalla-cages, 
cyclopentadienyl rhodium/iridium analogues were synthesized, and their 
antiproliferative activity evaluated. A series of rhodium/iridium metalla-rectangles was 
reported by our group in 2013 (Figure 46).
[201]
 They showed high cytotoxicity.  
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Figure 46: Structures of cyclopentadienyl rhodium/iridium metalla-rectangle 
 
 In 2014, rhodium/iridium metalla-prisms containing lipophilic side chains were 
synthesized (Figure 47).
[202]
 These cationic metalla-prisms showed excellent activities 
in vivo in tumor-induced C57L6/J mice, and also some selectivity. Furthermore, the Rh 
(III) metalla-prism showed higher potential than the Ir (III) metalla-prism for reducing 
tumors and inducing apoptosis in tumor cells. 
 
Figure 47: Structures of cyclopentadienyl rhodium/iridium metalla-prisms 
 
 Similarly, a series of metalla-cubes containing lipophilic side chains was 
synthesized to increase the size of metalla-cages (Figure 48).
[203]
 All metalla-cubes 
showed antiproliferative activities and IC50 values in the nanomolar range. The Rh (III) 
metalla-cube interacted with ctDNA and induced apoptosis in cancer cells. Thus, the Rh 
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(III) metalla-cube showed the strongest activity in comparison to the Ir (III) analogues 
and Ru (II) metalla-cubes. 
 
Figure 48: Structures of metalla-cubes with lipophilic side chains 
 
1.4  Aim of this thesis 
Hydrogen bonds are widely used in biological systems, thus being biocompatible. 
The diversity of hydrogen bonds can offer more possibilities for designing 
supramolecular complexes than only coordination chemistry. On the other hand, we 
have developed metalla-assemblies based on ruthenium (II), osmium (II), rhodium (III) 
and iridium (III) for nearly 15 years, and a large range of metalla-assemblies based on 
these four metals has been synthesized, characterized and evaluated as anticancer agents. 
Some of them possess promising potential to become anti-tumor drugs. 
The combination of hydrogen bonds and Ru(II), Rh(III) or Ir(III) metalla-
assemblies can open new directions. This combination was already tested by Dr. 
Appavoo-Gupta who associated arene ruthenium complexes with UPy dimers. Thus the 
aim of my thesis is to synthesize and analyze Ru(II), Rh(III) or Ir(III) metalla-
assemblies based on melamine/barbituric acid hydrogen-bonded rosette system, for the 
design of large complexes. The idea is to add pyridyl substituents on the rosette system 
to achieve metal-ligand coordinations. This work is divided in three parts: The first part 
consists of adding three mononuclear metal complexes at the periphery of hydrogen-
bonded rosette systems that are not only neutral but also cationic. The second part 
comprises the design and addition of different mononuclear metal complexes in similar 
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systems, while the last part shows our attempts to form double-decker rosette systems 
by addition of dinuclear metal complexes. 
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Chapter 2 
Coordination of piano-stool 
complexes to a hydrogen-bonded 
rosette-type assembly 
 
 
 
 
 
2.1  General introduction 
“Unity is strength” can be considered the motto of supramolecular chemistry. 
The multiplication of weak interactions allows complex structures to form and to 
remain stable in solution, despite the fragility of each individual interaction. Typical 
noncovalent interactions (< 20 kcal mol
–1
) include ionic, hydrophobic, hydrogen-bond, 
and metal-coordination.
[204-205]
 In nature, these interactions are crucial for biological 
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processes and essential for building up large molecules, such as DNA, enzymes, or 
proteins. Inspired by nature, chemists are using noncovalent interactions to generate 
structural complexity and to develop chemical systems.
[206-209]
 
In recent years, coordination-driven self-assembly has been exploited to prepare 
esthetical and functional complex structures.
[177, 210-212]
 Those including arene ruthenium 
units have shown great promises,
[160-161, 213-214]
 especially for biological applications.
[134, 
215-216]
 Until recently, these arene ruthenium metalla-assemblies were held together by 
covalent and multiple metal-coordination bonds.
[160-161, 213-214]
 However, last year our 
group inserted quadruple self-complementary hydrogen-bonding motifs to generate a 
new type of arene ruthenium metallacycle.
[72-73]
 Yet, this self-complementary approach 
was somehow limiting in terms of structural diversity, and therefore, the use of hetero 
hydrogen-bond-pairing systems can, in principle, offer more possibilities.  
Among non-self-complementary hydrogen-bonding motifs, melamine∙cyanuric 
acid/barbituric acid pairing is one of the most studied triple-hydrogen-bonding 
systems.
[10, 98, 217-218]
 As demonstrated by Whitesides, controlled formation of rosette-
type assemblies over tapelike structures can be achieved by steric constraints.
[76]
 Indeed, 
it was shown that the combination of the crowded N,N’-bis(4-tert-
butylphenyl)melamine (ME) with 5,5-diethylbarbituric acid (BA) formed an 
(ME)3·(BA)3 rosette-type structure exclusively (Figure 49), an arrangement that was 
confirmed by single-crystal X-ray diffraction structure analysis.
[76]
 This elegant strategy 
allows synthetic modifications on both the melamine and the barbituric acid units.
[90-92]
 
 
Figure 49 : Rosette-type structure developed by Whitesides using N,N’-bis(4-tert 
butylphenyl)melamine and 5,5-diethylbarbituric acid 
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 In our search to develop new strategies to synthesize supramolecular arene 
ruthenium assemblies, we have introduced a pyridyl coordination site to a barbituric 
acid unit, with a view to obtaining metal-coordinated rosette-type systems. Arene 
ruthenium complexes, as well as the pentamethylcyclopentadienyl iridium/rhodium 
analogues, have been coordinated to the new rosette. These assemblies are either neutral 
or ionic, depending on the nature of the piano-stool complex used. This simple strategy 
opens up new perspectives in the field of coordination driven self-assembly of piano-
stool complexes, and to the development of complex structures. 
 
2.2  Synthesis 
2.2.1  Synthesis of rosette-type ligands 
In this section, two building blocks were used to prepare the (ME)3∙(BApy)3 
rosettes [ME: N,N’-bis(4-tert-butylphenyl)melamine; BApy: 5-butyl-5-(pyridine-4-
ylmethyl)pyrimidine-2,4,6-trione]. The synthesis of these ligands can be divided in 
three parts. The first part was the formation of BApy which was obtained in two 
synthetic steps, starting from diethyl 2-butylmalonate and 4-(chloromethyl)pyridine. 
Then the ME derivative was also obtained in two synthetic steps, starting from 4-(tert-
butyl)aniline and cyanuric chloride. The final part was the formation of the 
(ME)3∙(BApy)3 rosette starting from melamine (ME) and the barbituric acid derivative 
containing a pyridyl group (BApy) (Scheme 17).  
The synthesis of (ME)3∙(BApy)3 was performed in chloroform to facilitate 
hydrogen-bonding interactions. To prepare the hydrogen-bonded rosettes-type assembly, 
another important factor is the concentration of reactants. Concentrations of ME and 
BApy need to be higher than 4 mM, otherwise assembly/disassembly of the rosette-type 
complex might occur.
[80]
 
Initially, N,N’-bis(4-methylphenyl)melamine was used to make a rosette, but this 
derivative was not soluble in chloroform, even in the presence of BApy. When we tried 
with N,N’-bis(4-tert-butylphenyl)melamine, the two reactants were almost insoluble in 
chloroform. But the rosette was well soluble in chloroform. Therefore, the solubility of 
the reactants needs to be considered for the design of rosette-type assemblies. 
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Scheme 17: Synthesis of the rosette-type assembly (ME)3∙(BApy)3 
 
2.2.2  Synthesis of neutral trinuclear hydrogen-bonded 
metalla-assemblies 
The three pyridyl groups at the periphery of (ME)3∙(BApy)3 can be used to 
coordinate metal centers. Addition of 1.5 equivalent of [Ru(cym)Cl2]2 (cym: para-
cymene), [Rh(Cp*)Cl2]2 or [Ir(Cp*)Cl2]2 (Cp*: pentamethylcyclopentadienyl) to a 
solution of (ME)3∙(BApy)3 in chloroform afforded the corresponding metal-containing 
rosettes (ME)3∙(BApyRu)3, (ME)3∙(BApyRh)3 or (ME)3∙(BApyIr)3 [Ru: Ru(cym)Cl2, Rh: 
Rh(Cp*)Cl2, Ir: Ir(Cp*)Cl2]. An excellent yield, around 90 %, was obtained for this 
reaction (Scheme 18). 
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Scheme 18: Synthesis of neutral trinuclear hydrogen-bonded rosettes  
 
 Coordination of the BApy unit to the metal centers can also be performed prior 
to the rosette formation. Indeed, the reaction of [Ru(cym)Cl2]2 or [Rh(Cp*)Cl2]2 with 
BApy afforded the mononuclear complexes BApyRu or BApyRh, respectively. We first 
used methanol as solvent, but the product showed impurities. Thus, a solvent effect 
cannot be ignored in this step. Then addition of ME to the solution of BApyRu or 
BApyRh in chloroform afforded the corresponding metal-containing rosettes 
(ME)3∙(BApyRu)3 or (ME)3∙(BApyRh)3 also in excellent yields (Scheme 19). This 
method consumes more energy in comparison with the previous method, thus being 
preferable. 
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Scheme 19: Synthesis of neutral trinuclear hydrogen-bonded metalla-assemblies 
(ME)3∙(BApyM)3 from BApyRu or BApyRh and ME  
 
2.2.3  Synthesis of cationic trinuclear hydrogen-bonded 
metalla-assemblies 
Coordination of triphenylphosphine to the metal centers affords the half-
sandwich complexes [Ru(cym)Cl2(PPh3)], [Rh(Cp*)Cl2(PPh3)] and [Ir(Cp*)Cl2(PPh3)] 
respectively (PPh3: triphenylphosphine). Addition of silver triflate affords the 
intermediate complexes [Ru(cym)(PPh3)(Sol)Cl](CF3SO3), 
[Rh(Cp*)(PPh3)(Sol)Cl](CF3SO3), and [Ir(Cp*)(PPh3)(Sol)Cl](CF3SO3), which is 
accompanied by precipitation of silver chloride (Scheme 20).  
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Scheme 20: Synthesis of triflate derivatives 
 
These cationic mononuclear complexes can also react with the (ME)3∙(BApy)3 
rosette to generate the cationic trinuclear assemblies 
{(ME)3∙[(BApy)Ru(cym)(PPh3)Cl]3}
3+
, {(ME)3∙[(BApy)Rh(Cp*)(PPh3)Cl]3}
3+ 
and 
{(ME)3∙[(BApy)Ir(Cp*)(PPh3)Cl]3}
3+
 respectively (Scheme 21). 
 
Scheme 21: Synthesis of cationic trinuclear hydrogen-bonded metalla-assemblies.  
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2.3  Characterizations 
2.3.1  Proton and carbon NMR spectroscopy 
 All synthesized rosettes were fully characterized by NMR spectroscopy. By 
comparing spectra of ME and BApy with the (ME)3∙(BApy)3 rosette (Figure 50), the 
most evident signal is at 14.0 ppm which is the NH signals of the BApy units 
confirming the formation of rosette-type assemblies. This NH signals are shifted by ca. 
2.4 ppm, while for the ME units, the signals are shifted by ca. 2.5 ppm (NH) and ca. 1.9 
ppm (NH2), respectively. On the other hand, the protons of the butyl, pyridyl, and tert-
butylphenyl groups are almost unaffected, being all located at the periphery of the 
rosette. 
 
Figure 50: 
1
H NMR spectra of BA, (ME)3∙(BApy)3, and ME, with an emphasis on the chemical 
shifts of the different NH protons (CDCl3, 25 °C) 
  
The coordination of the pyridyl group to the metal centers only slightly 
influences the 
1
H NMR chemical shift of the pyridyl protons (Figure 51). The most 
important shift is observed for the signals of the Hα protons of the pyridyl group (0.4 
CHCl
3
 
ppm 5 6 7 8 9 10 11 12 13 14 15 
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ppm). Similarly, the most affected carbon atoms as indicated by the 
13
C NMR signals of 
the BApyRu and BApyRh complexes are those adjacent to the nitrogen atom of the 
pyridyl groups (Figure 52). Other proton and carbon signals are almost unaffected or 
only slightly shifted. 
 
Figure 51: 
1
H NMR spectra of BApyRu, (ME)3∙(BApyRu)3 and (ME)3∙(BApy)3 (CDCl3, 25 °C) 
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Figure 52: 
13
C NMR spectra of BApyRu, (ME)3∙(BApyRu)3 and (ME)3∙(BApy)3 (CDCl3, 25 °C) 
 
 For the 
1
H NMR spectra of cationic trinuclear hydrogen-bonded metalla-
assemblies, as in the neutral metalla-assemblies, a chemical shift is observed for the 
pyridyl protons and the protons involved in the hydrogen-bonding network. However, 
additional multiplets can be seen at 7.3 ppm, which corresponds to the protons of the 
triphenylphosphine ligand. Moreover, the chirality at the metal centers is confirmed in 
{(ME)3∙[(BApy)Ru(cym)(PPh3)Cl]3}∙(3CF3SO3) by the occurrence of four doublets for 
the aromatic protons of the para-cymene ligand (Figure 53), while in the two other 
systems some signals tend to broaden.  
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Figure 53: 
1
H para-cymene signals of {(ME)3∙[(BApy)Ru(cym)(PPh3)Cl]3}∙(3CF3SO3) (CDCl3, 
25 °C) 
 
Theoretically, the presence of three stereogenic centers should give rise to eight 
isomers. However, upon formation of the rosette, the (S,R,R), (R,S,R), and (R,R,S) 
isomers  are identical to their enantiomers (R,S,S), (S,R,S), and (S,S,R), thus only four 
isomers are obtained (Figure 54). In addition, due to the lability of the chloride, 
inversion of the chirality at the arene ruthenium centers is fast in solution,
[219]
 thus 
limiting the resolution of the diastereotopic signals. 
 
 
 
 
 
 
5.0 5.2 5.4 5.6 5.8 6.0 6.2 ppm 
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                            (R,R,R)                                                       (S,S,S) 
 
                            (R,R,S)                                                       (S,S,R) 
Figure 54: The four isomers of {(ME)3∙[(BApy)Ru(cym)(PPh3)Cl]3}∙(3CF3SO3) 
 
The presence of the PPh3 ligand can also be confirmed by the 
31
P NMR spectra. 
Typical signals, 37.4 ppm for Ph3P-Ru and 8.8 ppm for Ph3P-Ir, are observed. A doublet 
at 33.6 ppm is observed for the rhodium derivative due to Rh-P coupling (
1
JRh-P = 142 
Hz) (Figure 55). 
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Figure 55: 
31
P signals of the cationic trinuclear hydrogen-bonded metalla-assemblies (CDCl3, 
25 °C) 
 
2.3.2  DOSY NMR spectroscopy 
 DOSY (diffusion ordered spectroscopy) NMR experiment was designed by 
Morris and Johnson in 1992.
[220]
 This NMR technique is a 2D-NMR experiment that 
detects the diffusion coefficients of species in solution. This method can be used to 
provide a global view of particle sizes and detect impurities in samples. It can also be 
used to separate different proton signals in a mixture through different diffusion 
coefficients of different molecules. The principle is similar to that of chromatograms, 
and it also provides NMR informations to analyze each individual molecule in a 
mixture.
[221]
  
 After DOSY measurements, diffusion coefficients can be extracted, which give 
the hydrodynamic radius of the molecule. The diffusion coefficient depends on physical 
parameters, like the size and shape of molecules, the temperature, and the viscosity of 
the solvent. It can be determined from the Stokes-Einstein equation. 
𝐷 =
KT
6πηr
 
D: Diffusion Coefficient (m
2
 s
-1
) 
K: Boltzmann Constant (1.38064852*10
-23
 m
2
 kg s
-2
 k
-1
) 
T: Absolute temperature (k) 
η: Viscosity (kg m-1 s-1) 
r: Radius hydrodynamic (m) 
35 40 32 34 10 5 
Ph3P-Ru Ph3P-Rh Ph3P-Ir 
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 All molecules and rosettes were analyzed by DOSY NMR to confirm the 
formation of rosette-type metalla-assemblies. The DOSY NMR experiments were 
performed in chloroform at room temperature. The results are listed in Table 4, and the 
hydrodynamic radius were calculated to estimate the size of the compounds. 
Name Diffusion 
coefficient 
[log(m
2
/s)] 
Diffusion 
coefficient 
(m
2
/s) 
Hydrodynamic 
radius (m) 
BApy -9.02 9.55 × 10
-10
 4.18 × 10
-10
 
ME -9.08 8.32 × 10
-10
 4.80 × 10
-10
 
BApyRu -9.31 4.90 × 10
-10
 8.15 × 10
-10
 
BApyRh -9.27 5.37 × 10
-10
 7.44 × 10
-10
 
(ME)3∙(BApy)3 -9.45 3.55 × 10
-10
 1.13 × 10
-9
 
(ME)3∙(BApyRu)3 -9.49 3.24 × 10
-10
 1.23 × 10
-9
 
(ME)3∙(BApyRh)3 -9.46 3.47 × 10
-10
 1.15 × 10
-9
 
(ME)3∙(BApyIr)3 -9.49 3.24 × 10
-10
 1.23 × 10
-9
 
{(ME)3∙[(BApy)Ru(cym)(PPh3)
Cl]3}∙(3CF3SO3) 
-9.52 3.02 × 10
-10
 1.32 × 10
-9
 
{(ME)3∙[(BApy)Rh(Cp*)(PPh3)
Cl]3}∙(3CF3SO3) 
-9.48 3.31 × 10
-10
 1.21 × 10
-9
 
{(ME)3∙[(BApy)Ir(Cp*)(PPh3)
Cl]3}∙(3CF3SO3) 
-9.50 3.16 × 10
-10
 1.26 × 10
-9
 
Table 4: Diffusion coefficients and hydrodynamic radius for molecules synthesized 
 
 Comparison of the DOSY NMR data show clear differences between 
(ME)3∙(BApy)3 and BApy or ME. The radius value of (ME)3∙(BApy)3 is 1.13 × 10
-9
 m, 
while BApy and ME possess radius values of 4.18 × 10
-10
 m and 4.80 × 10
-10
 m, 
respectively. All the neutral rosette-type metalla-assemblies show radius values 
[(ME)3∙(BApyRu)3: 1.23 × 10
-9 
m; (ME)3∙(BApyRh)3: 1.15 × 10
-9 
m; (ME)3∙(BApyIr)3: 
1.23 × 10
-9
 m] slightly higher than that of (ME)3∙(BApy)3 (1.13 × 10
-9 
m). Additionally, 
radius values of (ME)3∙(BApyRu)3 and (ME)3∙(BApyRh)3 are higher than those of 
individual BApyRu (8.15 × 10
-10
 m) or BApyRh (7.44 × 10
-10 
m). For all cationic 
rosette-type metalla-assemblies, radius values are between 1.21 × 10
-9
 m and 1.32 × 10
-9
 
m, thus being similar to those observed for the neutral rosette-type metalla-assemblies 
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and slightly higher than that of (ME)3∙(BApy)3. In summary, all the DOSY NMR results 
confirm the formation of rosette-type metalla-assemblies. 
 Moreover, all compounds show single diffusion coefficient in their DOSY NMR 
spectra, indicating the formation of single species without impurities. The superimposed 
spectra of BApy, ME, BApyRu, (ME)3∙(BApy)3, (ME)3∙(BApyRu)3 and 
{(ME)3∙[(BApy)Ru(cym)(PPh3)Cl]3}∙(3CF3SO3) are shown in Figure 56. 
 
Figure 56: DOSY NMR superimposed spectra (CDCl3, 25 °C) of BApy, ME, BApyRu, 
(ME)3∙(BApy)3, (ME)3∙(BApyRu)3 and {(ME)3∙[(BApy)Ru(cym)(PPh3)Cl]3}∙(3CF3SO3) 
 
2.3.3  IR spectroscopy 
 In the IR spectra of rosette-type assemblies, the band associated with the NH 
stretching vibration of the barbituric acid and melamine moieties is broadened and 
shifted by about 200 cm
-1
. This important redshift correlates with the lengthening of the 
NH bonds.
[10]
 Thus, the formation of the (ME)3∙(BApy)3 rosette structure was also 
confirmed by IR spectroscopy. 
 After the coordination of metals, the infrared absorptions of the rosette-type 
complexes are only slightly shifted. Additionally, the infrared absorptions of the 
trifluoromethanesulfonate anions are observed at 1248 cm
-1
 for 
{(ME)3∙[(BApy)Ru(cym)(PPh3)Cl]3}∙(3CF3SO3), 1245 cm
-1
 for 
{(ME)3∙[(BApy)Rh(Cp*)(PPh3)Cl]3}∙(3CF3SO3) and 1245 cm
-1
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{(ME)3∙[(BApy)Ir(Cp*)(PPh3)Cl]3}∙(3CF3SO3), that also confirm the presence of 
cationic complexes. 
 
2.3.4  UV spectroscopy 
 Rosette-type assemblies were studied by UV-visible spectroscopy; the spectra 
were obtained in chloroform at 1.0 × 10
-5
 M concentrations in the range 200 nm to 800 
nm. In the spectrum of rosette-type ligand (ME)3∙(BApy)3, a high energy absorption 
band is observed at 271 nm, which may be attributed to ligand π,π* transitions.[222] This 
band is also observed in other rosette-type metalla-assemblies, the bands are however 
slightly shifted for (ME)3∙(BApyRu)3 (272 nm), (ME)3∙(BApyRh)3 (270 nm), 
(ME)3∙(BApyIr)3 (273 nm), {(ME)3∙[(BApy)Ru(cym)(PPh3)Cl]3}∙(3CF3SO3) (270 nm), 
{(ME)3∙[(BApy)Rh(Cp*)(PPh3)Cl]3}∙(3CF3SO3) (268 nm) and 
{(ME)3∙[(BApy)Ir(Cp*)(PPh3)Cl]3}∙(3CF3SO3) (270 nm). The intensities of these bands 
are in the range from 1.16 × 10
5
 M
-1
 cm
-1
 to 1.39 × 10
5
 M
-1
 cm
-1
, being almost identical 
(Figure 57).  
 
Figure 57: UV spectra of rosette-type metalla-assemblies synthesized in comparison with the 
rosette-type ligand (ME)
3
∙(BApy)
3 
(CHCl3, 25 °C) 
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 The UV-vis spectra of mononuclear complexes BApyRu and BApyRh were 
performed in chloroform at 5 × 10
-5
 M in the range 200 nm to 800 nm. The high energy 
absorption band observed at 241 nm is attributed to ligand-localized transition. The 
broad low-energy band observed at 411 nm for BApyRu and 406 nm for BApyRh, may 
be associated to metal-to-ligand charge transfer (MLCT) transitions. They possess 
moderate intensities, 8.57 × 10
2
 M
-1
 cm
-1
 for BApyRu and 2.38 × 10
3
 M
-1
 cm
-1 
for 
BApyRh. Similar absorption bands are observed in the visible region at 434 nm for 
(ME)3∙(BApyRu)3 and at 408 nm for (ME)3∙(BApyRh)3. Another absorption band is 
observed at 297 nm for BApyRu, which may be assigned to intra-ligand charge transfer 
(ILCT) transitions (Figure 58). 
       
Figure 58: UV spectra of rosette-type assemblies (ME)3∙(BApyRu)3 and (ME)3∙(BApyRh)3 in 
comparison with mononuclear complexes BApyRu and BApyRh (CHCl3, 25 °C) 
 
Furthermore, a broad moderately intense band at 371 nm for 
{(ME)3∙[(BApy)Ir(Cp*)(PPh3)Cl]3}∙(3CF3SO3) is assigned to mixed metal-to-ligand 
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charge transfer (MLCT), intra-ligand charge transfer (ILCT) and the [dσ*, π*] transition 
due to metal-metal interactions (Figure 57).
[223]
 
 
2.3.5  RX spectroscopy 
The coordination of the pyridyl nitrogen atom to the metal centers was also 
confirmed by single crystal X-ray diffraction structure analysis of the complex BApyRh 
(Figure 59). This mononuclear complex crystallized in the centrosymmetric space group 
P21/c with two independent molecules per unit cell. The two molecules are almost 
identical, showing similar parametrical data, which are typical for pyridyl-Rh(Cp*)Cl2 
complexes.
[224-225]
 Despite having high rotational freedom, the barbituric ring points in 
the direction of the pentamethylcyclopentadienyl moiety, thus creating a relatively 
compact environment between the complex and the BA ligand. In the crystal packing, 
only weak interactions can be observed between neighboring molecules, mainly 
involving the two chloride ions with, however, no meaningful hydrogen bonds. 
 
Figure 59: ORTEP representation of BApyRh at 50 % probability level ellipsoids. Selected 
bond lengths [Å] and angles [°]: Rh1-N1 2.109(6), Rh1-Cl1 2.400(2), Rh1-Cl3 2.425(2), Rh1-
centroid 1.755; Cl1-Rh1-N1 87.94 (14), Cl3-Rh1-N1 89.89(17), C3-C6-C7 115.0(6) 
 
2.3.6  Mass spectroscopy 
 The mass spectrum of BApy was performed under electrospray ionization in 
positive and negative modes. The highest signal is observed at m/z = 276.1 or 274.0 
corresponding to [M + H]
+
 or [M – H]-.  The mass spectra of BApyRu and BApyRh 
were performed by electrospray ionization in positive mode. The parent peak is 
observed at m/z = 546.1 corresponding to [M – Cl]+ for BApyRu, and at m/z = 548.1 
corresponding to [M – Cl]+ for BApyRh. 
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 All attempts to obtain the mass spetra of the intact rosette or metal-containing 
rosettes were unsuccessful (ESI, MALDI-TOF), even after applying the Ag
+
 labeling 
technique, which has shown great results with analogous rosettes.
[226-227]
 
 
2.4  Conclusion 
Rosette-type assemblies mixing covalent, coordination, hydrogen-bonding, and 
ionic interactions have been synthesized and characterized. Coordination of metal 
centers at the periphery of the rosette was performed either prior to or after the 
formation of the hydrogen-bonded assembly, thus providing synthetic flexibility. 
Neutral and ionic systems were obtained, depending on the nature of the metal complex 
used. Overall, we have demonstrated that such supramolecular systems are easy to 
prepare, and functionality can be added to design complex structures. 
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Chapter 3 
Using a hydrogen-bonded rosette-
type scaffold to generate 
heteronuclear metalla-assemblies 
 
 
 
 
 
3.1  General introduction 
In the first part of the thesis (Chapter II), we used a pyridyl-containing barbituric 
acid derivative, 5-butyl-5-(pyridin-4-ylmethyl)pyrimidine-2,4,6-trione (BApy),
[228]
 in 
combination with N,N’-bis(4-tertbutylphenyl) melamine (ME),[76] to generate a 
(ME)3∙(BApy)3 rosette structure with three coordination sites at the periphery of the 
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hexameric rosette.
[228]
 Arene ruthenium and cyclopentadienyl rhodium/iridium piano-
stool complexes were coordinated to the rosette, giving rise to neutral and cationic 
trinuclear systems (Figure 60). 
 
Figure 60: Molecular structures of neutral (left) and ionic (right) hexameric rosettes 
incorporating three piano-stool complexes 
 
With the view of increasing the nuclearity of these systems and generating 
heteronuclear rosette-type assemblies, a pyridyl group has now been introduced to the 
melamine unit, thus providing six coordination sites to the (MEpy)3∙(BApy)3 rosette. 
Coordination of piano-stool complexes on the MEpy and BApy units, prior to the 
formation of the rosette, allows controlled formation of the desired heteronuclear 
system. These hexameric hexanuclear metalla-assemblies show good stability in 
solution, as demonstrated by various NMR spectroscopic experiments. 
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3.2  Synthesis 
3.2.1  Synthesis of rosette-type ligands 
In this section, two building blocks were used to prepare the (MEpy)3∙(BApy)3 
rosettes N-(4-tert-butylphenyl)-N’-(pyridine-4-ylmethyl)melamine (MEpy) and 5-butyl-
5-(pyridine-4-ylmethyl)pyrimidine-2,4,6-trione (BApy). Then MEpy unit was obtained 
in three synthetic steps, starting from 4-(tert-butyl)aniline and cyanuric chloride, 
following the procedure published by the group of Li.
[93]
 (MEpy)3∙(BApy)3 is obtained 
by mixing equivalent amount of MEpy and BApy. The reaction is straightforward and 
fast, as for the preparation of (ME)3∙(BApy)3 (chloroform, 25 °C for 30 min). The 
apolar and aprotic solvent chloroform is necessary, and the concentrations of MEpy and 
BApy need to be higher than 4 mM, otherwise no rosette structure is obtained (Scheme 
22).
[80]
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Scheme 22: Synthesis of rosette-type assembly (MEpy)3∙(BApy)3 
 
3.2.2  Synthesis of trinuclear hydrogen-bonded metalla-
assemblies 
First of all, coordination of the MEpy unit to the metal centers was realized by 
adding 0.5 equivalent of [Ru(cym)Cl2]2 or [Rh(Cp*)Cl2]2 to a solution of MEpy in 
tetrahydrofuran. The corresponding mononuclear piano-stool complexes MEpyRu and 
MEpyRh were obtained after stirring the mixture at 25 °C for 16 h (Scheme 23). The 
synthetic route follows the same principle as that of complexes BApyRu and BApyRh. 
Chapter 3 Using a hydrogen-bonded rosette-type scaffold to generate heteronuclear metalla-
assemblies 
 
77 
 
Scheme 23: Synthesis of mononuclear piano-stool complexes MEpyRu and MEpyRh 
 
As previously shown,
[228]
 trinuclear systems can be prepared by mixing a metal-
containing unit with the corresponding metal-free component. Here, equimolar amounts 
of MEpyRu or MEpyRh and BApy reacted in chloroform at 25 °C for 30 min, giving 
rise to the corresponding trinuclear rosettes: (MEpyRu)3∙(BApy)3 and 
(MEpyRh)3∙(BApy)3. Similarly, mixtures of BApyRu or BApyRh and MEpy generate 
the trinuclear rosettes (MEpy)3∙(BApyRu)3 and (MEpy)3∙(BApyRh)3 respectively 
(Scheme 24). 
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Scheme 24: Syntheses of trinuclear hydrogen-bonded rosettes  
 
3.2.3  Synthesis of hexanuclear hydrogen-bonded metalla-
assemblies 
Two methods were used to synthesize the hexanuclear hydrogen-bonded 
metalla-assembly (MEpyRu)3∙(BApyRu)3. The addition of three equivalents of 
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[Ru(cym)Cl2]2 in chloroform to the rosette-type ligand (MEpy)3∙(BApy)3 afforded the 
desired hexanuclear complex (MEpyRu)3∙(BApyRu)3. The other method involves 
mixing the MEpyRu and BApyRu in chloroform, and stirring at 25 °C for 30 min 
(Scheme 25). 
 
Scheme 25: Synthesis of the metalla-assembly (MEpyRu)3∙(BApyRu)3 (Paths A and B) 
 
From the trinuclear systems, (MEpy)3∙(BApyRu)3, (MEpyRu)3∙(BApy)3, 
(MEpy)3∙(BApyRh)3 and (MEpyRh)3∙(BApy)3, hexameric hexanuclear assemblies can 
be obtained by addition of 1.5 equivalent of [Ru(cym)Cl2]2 or [Rh(Cp*)Cl2]2 (Path A, 
Scheme 26). The same hexanuclear rosette-type metalla-assemblies can also be 
prepared by mixing in chloroform equimolar amounts of the mononuclear piano-stool 
complexes MEpyM and BApyM' (Path B, Scheme 26). Both strategies provide the 
desired hexanuclear rosette (MEpyRu)3∙(BApyRh)3 and (MEpyRh)3∙(BApyRu)3 in 
excellent yield (ca. 90 %). 
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Scheme 26: Syntheses of metalla-assemblies (MEpyRu)3∙(BApyRh)3 and 
(MEpyRh)3∙(BApyRu)3 (Paths A and B) 
 
3.3  Characterizations 
3.3.1  Proton and carbon NMR spectroscopy 
 All rosettes were fully characterized by NMR spectroscopy. As mentioned in the 
second chapter, the most evident signal is at about 14.0 ppm. This signal, which is the 
NH protons of the BApy units, was observed for all the rosette-type metalla-assemblies. 
By comparing spectra of BApyRu and MEpyRh with that of the (MEpyRh)3∙(BApyRu)3 
rosette, the NH signal of BApy is shifted by ca. 5.3 ppm, while for the ME units, the 
signals are shifted by ca. 0.7 ppm (NHCar), ca. 1.7 ppm (NHCH2) and 0.7 ppm (NH2) 
respectively (Figure 61). The broadening of the signals can be attributed to the presence 
of isomers. These isomers cannot be identified due to the complexity of the system. 
Other protons are relatively unaffected. All datas support the formation of the 
hexameric heteronuclear structures. 
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Figure 61: 
1
H NMR spectra of BApyRu, (MEpyRh)3∙(BApyRu)3, MEpyRh, with an emphasis 
on the chemical shifts of the different NH protons (CDCl3, 25 °C) 
  
By comparing spectra of (MEpyRh)3∙(BApyRu)3, (MEpyRh)3∙(BApy)3 and 
(MEpy)3∙(BApyRu)3 with that of (MEpy)3∙(BApy)3, the proton of NH∙∙∙N is shifted by 
about 0.6 ppm after coordination to metals. Other protons are almost unaffected (Figure 
62). Additionally, the signals for the protons of the pyridyl groups have changed from 
one singlet to two singlets after the coordination. 
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Figure 62: 
1
H NMR spectra of (MEpyRh)3∙(BApyRu)3, (MEpyRh)3∙(BApy)3, 
(MEpy)3∙(BApyRu)3 and (MEpy)3∙(BApy)3 (CDCl3, 25 °C) 
 
Temperature dependence spectra were measured to determine the stability of the 
rosette-type metalla-assemblies (Figure 63). The assemblies were stable at room 
temperature in chloroform. To ensure a wide range of temperatures, 1,1,2,2-
tetrachloroethane-d2 was chosen as deuterated solvent. The temperature varied from 
20 °C to 120 °C. After increasing the temperature, the O∙∙∙H-N and NH2∙∙∙O protons are 
downfield shifted, suggesting disassembly of the rosette structure. 
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Figure 63: Temperature dependence spectra of (MEpy)3∙(BApyRu)3 from 4.0 ppm to 10.5 ppm 
(Cl2CDCDCl2). 
  
The same observation was made for the NH∙∙∙N proton. This proton is downfield 
shifted, when the temperature increases. Interestingly, the signal of the NH protons at 
14.3 ppm remains visible up to 70 °C. However, a significant chemical shift is observed 
around 50 °C, showing the limit of the stability of the rosette. The superimposed spectra 
and the different chemical shifts are presented in Figure 64.  
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Figure 64: Temperature dependence spectra of (MEpy)3∙(BApyRu)3 from 9.0 ppm to 15.0 ppm 
(Cl2CDCDCl2) 
 
 The temperature-dependence experiment provides thermodynamic data on the 
system.
[229-230]
 An equilibrium constant of 4400 s
-1
 is associated to the assembly-
disassembly process, which corresponds to a chemical stability for the supramolecular 
rosette structure of approximately 13.5 kJ. This value is in agreement with those found 
by Timmerman, de Jong et al. for analogous (ME)3∙(BA)3 rosettes.
[85]
 
 Calculations of the equilibrium constant and chemical stability by Dynamic 
NMR have been performed. The coalescence temperature and frequency difference 
were obtained from Figure 64, while the equilibrium constant was calculated by the 
equation
[229]
: 
k = πΔν/21/2 ≈ 2.22Δν 
k: Equilibrium constant (s
-1
) 
π: 3.1415926 
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Δν: Frequency difference (Hz) 
Then free energy of activation was calculated by the equation
[231]
: 
ΔG≠ = ΔH≠ - TΔS≠ = -RT ln 
𝑘 ℎ
𝐾 𝑇
 = 1.987 T (23.760 + ln (T/k)) 
ΔG≠: Free energies of activation (J) 
R: Gas constant (8.3144598 J mol
-1
 K
-1
) 
T: Temperature (K) 
h: Planck’s constant (6.626070040 × 10-34 J s) 
K: Boltzmann constant (1.38064852 × 10
-23
 m
2
 kg s
-2
 K
-1
) 
k: Equilibrium constant (s
-1
) 
 The solution stability of piano-stool complexes is crucial for various 
applications.
[133-134, 215-216]
 It is well known that chloro ligands of piano-stool complexes 
are easily exchanged by water (aquation) or by other coordinating solvent 
molecules.
[232-234]
 Moreover, even monodentate pyridyl-based ligands can be removed 
from the coordination sphere and replaced by dmso molecules.
[235]
 Therefore, the 
stability in solution of the mononuclear pyridyl-based complexes and of the rosettes was 
evaluated.  
The mononuclear pyridyl-based complexes are stable in solution for weeks as 
demonstrated by 
1
H NMR experiments. Similarly, when the hexanuclear rosettes, 
(MEpyRu)3∙(BApyRh)3 and (MEpyRh)3∙(BApyRu)3, are left in chloroform-d1 for a long 
period of time (up to two weeks), all signals remain intact (chemical shift and 
integration), and no additional signals are observed. Thus, a good solution stability of 
the mononuclear complexes and of the rosettes was demonstrated (Figure 65). 
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Figure 65: Evolution of the 
1
H NMR spectra of (MEpyRh)3∙(BApyRu)3 over a period of 12 days 
(CDCl3, 25 °C) 
 
3.3.2  DOSY NMR spectroscopy 
 All synthesized molecules were analyzed by DOSY NMR to confirm the 
formation of the rosette-type metalla-assemblies. The DOSY NMR experiments were 
performed in chloroform at room temperature. All results are listed in Table 5, and the 
calculated hydrodynamic radius provide an estimation of the size of the molecules. 
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Name 
Diffusion 
coefficient 
[log(m
2
/s)] 
Diffusion 
coefficient 
(m
2
/s) 
Hydrodynamic 
radius (m) 
MEpy -9.10 7.94 × 10
-10
 5.03 × 10
-10
 
MEpyRu -9.30 5.01 × 10
-10
 7.98 × 10
-10
 
MEpyRh -9.14 7.24 × 10
-10
 5.52 × 10
-10
 
(MEpy)3∙(BApy)3 -9.40 3.98 × 10
-10
 1.00 × 10
-9
 
(MEpy)3 ∙(BApyRu)3 -9.41 3.89 × 10
-10
 1.03 × 10
-9
 
(MEpyRu)3∙(BApy)3 -9.53 2.95 × 10
-10
 1.35 × 10
-9
 
(MEpy)3 ∙(BApyRh)3 -9.41 3.89 × 10
-10
 1.03 × 10
-9
 
(MEpyRh)3∙(BApy)3 -9.43 3.72 × 10
-10
 1.07 × 10
-9
 
(MEpyRu)3∙(BApyRu)3 -9.48 3.31 × 10
-10
 1.21 × 10
-9
 
(MEpyRu)3∙(BApyRh)3 -9.53 2.95 × 10
-10
 1.35 × 10
-9
 
(MEpyRh)3∙(BApyRu)3 -9.45 3.55 × 10
-10
 1.13 × 10
-9
 
Table 5: Diffusion coefficients and hydrodynamic radius 
 
Comparison of the DOSY NMR data of (MEpy)3∙(BApy)3 and BApy or MEpy 
shows differences. The radius value of (MEpy)3∙(BApy)3 is 1.00 × 10
-9
 m, while BApy 
and MEpy possess radius values of 4.18 × 10
-10
 m and 5.03 × 10
-10 
m, respectively. Like 
(ME)3∙(BApy)3, the diffusion coefficient of these trinuclear systems are about 4 × 10
-1
 
m
2
 s
-1
, which correspond to a hydrodynamic radius of more than 10 Å.  
As deduced by DOSY NMR spectroscopy, the average hydrodynamic radius of 
the hexameric hexanuclear rosettes is 12.4 Å, which is slightly larger than those found 
for the trinuclear species (MEpy)3∙(BApyRu)3, (MEpyRu)3∙(BApy)3, 
(MEpy)3∙(BApyRh)3 and (MEpyRh)3∙(BApy)3 (Chapter II).  
Moreover, all compounds have shown single diffusion coefficient in their DOSY 
spectra, indicating the formation of single species. The superimposed spectra of MEpy, 
MEpyRh, (MEpy)3∙(BApy)3, (MEpy)3∙(BApyRu)3 and (MEpyRh)3∙(BApyRu)3 are 
shown in Figure 66. 
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Figure 66: Superimposed DOSY NMR spectra (CDCl3, 25 °C) of compounds MEpy, MEpyRh, 
(MEpy)3∙(BApy)3, (MEpy)3∙(BApyRu)3 and (MEpyRh)3∙(BApyRu)3 
 
3.3.3  NOESY NMR spectroscopy 
In the NOESY NMR spectrum of (MEpy)3∙(BApyRu)3, cross peaks between the 
protons of the NH groups of BApyRu and the protons of the NH2 and NH groups of 
MEpy are observed (Figure 67). Thus, the presence of hydrogen-bond interactions 
between the MEpy and BApy units is confirmed. 
 
Figure 67: NOESY NMR spectrum of (MEpy)3∙(BApyRu)3, showing the NH hydrogen-bond 
cross peaks (CDCl3, 25 °C) 
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3.3.4  IR spectroscopy 
 Upon formation of six triple ME-BA hydrogen-bonds (NH∙∙∙O, N∙∙∙HN, NH∙∙∙O), 
the stretching vibrations of NH broadened and shifted by almost 200 cm
-1
 in the infrared 
spectra, as compare with pure MEpy and BApy. Similar absorption bands are also 
observed in the trinuclear complexes and rosette-type ligand. After the coordination of 
metals, the infrared spectra of the rosette-type complexes are almost identical. 
 
3.3.5  UV spectroscopy 
 The rosette-type assemblies were studied by UV-visible spectroscopy. The 
spectra were recorded in chloroform at 1.0 × 10
-5
 M concentrations in the range 200 nm 
to 800 nm. The spectrum of the rosette-type ligand (MEpy)3∙(BApy)3 shows a high 
energy absorption band at 265 nm, which may be attributed to ligand π,π* 
transitions,
[222]
 and the value is close to that of rosette-type ligand (ME)3∙(BApy)3. This 
band is also observed in the rosette-type metalla-assemblies, (MEpy)3∙(BApyRu)3 (267 
nm) and (MEpyRu)3∙(BApy)3 (267 nm). The intensities of these bands are in the range 
8.00 × 10
4
 M
-1
 cm
-1
 to 1.02 × 10
5
 M
-1
 cm
-1
 (Figure 68). 
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Figure 68: UV spectra of rosette-type metalla-assemblies synthesized in comparison with the 
rosette-type ligand (MEpy)
3
∙(BApy)
3 
(CHCl3, 25 °C) 
  
Moreover, the UV-vis spectra of mononuclear complexes MEpyRu and 
MEpyRh were performed in chloroform at 5 × 10
-5
 M in the range 200 nm to 800 nm. A 
high energy absorption band is observed at 267 nm for MEpyRu and 265 nm for 
MEpyRh, which may be attributed to ligand-localized transition. The broad low-energy 
band observed at 422 nm for MEpyRu and 407 nm for MEpyRh, is associated to metal-
to-ligand charge transfer (MLCT) transitions. They are of moderate intensity, 7.48 × 10
2
 
M
-1
 cm
-1
 for MEpyRu and 2.78 × 10
3
 M
-1
 cm
-1 
for MEpyRh (Figure 69). 
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Figure 69: UV spectra of rosette-type assemblies (MEpyRu)3∙(BApy)3, (MEpyRh)3∙(BApy)3, 
(MEpyRu)3∙(BApyRu)3, (MEpyRu)3∙(BApyRh)3, (MEpyRh)3∙(BApyRu)3 in comparison with 
mononuclear complexes MEpyRu and MEpyRh (CHCl3, 25 °C) 
 
3.3.6  Mass spectroscopy 
The mass spectra of MEpyRu and MEpyRh were performed by using 
electrospray ionization in a positive mode. The parent peak is observed at m/z = 620.1 
corresponding to [M – Cl]+ for MEpyRu, and at m/z = 622.1 corresponding to [M – Cl]+ 
for MEpyRh. As often encountered in such neutral dichloro piano-stool complexes,
[73, 
236-238]
 a peak corresponding to the cationic [M – Cl]+ species is observed in their ESI 
mass spectrum (positive mode). 
The electrospray ionization mass spectra (ESI-MS) of the hexameric 
hexanuclear rosettes show, in both cases, a parent peak at m/z = 580.9, together with 
other metal-containing fragments of lower intensities. This main peak corresponds to 
the trichloro-bridged dinuclear complex [Rh2(Cp*)2(μ-Cl)3]
+
, a cationic trichloro-
bridged dinuclear complex that is often produced upon decomposition of piano-stool 
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complexes.
[239]
 The decomposition occurs during the ionization process, as the 
1
H NMR 
spectra of the rosettes in chloroform-d1 suggest high stability in solution. 
 
3.4  Conclusion 
In conclusion, two heterohexanuclear and four homotrinuclear rosette-type 
assemblies have been prepared and characterized. The combination of pyridyl-
functionalized melamine and barbituric acid derivatives allows a controlled synthesis of 
the designed heteronuclear systems. The rosette-type assemblies are stable in solution at 
room temperature, showing an equilibrium constant of 4400 s
-1
 and a stability constant 
of approximately 13.5 kJ in 1,1,2,2-tetrachloroethane-d2. In the future, we would like to 
insert additional complexity to such supramolecular assemblies, and expand, in a 
controlled manner, the system to the third dimension. 
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Chapter 4 
Coordination of dinuclear 
complexes to a hydrogen-bonded 
rosette-type assembly 
 
 
 
 
 
4.1  General introduction 
Supramolecular interactions are powerful tools to design complicated complexes 
such as rosette-type assemblies.
[204, 206]
 Rosette-type assemblies can be designed by 
directional multi-hydrogen-bonded systems
[10, 80-81, 84]
 and the metal ligand coordination 
can be used to modify their properties. Only limited examples have been reported in the 
area of rosette-type metalla-assemblies,
[90-93]
 thus it is still an emerging area. Arene 
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ruthenium and cyclopentadienyl rhodium/iridium complexes show great biological 
potential in medical applications.
[133, 186, 191, 201-202, 240-243]
 Thus, addition of piano-stool 
complexes can offer new perspectives in the area of rosette-type metalla-assemblies. 
Pyridyl groups were successfully added at either the barbituric acid part or the 
melamine part.
[244]
 As previously seen, two different substituents can be inserted on the 
melamine unit. However, two identical substituents can also be added on melamine. 
Thus, the modifications of the melamine units can offer new opportunities to develop 
rosette-type metalla-assemblies. For example, additional groups with π-π stacking 
interactions were introduced by Yagai, providing π-conjugated rosette-type assemblies 
with stimuli-responsive properties.
[95-98]
 
The π-π stacking interactions can play a key role for the controlled formation of 
metalla-assemblies. This concept was widely used for the formation of metalla-
rectangles,
[180-181]
 metalla-prisms
[184, 190]
 and metalla-cubes.
[189, 191]
 Indeed, two pyridyl 
groups showing π-π stacking interactions were added at the periphery of the melamine 
unit. Then addition of metalla-clips with long chains can modify the solubility of the 
rosettes.
[202, 245]
 Accordingly, a series of cationic hexanuclear rosette-type metalla-
assemblies were synthesize and characterized. 
 
4.2  Synthesis 
4.2.1  Synthesis of the bis-functionalized melamine ligand 
The synthesis of the bis-functionalized melamine ligand can be divided in three 
steps. The first step was the formation of N,N’-bis(4-iodophenyl)melamine which was 
obtained in two synthetic steps, starting from 4-iodoaniline and cyanuric chloride. In 
parallel, 3-ethynyl-5-methoxypyridine was prepared in two synthetic steps, starting 
from 3-bromo-5-methoxypyridine and ethynyltrimethylsilane (Scheme 27). 
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Scheme 27: Syntheses of two reactants N,N’-bis(4-iodophenyl)melamine (top) and 3-ethynyl-5-
methoxypyridine (bottom) 
 
 Then the formation of the new melamine ligand was achieved by combining the 
two previously mentioned products. This final step was performed by a Sonogashira 
coupling in the presence of PdCl2(PPh3)2 catalyst and CuI co-catalyst (Scheme 28).
[98]
  
 
Scheme 28: Synthesis of the melamine ligand MEbispy 
 
To prepare the bis-functionalized ligand, the first reaction was performed 
between 4-ethynylpyridine and N,N’-bis(4-iodophenyl)melamine (Scheme 29). But, the 
desired product was not obtained because of the poor solubility of 4-ethynylpyridine in 
the selected solvent. Then, the 3-ethynyl-5-methoxypyridine was used to modify the 
solubility and to give the desired melamine product (MEbispy). 
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Scheme 29: Synthesis of the melamine ligand MEbispy 
 
4.2.2  Synthesis of dinuclear melamine-type metalla-
assemblies 
Dinuclear melamine-type metalla-assemblies can be obtained starting from the 
dinuclear metalla-clips and MEbispy, as the distance between the two N-pyridyl 
coordinating sites in MEbispy is optimal for bis-coordination. Two dinuclear metalla-
clips (oxalamide clip and benzoquinone clip) were used based on the length of the 
metalla-clips. A solvent mixture (methanol/tetrahydrofuran) was used to ensure that 
both reactants were soluble. After removal of silver chloride, addition of MEbispy gave 
the desired dinuclear melamine-type unit in excellent yields (> 86 %) (Scheme 30). 
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Scheme 30: Syntheses of cationic dinuclear melamine-type units 
 
4.2.3  Synthesis of cationic hexanuclear hydrogen-bonded 
metalla-assemblies 
The cationic hexanuclear metalla-assembly (MEbispyRu2L
C
)3∙(BA)3 [Ru2: 
Ru2(cym)2, H2L
C
: 2,5-dihydroxy-3-icosyl-2,5-diene-1,4-dione] was prepared by mixing 
in chloroform equimolar amounts of the dinuclear melamine-type unit (MEbispyRu2L
C
) 
and 5,5-diethylbarbituric acid (BA). The reaction mixture was stirred at 25 °C for 48 h. 
The expected rosette (MEbispyRu2L
C
)3∙(BA)3 was obtained in high yield (80 %). 
Then the same method was used to prepare other cationic hexanuclear metalla-
assemblies. Unfortunately, the rosette assemblies were not obtained because of the poor 
solubility of the melamine-type unit. Thus, a different mixture of solvents 
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(chloroform/dichloromethane) was used. Indeed, different metalla-assemblies have been 
synthesized by varying the reaction conditions. These cationic hexanuclear metalla-
assemblies are all obtained in excellent yields (> 86 %) (Scheme 31). 
 
Scheme 31: Syntheses of cationic hexanuclear hydrogen-bonded metalla-assemblies 
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4.3  Characterizations 
4.3.1  Proton and carbon NMR spectroscopy 
The new cationic rosettes were fully characterized by NMR spectroscopy. Due 
to the poor solubility of the rosettes, dichloromethane-d2 was used, which do not allow a 
clear detection of the typical N-H signal (around 14.0 ppm) of the hydrogen-bonded 
systems. This characteristic signal was only observed for (MEbispyRu2L
C
)3∙(BA)3 and 
(MEbispyIr2L
C
)3∙(BA)3, and in both cases as broad signals. To solve this problem, a 
1
H 
NMR spectrum at low temperature was performed. The selected temperature was based 
on published results, saying that the characteristic signal of rosette structures are only 
present in the -60 °C to -30 °C range.
[91]
 Indeed, a sharp signal was observed at 14.2 
ppm for (MEbispyRu2L
C
)3∙(BA)3 at -30 °C. The signals of hydrogen bonds are slightly 
upfield shifted, when the temperature decreases (Figure 70). The same phenomenon is 
observed for the temperature dependence spectra of the trinuclear metalla-assembly 
(MEpy)3∙(BApyRu)3 (Chapter III). 
 
Figure 70: Temperature dependence spectra of (MEbispyRu2L
C
)3∙(BA)3 from 5.0 ppm to 15.0 
ppm (CD2Cl2) 
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 By comparing spectra of BA and MEbispyRu2L
C
 with the 
(MEbispyRu2L
C
)3∙(BA)3 rosette, the NH signal of the BA units is shifted by 5.6 ppm, 
while for the MEbispy units the signals are shifted by 1.3 ppm (NHCar) and 1.0 ppm 
(NH2). These results are quite similar to those observed in the previous chapters. Other 
protons remain unaffected (Figure 71). All these informations support the formation of 
the cationic hexanuclear hydrogen-bonded metalla-assemblies. 
 
Figure 71: 1H NMR spectra of BA, (MEbispyRu2L
C
)3∙(BA)3, MEbispyRu2L
C
, with an emphasis 
on the chemical shifts of the different NH protons (CD2Cl2, 25 °C) 
 
The formation of (MEbispy)3∙(BA)3 was also confirmed by 
1
H NMR in 
chloroform-d1, in which the signal of the NH protons of the BA units was observed at 
13.5 ppm. Because of the poor solubility of (MEbispyRu2L
C
)3∙(BA)3 in chloroform-d1, 
the superimposition of the spectra was done in dichloromethane-d2. The coordination of 
metalla-clips can be confirmed by the additional signals of the para-cymene ligands at 
5.9 ppm and 5.7 ppm. Important chemical shifts are observed for the signals of the 
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pyridyl protons. One of the signal of the pyridyl groups is upfield shifted, and two other 
signals are downfield shifted (Figure 72). 
 
Figure 72: 1H NMR spectra of (MEbispyRu2L
C
)3∙(BA)3 and (MEbispy)3∙(BA)3 (CD2Cl2, 25 °C) 
 
4.3.2  DOSY NMR spectroscopy 
As suggested in the third chapter, the assembly/disassembly process will occur 
in chloroform, if the temperature is higher than 50 °C. The cationic hexanuclear 
metalla-assemblies cannot be solubilized in chloroform, thus all the NMR spectra were 
performed in dichloromethane-d2. Unfortunately, the disassembly occurred at room 
temperature in dichloromethane-d2. As shown in the 
1
H NMR spectra of the rosettes, 
only broad signals were observed at room temperature. The same conclusion was made 
from the DOSY NMR experiments, as the proton signals of the rosette-type metalla-
assemblies were not on the same line in the DOSY NMR spectra, confirming the 
presence of two species. 
To solve this problem, a DOSY NMR spectrum was performed at -30 °C in 
dichloromethane-d2 for (MEbispyRu2L
C
)3∙(BA)3. At low temperature, all proton signals 
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were observed on the same line (Figure 73). The large signals observed are due to the 
difficulties of maintaining the temperature at exactly -30 °C during the measurement. 
The diffusion coefficient obtained is 1.38 × 10
-10
 m
2
 s
-1
, and the calculated 
hydrodynamic radius is 1.92 × 10
-9
 m. The radius of the cationic rosette-type metalla-
assembly (MEbispyRu2L
C
)3∙(BA)3 is higher than that of the neutral hexanuclear rosette-
type metalla-assemblies. However, these results suggest the formation of the rosette. 
 
Figure 73: DOSY spectrum (CD2Cl2, -30 °C) of (MEbispyRu2L
C
)3∙(BA)3 
 
4.3.3  IR spectroscopy 
All products were analyzed by IR spectroscopy. In the IR spectra of the rosettes, 
a significant band associated with the NH stretching vibration of BA and MEbispy is 
shifted and broadened by about 200 cm
-1
. This important redshift correlates with the 
lengthening of the NH bonds.
[10]
 Thus, the formations of the rosette-type metalla-
assemblies was also confirmed by IR spectroscopy. 
Bands associated to the presence of the trifluoromethanesulfonate anions are 
observed at 1223 cm
-1
 to 1255 cm
-1
. These typical peaks suggest the presence of 
cationic complexes and support the formation of melamine-type metalla-assemblies and 
rosette-type metalla-assemblies. 
 
4.3.4  UV spectroscopy 
Rosette-type assemblies were studied by UV-visible spectroscopy. All spectra 
were measured in dichloromethane at 1.0 × 10
-5
 M concentrations in the range 200 nm 
to 800 nm. The spectrum of the rosette-type ligand (MEbispy)3∙(BA)3 shows two energy 
absorption bands at 230 nm and 323 nm, which may be attributed to ligand π,π* 
transitions.
[222]
 These bands are also observed in the rosette-type metalla-assemblies, the 
 -9 
 -10 
Log (m
2
/s) 
ppm 6 8 4 2 
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bands being however slightly shifted. The intensities of these bands varied from 1.51 × 
10
5
 M
-1
 cm
-1
 to 2.32 × 10
5
 M
-1
 cm
-1 
for the band at 230 nm, while the intensities of the 
band around 323 nm varied from 1.57 × 10
5
 M
-1
 cm
-1
 to 1.91 × 10
5
 M
-1
 cm
-1
 (Figure 74). 
 
Figure 74: UV spectra of rosette-type metalla-assemblies synthesized in comparison with the 
rosette-type ligand (MEbispy)3∙(BA)3 (CHCl3, 25 °C) 
 
These bands around 230 nm and 323 nm are also observed for the melamine-
type metalla-assemblies. Thus, these two bands may be attributed to ligand π,π* 
transitions of the melamine parts. The intensities of these bands in the rosette-type 
metalla-assemblies are three times higher than those of the melamine-type complexes. 
This is in agreement with a three times higher concentration of the melamine-type 
complex in the corresponding rosette. 
An additional band observed in the visible region at 496 nm for 
(MEbispyRu2L
C
)3∙(BA)3, at 422 nm for (MEbispyRh2L
C
)3∙(BA)3 and at 451 nm for 
(MEbispyIr2L
C
)3∙(BA)3 is attributed to metal-to-ligand charge transfer (MLCT) 
transitions (Figure 75). Similar absorption bands are also observed for the 
corresponding melamine-type metalla-assemblies, but with less intensity. 
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Figure 75: UV spectra of melamine-type metalla-assemblies synthesized in comparison with 
rosette-type metalla-assemblies synthesized (CHCl3, 25 °C) 
 
4.3.5  Mass spectroscopy 
The mass spectra of [Rh2(Cp*)2(L
C
)Cl2] and [Ir2(Cp*)2(L
C
)Cl2] were measured 
by electrospray ionization technique in a positive mode. The parent peak is observed at 
m/z = 929.2 and 1109.2, which correspond to [M – Cl]+ cations, as often encountered in 
such dinuclear metalla-clips.
[202, 245]
 
The mass spectrum of N,N’-bis{4-[(5-methoxypyridin-3-
yl)ethynyl]phenyl}melamine (MEbispy) was also performed in positive mode, showing 
a parent peak at m/z = 541.1 corresponding to the [MEbispy + H]
+
 cation. 
The reaction between the melamine unit and the dinuclear clip can in principle 
give [1 + 1] or [2 + 2] metalla-assemblies (Figure 76). Thus, to confirm the structure of 
the melamine-type metalla-assemblies, electrospray ionization mass spectra were 
performed (positive mode). Two signals were observed for each melamine-type metalla-
assemblies, at m/z = 1579.0 corresponding to [M – CF3SO3]
+
 and at m/z = 715.2 
corresponding to [M – 2 CF3SO3]
2+
 for MEbispyRu2L
C
, m/z = 1582.9 and m/z = 717.3 
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for MEbispyRh2L
C
, m/z = 1760.9 and m/z = 807.3 for MEbispyIr2L
C
, m/z = 1415.0 and 
m/z = 633.4 for MEbispyRu2L
A
, and m/z = 1470.0 and m/z = 660.8 for MEbispyRu2L
B
. 
 
 
Figure 76: [1 + 1] and [2 + 2] melamine-derived metalla-assemblies 
 
 The isotopic patterns of these two signals have been compared to those of the 
calculated patterns for [1 + 1] and [2 + 2] metalla-assemblies. The results show that the 
measured spectra match perfectly with the [1 + 1] calculated patterns, but they are 
different in comparison with the [2 + 2] metalla-assemblies. The values of the mass 
being the same but the patterns being different. For example, the superimposed spectra 
of MEbispyRu2L
C
 are shown in Figure 77. The measured pattern of the signal at m/z = 
715.2 (top) matches perfectly with the calculated pattern for [M – 2 CF3SO3]
2+
 of the [1 
+ 1] metalla-assemblies (bottom). But the measured pattern of the signal at m/z = 1579.0 
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(top) does not match with the calculated pattern for [M – 2 CF3SO3]
2+
 of the [2 + 2] 
metalla-assemblies (bottom). 
 
 
Figure 77: Measured isotopic patterns and calculated isotopic patterns for the metalla-assembly 
MEbispyRu2L
C
 
 
4.3.6  Concentration effects 
A concentration dependence experiment was performed to study the stability of 
the rosette-type assembly. This study followed the method published by Whitesides.
[80]
 
This experiment was performed on the (MEbispy)3∙(BApy)3 rosette. The chemical shifts 
of the melamine NH protons were measured in chloroform-d1 at different concentrations. 
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The results are shown in Figure 78 and the corresponding data listed in Table 6. The 
melamine (MEbispy) alone shows a chemical shift of the NH proton at 8.0 ppm. When 
the concentrations of the two rosette components reach 2.5 mM, the formation of the 
rosette-type structure increases rapidly, until it reaches a plateau at 20 mM. When the 
concentration is higher than 20 mM, the rosette-type structure is stable. These results 
are similar to those observed by Whitesides with the (ME)3∙(BA)3 rosette.  
 
Figure 78: Concentration dependence curve 
Concentration 
(mM) 
MEbispy 0.5 0.5 1.5 2.5 3.5 4 6 
BApy 0 0.5 1.5 2.5 3.5 4 6 
Chemical shift of O∙∙∙H-N 
(ppm) 
8.04 8.15 8.67 9.20 9.25 9.26 9.30 
Concentration 
(mM) 
MEbispy 8 10 20 30 40 60 80 
BApy 8 10 20 30 40 60 80 
Chemical shift of O∙∙∙H-N 
(ppm) 
9.32 9.36 9.41 9.43 9.43 9.43 9.43 
Table 6: Concentration dependence data of the O∙∙∙HN proton chemical shifts 
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4.4  Conclusion 
Two pyridyl groups have been inserted on the melamine unit, thus generating 
additional π-π stacking interactions within the rosette-type metalla-assemblies. 
Coordination of metalla-clips to the melamine units was performed showing [1 + 1] 
addition of metalla-clips, which was confirmed by mass spectroscopy. Five rosette-type 
metalla-assemblies with different metalla-clips were synthesized and characterized. The 
cationic hexanuclear metalla-assemblies were not stable in dichloromethane at room 
temperature, thus NMR spectra at low temperature was performed to establish their 
structures. In the following work, the solubility of the rosette-type metalla-assemblies in 
water needs to be adjusted to evaluate possible biological applications. 
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Chapter 5 
Conclusions and perspectives 
 
 
 
 
 
5.1  Conclusions 
The combination of hydrogen bonds and metal coordinations to design 
supramolecular assemblies remains unexplored. The objective of my thesis was to 
exploit hydrogen-bonded systems to form in combination with piano-stool complexes, 
2D and 3D metalla-assemblies. To achieve these goals, a rosette-type scaffold was used, 
more specifically the melamine barbituric acid pairing system. Overall, the thesis can be 
divided in three parts, with a general strategy, which is described in Scheme 32. 
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Scheme 32: General strategy for the formation of rosette-type metalla-assemblies 
 
In the first section, the possibility of coordinating piano-stool complexes to a 
hydrogen-bonded rosette-type assembly was confirmed through the formation of 
trinuclear rosette-type metalla-assemblies. Neutral and cationic trinuclear rosette-type 
metalla-assemblies were synthesized and characterized. Two different methods were 
used to obtain the neutral trinuclear rosette-type metalla-assemblies. In the first method, 
after formation of the rosette, the coordination to the pyridyl groups was performed. In 
the second method, the coordination of the metal centers was done prior to the rosette 
formation. 
In the second part of my thesis, neutral hexanuclear rosette-type metalla-
assemblies incorporating homo- and hetero-metallic units have been synthesized and 
characterized. BA and ME ligands offer great flexibility to connect different metals. 
Thus, heteronuclear metalla-assemblies were generated with success, and they have 
showed good stability in chloroform. 
Finally, cationic hexanuclear metalla-assemblies were synthesized and 
characterized, using dinuclear piano-stool complexes. This strategy has allowed the 
insertion of three metalla-clips at the periphery of the rosette, thus generating large 
rosette-type metalla-assemblies. 
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5.2  Perspectives 
Different supramolecular interactions were introduced in the same rosette-type 
metalla-assembly. Hydrogen bonds are crucial for the formation of rosettes, while π-π 
stacking, electrostatic, metal-ligand and other weak interactions can be used to add 
functionality to these supramolecular systems. In the future work, more supramolecular 
interactions can be used in the rosette-type systems to increase complexity and diversity. 
A series of cationic hexanuclear metalla-assemblies based on metalla-clips has 
been synthesized (Chapter IV). But the stability of these cationic hexanuclear metalla-
assemblies in dichloromethane at room temperature became a challenge for their 
characterization. Thus, their stability needs to be modified in the future. Moreover, 
addition of nine metallic centers can be an idea: Both mononuclear piano-stool 
complexes or dinuclear metalla-clips can be added at the periphery of the rosettes for 
the formation of nona-nuclear rosette-type metalla-assemblies. Three types of nona-
nuclear rosette-type metalla-assemblies can be prepared: A metalla-assembly with nine 
identical piano-stool complexes, a metalla-assembly with six identical piano-stool 
complexes at the melamine part and three other piano-stool complexes on the barbituric 
acid part and finally, a metalla-assembly with three metalla-clips at the melamine part 
and three piano-stool complexes on the barbituric acid part (Figure 79). 
 
Figure 79 : Three types of nona-nuclear rosette-type metalla-assemblies 
 
The synthesis of double-decker rosette systems may be a target in the future. 
Several arene ruthenium metalla-cages have been synthesized by our group. They were 
used for the encapsulation of planar aromatic molecules, and these molecular-cages can 
be used to transport unsoluble molecules to cells. If metalla-cages based on hydrogen 
bonds are obtained, they can be used to encapsulate non-planar molecules, actually most 
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of pharmaceutical drugs are non-planar. Hydrogen-bonded metalla-cages can in 
principle be more biocompatible than coordination-driven metalla-cages, and they can 
be pH-dependent, thus seeking more medical applications. Two strategies can be 
considered for the formation of hydrogen-bonded metalla-cages (Scheme 33): The 
formation of a rosette structure, followed by the addition of metalla-clips (Route A, 
Scheme 33); or by mixing melamine-based dinuclear clips with barbituric acid (Route B, 
Scheme 33). Additionally, the limit of solubility of the rosette assemblies, their stability 
and their selectivity need to be considered for the design of hydrogen-bonded metalla-
cages. 
 
Scheme 33: Two general strategies for the formation of hydrogen-bonded metalla-cages 
 
All attempts to obtain the mass spectra of rosette-type metalla-assemblies were 
unsuccessful (Chapter II). Thus, vapor pressure osmometry (VPO) can be applied in the 
future to determine the molecular weight of rosettes. This method was already used by 
researchers to determine the molecular weight of rosette-type assemblies.
[246],[80]
 
Moreover, atomic force microscopy (AFM) can also be used to determine the three-
dimensional surface profile of the rosette-type metalla-assemblies, thus potentially 
excluding the formation of the other structures, the linear and crinkled tapes.
[98]
 
 
Route A 
Route B 
Chapter 6 Experimental 
113 
 
 
 
Chapter 6 
Experimental 
 
 
 
 
 
6.1  General remarks 
All solvents were dried before use following standard procedures and all 
reactions were manipulated under an inert atmosphere. 3-Ethynyl-5-
methoxypyridine,
[247]
 N,N’-bis(4-iodophenyl)melamine,[82] N,N’-bis(4-tert-
butylphenyl)melamine (ME),
[80]
 N-(4-tert-butylphenyl)-N’-(pyridin-4-
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ylmethyl)melamine (MEpy),
[93]
 5-butyl-5-(pyridin-4-ylmethyl)pyrimidine-2,4,6-trione 
(BApy),
[228]
 [Ru(cym)Cl2]2,
[248]
 [Rh(Cp*)Cl2]2,
[249]
 [Ir(Cp*)Cl2]2,
[250]
 
[Ru(cym)(PPh3)Cl2],
[144]
 [Rh(Cp*)(PPh3)Cl2],
[251]
 [Ir(Cp*)(PPh3)Cl2],
[250]
  2,5-
dihydroxy-3-icosylcyclohexa-2,5-diene-1,4-dione (H2L
C
),
[170]
 [Ru2(cym)2(L
A
)Cl2] 
(H2L
A
: N,N’-dihexyloxalamide) (Ru2L
A
), [Ru2(cym)2(L
B
)Cl2] (H2L
B
: N,N’-
dioctyloxalamide) (Ru2L
B
), and [Ru2(cym)2(L
C
)Cl2] (Ru2L
C
)
[170]
 were prepared 
according to published methods. All other reagents were commercially available and 
used as received. NMR spectra were recorded with a Bruker Avance II 400 
spectrometer. The chemical shifts are referenced to deuterated solvent residual peaks 
[CDCl3 : δ = 7.26 ppm; CD2Cl2 : δ = 5.32 ppm; (CD3)2SO : δ = 2.50 ppm and CD3OD = 
3.31 ppm]. DOSY experiments were conducted using standard parameters.
[167]
 UV/Vis 
absorption spectra were recorded with a Perkin-Elmer UV/Vis spectrophotometer. 
Infrared spectra were recorded with a Perkin-Elmer FTIR spectrometer. Electrospray 
mass spectra were obtained in the positive mode with an LCQ Finnigan mass 
spectrometer (University of Fribourg, Switzerland). Microanalyses were carried out by 
the Mikroelementaranalytisches Laoratorium (ETH Zürich, Switzerland). 
 
6.2  Syntheses and characterizations 
6.2.1  Neutral and cationic trinuclear metalla-assemblies 
Diethyl 2-butyl-2-(pyridin-4-ylmethyl)malonate 
Sodium hydride (1.10 g, 27.44 mmol) was added to a solution of diethyl 2-
butylmalonate (2.69 g, 12.30 mmol) in dry tetrahydrofuran (100 mL). After stirring for 
30 min, 4-(chloromethyl)pyridine (1.60 g, 9.46 mmol) was added progressively. The 
mixture was stirred at reflux for 16 h, and then the solvent was evaporated. The residue 
was triturated with diethyl ether, and the organic phase was washed with water and 
brine and dried with magnesium sulfate. After evaporation of the solvent and column 
chromatography (CH2Cl2/EtOAc, 15:1), the desired product was obtained. 
Diethyl 2-butyl-2-(pyridin-4-ylmethyl)malonate: Colorless oil, yield 80 % (2.32 g, 
7.53 mmol). 
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1
H NMR (400 MHz, CDCl3): δ = 8.45 (d, 
3
JH,H = 5.7 Hz, 2 H, CHPyN), 6.99 (d, 
3
JH,H = 
5.7 Hz, 2 H, CHPyC), 4.14 (m, 4 H, CH2O), 3.18 (s, 2 H, CH2CPy), 1.75 (m, 2 H, CH2C), 
1.28 (m, 4 H, CH2 and CH2CH3), 1.20 (t, 
3
JH,H = 7.0 Hz, 6 H, CH3CH2O), 0.87 (t, 
3
JH,H 
= 7.2 Hz, 3 H, CH3) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 170.95 (CO); 149.77 (CHPyN); 145.69 (CPy); 125.27 
(CHPyC); 61.47(CH2O); 58.47 (C); 37.62 (CH2CPy); 31.97 (CH2C); 26.35 (CH2); 22.88 
(CH2CH3); 14.10 (CH3CH2O); 13.96 (CH3) ppm. 
 
5-Butyl-5-(pyridin-4-ylmethyl)pyrimidine-2,4,6-trione (BApy) 
Urea (0.50 g, 8.28 mmol) and sodium ethoxide (5.62 mL, 15.06 mmol) were 
added to a solution of diethyl 2-butyl-2-(pyridin-4-ylmethyl)malonate (2.32 g, 7.53 
mmol) in dry ethanol (30 mL). The reaction mixture was heated under reflux for 16 h 
and then the solvent was evaporated. After column chromatography (CH2Cl2/MeOH, 
15:1), and recrystallization from ethanol, the pure product was obtained. 
BApy: White solid, yield 35 % (0.73 g, 2.64 mmol). 
1
H NMR [400 MHz, (CD3)2SO]: δ = 11.51 (br., 2 H, NH), 8.46 (d, 
3
JH,H = 5.5 Hz, 2 H, 
CHPyN), 6.99 (d, 
3
JH,H = 5.5 Hz, 2 H, CHPyC), 3.13 (s, 2 H, CH2CPy), 1.95 (m, 2 H, 
CH2CBA), 1.24 (m, 2 H, CH2), 1.09 (m, 2 H, CH2CH3), 0.82 (t, 
3
JH,H = 7.2 Hz, 3 H, CH3) 
ppm.  
13
C NMR [100 MHz, (CD3)2SO]: δ = 172.27 (CO); 149.79 (CHPyN); 149.33 
(HNCONH); 144.32 (CPy); 124.57 (CHPyC); 56.35 (CBA); 42.45 (CH2CPy); 38.40 
(CH2CBA); 26.56 (CH2); 22.12 (CH2CH3); 13.64 (CH3) ppm. 
UV/Vis (DMF, 1.0 × 10
-4
 M): λmax (ε) = 257 nm (3.99 × 10
3
 M
-1
 cm
-1
). 
IR: ṽ = 3225 (br., NH), 2937 (br., CH aromatic), 1716 (s, NH), 1696 (s, C=O), 1607 (s, 
C···N), 1406 (s, C···C) cm
-1
. 
D (CDCl3): 9.5 × 10
-10
 m
2
 s
-1
. 
C14H17N3O3 (275.3): calcd. C 61.08, H 6.22, N 15.26; found: C 61.04, H 6.22, N 15.07. 
ESI-MS: m/z = 276.1 [M + H]
+
. 
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BApyRu and BApyRh 
A mixture of BApy (0.18 g, 0.65 mmol) and [Ru(cym)Cl2]2 or [Rh(Cp*)Cl2]2 
(0.20 g, 0.33 mmol) in dry tetrahydrofuran (10 mL) was stirred at 70 °C for 16 h. Then 
the solvent was evaporated, the residue was solubilized in dichloromethane (5 mL), and 
pentane was added to precipitate the product. 
BApyRu: Yellow solid, yield 92 % (0.35 g, 0.60 mmol). 
1
H NMR (400 MHz, CDCl3): δ = 8.91 (br., 2 H, NH), 8.86 (d, 
3
JH,H = 5.9 Hz, 2 H, 
CHPyN), 7.12 (d, 
3
JH,H = 5.9 Hz, 2 H, CHPyC), 5.45 (d, 
3
JH,H = 5.7 Hz, 2 H, CHcym), 5.22 
(d, 
3
JH,H = 5.7 Hz, 2 H, CHcym), 3.29 (s, 2 H, CH2CPy), 2.93 (m, 1 H, CH), 2.05 (m, 2H, 
CH2CBA), 1.97 (s, 3 H, CH3Ccym), 1.29 (m, 4 H, CH2 and CH2CH3), 1.27 (d, 
3
JH,H = 6.8 
Hz, 6 H, CH3CH), 0.87 (t, 
3
JH,H = 6.6 Hz, 3 H, CH3) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 171.09 (CO), 155.07 (CHPyN), 148.19 (HNCONH), 
146.49 (CPy), 126.14 (CHPyC), 103.37 (CcymCH), 97.40 (CcymCH3), 83.31 (CHcym), 
82.13 (CHcym), 57.59 (CBA), 41.14 (CH2CPy), 40.65 (CH2CBA), 30.81 (CH), 26.72 (CH2), 
22.63 (CH2CH3), 22.46 (CH3CH), 18.25 (CH3Ccym), 13.79 (CH3) ppm. 
UV/Vis (CHCl3, 5.0 × 10
-5
 M): λmax (ε) = 241 (8.72 × 10
3
), 297 (4.17 × 10
3
), 411 nm 
(8.57 × 10
2
 M
-1
 cm
-1
). 
IR: ṽ = 3185 (br., NH), 2960 (br., CH aromatic), 1722 (s, NH), 1700 (s, C=O), 1616 (s, 
C···N), 1404 (s, C···C) cm
-1
. 
D (CDCl3): 4.9 × 10
-10
 m
2
 s
-1
. 
C24H31Cl2N3O3Ru (581.5): calcd. C 49.57, H 5.37, N 7.23; found C 48.89, H 5.57, N 
7.32. 
ESI-MS: m/z = 546.1 [M - Cl]
+
. 
BApyRh: Orange solid, yield 88 % (0.34 g, 0.57 mmol). 
1
H NMR (400 MHz, CDCl3): δ = 8.84 (br., 2 H, NH), 8.83 (d, 
3
JH,H = 5.3 Hz, 2 H, 
CHPyN), 7.18 (d, 
3
JH,H = 5.3 Hz, 2 H, CHPyC), 3.30 (s, 2 H, CH2CPy), 2.07 (m, 2 H, 
CH2CBA), 1.51 (s, 15 H, CH3CCp*), 1.28 (m, 4 H, CH2 and CH2CH3), 0.87 (t, 
3
JH,H = 7.0 
Hz, 3 H, CH3) ppm. 
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13
C NMR (100 MHz, CDCl3): δ = 171.07 (CO), 153.65 (CHPyN), 148.04 (HNCONH), 
146.74 (CPy), 126.87 (CHPyC), 94.25 (CCp*), 57.64 (CBA), 41.22 (CH2CPy), 40.65 
(CH2CBA), 26.77 (CH2), 22.61 (CH2CH3), 13.80 (CH3), 8.94 (CH3CCp*) ppm. 
UV/Vis (CHCl3, 5.0 × 10
-5
 M): λmax (ε) = 241 (1.58 × 10
4
), 406 nm (2.38 × 10
3
 M
-1
 cm
-
1
). 
IR: ṽ = 3190 (br., NH), 2959 (br., CH aromatic), 1724 (s, NH), 1699 (s, C=O), 1614 (s, 
C···N), 1403 (s, C···C) cm
-1
. 
D (CDCl3): 5.4 × 10
-10
 m
2
 s
-1
. 
C24H31Cl2N3O3Ru (584.4): calcd. C 49.33, H 5.52, N 7.19; found C 49.10, H 5.80, N 
7.06. 
ESI-MS: m/z 548.1 [M - Cl]
+
. 
 
(ME)3∙(BApy)3 
A mixture of BApy (50.0 mg, 0.18 mmol) and ME (70.9 mg, 0.18 mmol) in dry 
chloroform (1.5 mL) was stirred at 25 °C for 30 min. Then pentane was added to 
precipitate the product as a white solid. 
(ME)3∙(BApy)3 : White solid, yield 89 % (0.11 g, 0.05 mmol). 
1
H NMR (400 MHz, CDCl3): δ = 13.87 (br., 6 H, NH∙∙∙N), 9.35 (br., 6 H, O∙∙∙HN), 8.49 
(d, 
3
JH,H = 4.2 Hz, 6 H, CHPyN), 7.66 (d, 
3
JH,H = 8.1 Hz, 12 H, CHarCC), 7.39 (d, 
3
JH,H = 
8.1 Hz, 12 H, CHarCN), 7.09 (d, 
3
JH,H = 4.2 Hz, 6 H, CHPyC), 6.83 (br., 6 H, NH2∙∙∙O), 
3.37 (s, 6 H, CH2CPy), 2.23 (m, 6 H, CH2CBA), 1.39 [s, 66 H, CH2, CH2CH3 and 
C(CH3)3], 0.93 (t, 
3
JH,H = 5.6 Hz, 9 H, CH3) ppm.   
13
C NMR (100 MHz, CDCl3): δ = 175.18 (CO), 166.13 (CNH2), 163.91 (CNH), 152.78 
(HNCONH), 150.46 (CHPyN), 146.52 (CarC), 143.90 (CPy), 136.43 (CarNH), 125.49 
(CHarCN), 124.76 (CHPy), 121.92 (CHarCC), 57.72 (CBA), 42.92 (CH2CPy), 40.04 
(CH2CBA), 34.49 [C(CH3)3], 31.61 [C(CH3)3], 27.13 (CH2), 22.74 (CH2CH3), 13.78 
(CH3) ppm. 
UV/Vis (CDCl3, 1.0 × 10
-5
 M): λmax (ε) = 271 nm (1.22× 10
5
 M
-1
 cm
-1
).  
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IR: ṽ = 3302 (br., NH), 2959 (br., CH aromatic), 1724 (s, NH), 1693 (s, C=O), 1613 (s, 
C···N), 1565 (s, C=N), 1506 (s, CN), 1410 (s, C···C) cm
-1
. 
D (CDCl3): 3.6 × 10
-10
 m
2
 s
-1
. 
C111H141N27O9 (1997.5): calcd. C 66.74, H 7.11, N 18.93; found C 66.23, H 7.06, N 
18.63. 
 
(ME)3 ∙(BApyRu)3 and (ME)3 ∙(BApyM)3 (M = Rh, Ir) 
Method 1: A mixture of BApy (0.09 g, 0.33 mmol) and ME (0.13 g, 0.33 mmol) 
in dry chloroform (5 mL) was stirred at 25 °C. After 30 min, [Ru(cym)Cl2]2 (0.10 g, 
0.17 mmol) or [M(Cp*)Cl2]2 (Rh, 0.10 g; Ir, 0.13 g; 0.17 mmol)was added, and the 
mixture was stirred at 25 °C for 16 h. Then the mixture was concentrated, and pentane 
was added to precipitate the product. 
Method 2: A mixture of BApyRu or BApyRh (Ru 0.19 g, Rh 0.19 g; 0.33 mmol) 
and ME (0.13 g, 0.33 mmol) in dry chloroform (5 mL) was stirred at 25 °C for 30 min. 
Then the mixture was concentrated and pentane was added to precipitate the product. 
(ME)3 ∙(BApyRu)3: Orange solid, yield 90 % (Method 1: 0.29 g, 0.10 mmol); 88 % 
(Method 2: 0.28 g, 0.10 mmol).  
1
H NMR (400 MHz, CDCl3): δ = 14.18 (br., 6 H, NH∙∙∙N), 9.27 (br., 6 H, O∙∙∙HN), 8.88 
(d, 
3
JH,H = 4.9 Hz, 6 H, CHPyN), 7.60 (d, 
3
JH,H = 7.8 Hz, 12 H, CHarCC), 7.37 (d, 
3
JH,H = 
7.8 Hz, 12 H, CHarCN), 7.12 (d, 
3
JH,H = 4.9 Hz, 6 H, CHPyC), 6.90 (br., 6 H, NH2∙∙∙O), 
5.37 (d, 
3
JH,H = 4.6 Hz, 6 H, CHcym), 5.11 (d, 
3
JH,H = 4.6 Hz, 6 H, CHcym), 3.40 (s, 6 H, 
CH2CPy), 2.90 (m, 3 H, CH), 2.17 (m, 6 H, CH2CBA), 1.95 (s, 9 H, CH3Ccym), 1.37 [s, 66 
H, CH2, CH2CH3 and C(CH3)3], 1.23 (d, 
3
JH,H = 6.8 Hz, 18H, CH3CH), 0.91 (t, 
3
JH,H = 
5.6 Hz, 9 H, CH3) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 174.87 (CO), 165.87 (CNH2), 163.68 (CNH), 155.12 
(CHPyN), 153.01 (HNCONH), 146.71 (CarC), 146.48 (CPy), 136.13 (CarNH), 125.81 
(CHPy), 125.53 (CHarCN), 121.95 (CHarCC), 103.39 (CcymCH), 97.14 (CcymCH3), 83.07 
(CHcym), 82.18 (CHcym), 57.53 (CBA), 41.06 (CH2CPy), 41.00 (CH2CBA), 34.48 
[C(CH3)3], 31.58 [C(CH3)3], 30.77 (CH), 26.79 (CH2), 22.61 (CH2CH3), 22.35 
(CH3CH), 18.09 (CH3Ccym), 13.75 (CH3) ppm. 
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UV/Vis (CDCl3, 1.0 × 10
-5
 M): λmax (ε) = 272 (1.28 × 10
5
), 434 nm (1.79 × 10
3
 M
-1
 cm
-
1
). 
IR: ṽ = 3311 (br., NH), 2960 (br., CH aromatic), 1725 (s, NH), 1698 (s, C=O), 1614 (s, 
C···N), 1566 (s, C=N), 1498 (s, CN), 1410 (s, C···C) cm
-1
. 
D (CDCl3): 3.2 × 10
-10
 m
2
 s
-1
. 
C141H183Cl6N27O9Ru3 (2916.1): calcd. C 58.08, H 6.33, N 12.97; found C 57.11, H 6.35, 
N 12.64. 
(ME)3 ∙(BApyRh)3: Dark-orange solid, yield 93 % (Method 1: 0.30 g, 0.10 mmol); 90 % 
(Method 2: 0.29 g, 0.10 mmol).  
1
H NMR (400 MHz, CDCl3): δ = 14.16 (br., 6 H, NH∙∙∙N), 9.29 (br., 6 H, O∙∙∙HN), 8.84 
(d, 
3
JH,H = 4.2 Hz, 6 H, CHPyN), 7.61 (d, 
3
JH,H = 8.4 Hz, 12 H, CHarCC), 7.37 (d, 
3
JH,H = 
8.4 Hz, 12 H, CHarCN), 7.17 (d, 
3
JH,H = 4.2 Hz, 6 H, CHPyC), 6.87 (br., 6 H, NH2∙∙∙O), 
3.42 (s, 6 H, CH2CPy), 2.20 (m, 6 H, CH2CBA), 1.45 (s, 45 H, CCp*CH3), 1.38 [s, 66 H, 
CH2, CH2CH3 and C(CH3)3], 0.91 (t, 
3
JH,H = 6.4 Hz, 9 H, CH3) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 174.96 (CO), 165.91 (CNH2), 163.71 (CNH), 153.81 
(CHPyN), 152.94 (HNCONH), 146.73 (CarC), 146.66 (CPy), 136.14 (CarNH), 126.51 
(CHPy), 125.56 (CHarCN), 121.92 (CHarCC), 94.23, 94.20 (CCp*), 57.69 (CBA), 41.59 
(CH2CPy), 40.87 (CH2CBA), 34.49 [C(CH3)3], 31.58 [C(CH3)3], 26.93 (CH2), 22.63 
(CH2CH3), 13.74 (CH3), 8.80 (CH3CCp*) ppm. 
UV/Vis (CDCl3, 1.0 × 10
-5
 M): λmax (ε) = 270 (1.37 × 10
5
), 408 nm (8.01× 10
3
 M
-1
 cm
-1
).  
IR: ṽ = 3315 (br., NH), 2960 (br., CH aromatic), 1726 (s, NH), 1698 (s, C=O), 1612 (s, 
C···N), 1564 (s, C=N), 1494 (s, CN), 1409 (s, C···C) cm
-1
. 
D (CDCl3): 3.5 × 10
-10
 m
2
 s
-1
. 
C141H186Cl6N27O9Rh3 (2924.6): calcd. C 57.91, H 6.41, N 12.93; found C 57.64, H 6.50, 
N 12.83. 
(ME)3 ∙(BApyIr)3: Yellow solid, yield 88 % (Method 1: 0.31 g, 0.10 mmol). 
1
H NMR (400 MHz, CDCl3): δ = 14.22 (br., 6 H, NH∙∙∙N), 9.29 (br., 6 H, O∙∙∙HN), 8.81 
(d, 
3
JH,H = 5.1 Hz, 6 H, CHPyN), 7.61 (d, 
3
JH,H = 8.1 Hz, 12 H, CHarCC), 7.37 (d, 
3
JH,H = 
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8.1 Hz, 12 H, CHarCN), 7.14 (d, 
3
JH,H = 5.1 Hz, 6 H, CHPyC), 6.91 (br., 6 H, NH2∙∙∙O), 
3.44 (s, 6 H, CH2CPy), 2.20 (m, 6 H, CH2CBA), 1.42 (s, 45 H, CCp*CH3), 1.38 [s, 66 H, 
CH2, CH2CH3 and C(CH3)3], 0.91 (t, 
3
JH,H = 5.9 Hz, 9H, CH3) ppm.  
13
C NMR (100 MHz, CDCl3): δ = 174.90 (CO), 165.81 (CNH2), 163.64 (CNH), 153.68 
(CHPyN), 152.87 (HNCONH), 146.74 (CarC), 146.62 (CPy), 136.11 (CarNH), 126.65 
(CHPy), 125.55 (CHarCN), 121.93 (CHarCC), 85.92 (CCp*), 57.70 (CBA), 41.29 (CH2CPy), 
40.96 (CH2CBA), 34.49 [C(CH3)3], 31.58 [C(CH3)3], 26.88 (CH2), 22.61 (CH2CH3), 
13.74 (CH3), 8.49 (CH3CCp*) ppm.  
UV/Vis (CDCl3, 1.0 × 10
-5
 M): λmax (ε) = 273 nm (1.30 × 10
5
 M
-1
 cm
-1
).  
IR: ṽ = 3321 (br., NH), 2960 (br., CH aromatic), 1727 (s, NH), 1699 (s, C=O), 1615 (s, 
C···N), 1564 (s, C=N), 1495 (s, CN), 1409 (s, C···C) cm
-1
. 
D (CDCl3): 3.2 × 10
-10
 m
2
 s
-1
. 
C141H186Cl6N27O9Ir3∙2H2O (3228.6): calcd. C 52.45, H 5.93, N 11.71; found C 51.71, H 
5.85, N 11.41. 
 
{(ME)3∙[(BApy)Ru(cym)(PPh3)Cl]3}∙(3CF3SO3) and 
{(ME)3∙[(BApy)M(Cp*)(PPh3)Cl]3}∙(3CF3SO3) (M = Rh, Ir) 
A mixture of [Ru(cym)(PPh3)Cl2] (45.5 mg, 0.08 mmol) or [M(Cp*)(PPh3)Cl2] 
(Rh 45.7 mg, Ir 52.9 mg; 0.08 mmol) and AgSO3CF3 (25.7 mg, 0.10 mmol) in dry 
chloroform (2 mL) was stirred at 25 °C for 2 h and filtered to remove AgCl. In parallel, 
a mixture of BApy (21.3 mg, 0.08 mmol) and ME (30.2 mg, 0.08 mmol) in dry 
chloroform (1 mL) was stirred at 25 °C for 30 min. The solution containing the 
(ME)3∙(BA)3 rosette was added to the solution containing the complex, and the mixture 
was stirred at 25 °C for 16 h. Then the volume was reduced, and pentane was added to 
precipitate the product. 
{(ME)3∙[(BApy)Ru(cym)(PPh3)Cl]3}∙(3CF3SO3): Orange solid, yield 95 % (99.0 mg, 
0.02 mmol). 
1
H NMR (400 MHz, CDCl3): δ = 8.76 (d, 
3
JH,H = 5.3 Hz, 6 H, CHPyN), 7.52 (d, 
3
JH,H = 
8.0 Hz, 12 H, CHarCC), 7.33 (d, 
3
JH,H = 8.0 Hz, 12 H, CHarCN), 7.32 (m, 45 H, CHPh), 
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6.91 (d, 
3
JH,H = 5.3 Hz, 6 H, CHPyC), 6.03 (d, 
3
JH,H = 5.9 Hz, 3 H, CHcym), 5.71 (d, 
3
JH,H 
= 4.5 Hz, 3 H, CHcym), 5.49 (d, 
3
JH,H = 5.9 Hz, 3 H, CHcym), 5.27 (d, 
3
JH,H = 4.5 Hz, 3 H, 
CHcym), 3.24 (d, 
2
JH,H = 12.3 Hz, 3 H, CH2CPy), 3.14 (d, 
2
JH,H = 12.3 Hz, 3 H, CH2CPy), 
2.09 (m, 9 H, CH and CH2CBA), 1.58 (s, 9 H, CH3Ccym), 1.32 [s, 66 H, CH2, CH2CH3 
and C(CH3)3], 1.03 (d, 
3
JH,H = 5.3 Hz, 9 H, CH3CH), 0.98 (d, 
3
JH,H = 6.6 Hz, 9 H, 
CH3CH), 0.86 (t, 
3
JH,H = 6.6 Hz, 9 H, CH3) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 173.70 (CO), 164.16 (CNH2), 162.51 (CNH), 156.80 
(CHPyN), 151.16 (HNCONH), 147.35 (CPy), 147.17 (CarC), 135.44 (CarNH), 134.21 
(CHPh-ortho), 131.24 (CHPh-para), 129.26 (CPh), 128.72 (CHPh-meta), 126.63 (CHPy), 125.61 
(CHarCN), 121.89 (CHarCC), 113.63 (CcymCH), 104.33 (Cp-cymCH3), 93.62 (CHcym), 
90.27 (CHcym), 89.45 (CHcym), 84.89 (CHcym), 57.19 (CBA), 41.68 (CH2CPy), 39.89 
(CH2CBA), 34.47 [C(CH3)3], 31.52 [C(CH3)3], 30.82 (CH), 26.89 (CH2), 22.77 (CH3CH), 
22.61 (CH2CH3), 21.30 (CH3CH), 18.00 (CH3Ccym), 13.73 (CH3) ppm. 
31
P NMR (162 MHz, CDCl3, 298 K): δ = 37.38 (s, PPh3) ppm. 
UV/Vis (CDCl3, 1.0 × 10
-5
 M): λmax (ε) = 270 nm (1.39 × 10
5
 M
-1
 cm
-1
).  
IR: ṽ = 3315 (br., NH), 2961 (br., CH aromatic), 1729 (s, NH), 1699 (s, C=O), 1615 (s, 
C···N), 1565 (s, C=N), 1506 (s, CN), 1411 (s, C···C), 1248 (s, CF3) cm
-1
. 
D (CDCl3): 3.0 × 10
-10
 m
2
 s
-1
. 
C198H228Cl3F9N27O18P3S3Ru3∙CHCl3∙H2O (4181.2): calcd. C 57.17, H 5.57, N 9.04; 
found C 56.35, H 5.51, N 8.42. 
{(ME)3∙[(BApy)Rh(Cp*)(PPh3)Cl]3}∙(3CF3SO3)  Dark-orange solid, yield 96 % (0.10 
g, 0.02 mmol). 
1
H NMR (400 MHz, CDCl3): δ = 11.59 (br., 3 H, NH∙∙∙N), 10.95 (br., 3 H, NH∙∙∙N), 
8.86 (br., 3 H, O∙∙∙HN), 8.69 (d, 3JH,H = 5.3 Hz, 6 H, CHPyN), 8.38 (br., 3 H, O∙∙∙H-N), 
7.50 (d, 
3
JH,H = 8.4 Hz, 12 H, CHarCC), 7.33 (d, 
3
JH,H = 8.4 Hz, 12 H, CHarCN), 7.32 (m, 
45 H, CHPh), 7.08 (d, 
3
JH,H = 5.3 Hz, 6 H, CHPyC), 6.91 (br., 6 H, NH2∙∙∙O), 3.31 (d, 
2
JH,H = 12.3 Hz, 3 H, CH2CPy), 3.12 (d, 
2
JH,H = 12.3 Hz, 3 H, CH2CPy), 2.11 (m, 6 H, 
CH2CBA), 1.52 (d, 
2
JH,H = 17.8 Hz, 6 H, CH2), 1.33 (s, 45 H, CH3CCp*), 1.28 [d, 
2
JH,H = 
12.3 Hz, 60 H, CH2CH3 and C(CH3)3], 0.85 (t, 
3
JH,H = 7.0 Hz, 9 H, CH3) ppm. 
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13
C NMR (100 MHz, CDCl3): δ = 173.49 (CO), 163.41 (CNH2), 161.97 (CNH), 156.07 
(CHPyN), 150.48 (HNCONH), 147.69 (CPy), 147.51 (CarC), 135.07 (CarNH), 134.05 
(CHPh-ortho), 131.84 (CHPh-para), 128.90 (CPh), 128.73 (CHPh-meta), 127.77 (CHPy), 125.75 
(CHarCN), 121.83 (CHarCC), 101.45 (CCp*), 57.40 (CBA), 42.83 (CH2CPy), 39.04 
(CH2CBA), 34.52 [C(CH3)3], 31.52 [C(CH3)3], 27.13 (CH2), 22.69 (CH2CH3), 13.78 
(CH3), 8.81 (CH3CCp*) ppm. 
31
P NMR (162 MHz, CDCl3, 298 K): δ = 33.58 (d, 
1
JP-Rh = 141.7 Hz, PPh3) ppm. 
UV/Vis (CDCl3, 1.0 × 10
-5
 M): λmax (ε) = 268 (1.37 × 10
5
), 371 nm (1.60× 10
4
 M
-1
 cm
-1
).  
IR: ṽ = 3316 (br., NH), 2961 (br., CH aromatic), 1729 (s, NH), 1704 (s, C=O), 1614 (s, 
C···N), 1567 (s, C=N), 1503 (s, CN), 1411 (s, C···C), 1245 (s, CF3) cm
-1
. 
D (CDCl3): 3.9 × 10
-10
 m
2
 s
-1
. 
C198H231Cl3F9N27O18P3S3Rh3∙2CHCl3 (4291.1): calcd. C 55.98, H 5.47, N 8.81; found C 
55.47, H 5.49, N 8.12. 
{(ME)3∙[(BApy)Ir(Cp*)(PPh3)Cl]3}∙(3CF3SO3): Yellow solid, yield 94 % (0.10 g, 0.02 
mmol). 
1
H NMR (400 MHz, CDCl3): δ = 10.50 (br., 6 H, NH∙∙∙N), 8.77 (br., 6 H, O∙∙∙HN), 8.50 
(d, 
3
JH,H = 5.3 Hz, 6 H, CHPyN), 7.47 (d, 
3
JH,H = 8.4 Hz, 12 H, CHarCC), 7.34 (d, 
3
JH,H = 
8.4 Hz, 12 H, CHarCN), 7.30 (m, 45 H, CHPh), 7.00 (d, 
3
JH,H = 5.3 Hz, 6 H, CHPyC), 
6.54 (br., 6 H, NH2∙∙∙O), 3.31 (d, 
2
JH,H = 12.3 Hz, 3 H, CH2CPy), 3.08 (d, 
2
JH,H = 12.3 
Hz, 3 H, CH2CPy), 2.16 (m, 3 H, CH2CBA), 2.05 (m, 3 H, CH2CBA), 1.36 (s, 6 H, CH2), 
1.33 [s, 60 H, CH2CH3 and C(CH3)3], 1.28 (s, 45 H, CH3CCp*), 0.86 (t, 
3
JH,H = 7.0 Hz, 9 
H, CH3) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 173.00 (CO), 159.87 (CNH2), 158.97 (CNH), 153.17 
(CHPyN), 150.02 (HNCONH), 148.27 (CPy), 147.88 (CarC), 134.93 (CarNH), 133.70 
(CHPh-ortho), 132.70 (CHPh-para), 129.39 (CPh), 128.58 (CHPy), 127.98 (CHPh-meta), 125.78 
(CHarCN), 122.22 (CHarCC), 94.94 (CCp*), 57.42 (CBA), 42.61 (CH2CPy), 39.11 
(CH2CBA), 34.57 [C(CH3)3], 31.47 [C(CH3)3], 27.08 (CH2), 22.66 (CH2CH3), 13.75 
(CH3), 8.22 (CH3CCp*) ppm. 
31
P NMR (162 MHz, CDCl3 , 298 K): δ = 8.80 (s, PPh3) ppm. 
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UV/Vis (CDCl3, 1.0 × 10
-5
 M): λmax (ε) = 270 nm (1.16 × 10
5
 M
-1
 cm
-1
).  
IR: ṽ = 3321 (br., NH), 2961 (br., CH aromatic), 1729 (s, NH), 1699 (s, C=O), 1617 (s, 
C···N), 1568 (s, C=N), 1505 (s, CN), 1412 (s, C···C), 1245 (s, CF3) cm
-1
. 
D (CDCl3): 3.8 × 10
-10
 m
2
 s
-1
. 
C198H231Cl3 F9N27O18P3S3Ir3∙2CHCl3∙H2O (4577.0): calcd. C 52.48, H 5.18, N 8.26; 
found C 51.68, H 5.17, N 7.80. 
 
6.2.2  Neutral hexanuclear metalla-assemblies 
MEpyRu and MEpyRh 
A mixture of MEpy (91.3 mg, 0.26 mmol) and [Ru(cym)Cl2]2 (80.0 mg, 0.13 
mmol) or [Rh(Cp*)Cl2]2 (80.7 mg, 0.13 mmol) in dry tetrahydrofuran (7 mL) was 
stirred at 25 °C for 16 h. Then the solvent was evaporated, the residue was solubilized 
in chloroform (2 mL), and pentane was added to precipitate the product.  
MEpyRu: Orange solid, yield 89 % (0.15 g, 0.23 mmol).  
1
H NMR (400 MHz, CDCl3): δ = 8.77 (br., 2 H, CHPyN), 7.40 (br., 2 H, CHarCC), 7.22 
(br., 2 H, CHarCN), 7.13 (br., 2 H, CHPyC), 5.38 (br., 2 H, CHcym), 5.15 (br., 2 H, 
CHcym), 4.45 (br., 2 H, CH2), 2.89 (br., 1 H, CH), 1.90 (br., 3 H, CH3Ccym), 1.26 [s, 9 H, 
C(CH3)3], 1.22 [m, 6 H, (CH3)2CH] ppm.  
13
C NMR (100 MHz, CDCl3): δ = 165.73 (CNHCH2), 165.53 (CNH2), 163.74 (CNHC), 
154.40 (CHPyN), 151.63 (CPy), 146.13 (CarC), 136.07 (CarNH), 125.62 (CHarCN), 
123.32 (CHPyC), 120.54 (CHarCC), 103.33 (CcymCH), 97.24 (CcymCH3), 83.04 (CHcym), 
82.10 (CHcym), 43.07 (CH2), 34.39 [C(CH3)3], 31.57 [C(CH3)3], 30.75 (CH), 22.41 
[(CH3)2CH], 18.24 (CH3Ccym) ppm.  
UV/Vis (CHCl3, 5.0 × 10
-5
 M): λmax (ε) = 267 (2.49 × 10
4
), 422 nm (7.48 × 10
2
 M
-1
 cm
-
1
). 
IR: ṽ = 3311 (br., NH), 2960 (br., CH aromatic), 1590 (s, C···N), 1567 (s, C=N), 1497 
(s, CN), 1412 (s, C···C) cm
-1
.  
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D (CDCl3): 5.0 × 10
-10
 m
2
 s
-1
.  
C29H37Cl2N7Ru∙H2O (673.7): calcd. C 51.71, H 5.84, N 14.55; found C 51.20, H 5.72, N 
14.12. 
ESI-MS: m/z = 620.1 [M - Cl]
+
.  
MEpyRh: Dark orange solid, yield 94 % (0.16 g, 0.25 mmol).  
1
H NMR (400 MHz, CDCl3): δ = 8.73 (br., 2 H, CHPyN), 8.51 (br., 1 H, NHCar), 7.42 
(br., 2 H, CHarCC), 7.21 (br., 4 H, CHarCN and CHPyC), 6.25 (br., 1 H, NHCH2), 5.46 
(br., 2 H, NH2), 4.47 (br., 2 H, CH2), 1.47 (s, 15 H, CH3CCp*), 1.27 (s, 9 H, CH3) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 166.97 (CNHCH2), 166.22 (CNH2), 164.41 (CNHC), 
152.90 (CHPyN), 152.17 (CPy), 145.98 (CarC), 136.31 (CarNH), 125.59 (CHarCN), 
123.97 (CHPyC), 120.33 (CHarCC), 94.13 (CCp*), 43.27 (CH2), 34.36 [C(CH3)3], 31.55 
[C(CH3)3], 8.92 (CH3CCp*) ppm.  
UV/Vis (CHCl3, 5.0 × 10
-5
 M): λmax (ε) = 265 (2.95 × 10
4
), 407 nm (2.78 × 10
3
 M
-1
 cm
-
1
).  
IR: ṽ = 3310 (br., NH), 2961 (br, CH aromatic), 1597 (s, C···N), 1568 (s, C=N), 1504 (s, 
CN), 1414 (s, C···C) cm
-1
.  
D (CDCl3): 7.2 × 10
-10
 m
2
 s
-1
.  
C29H38Cl2N7Rh∙2H2O (694.5): calcd. C 50.15, H 6.10, N 14.12; found C 49.76, H 5.88, 
N 13.31. 
ESI-MS: m/z = 622.1 [M - Cl]
+
. 
 
(MEpy)3∙(BApy)3 
A mixture of (BApy) (39.4 mg, 0.14 mmol) and (MEpy) (50.0 mg, 0.14 mmol) 
in dry chloroform (1 mL) was stirred at 25 °C for 30 min. Then pentane was added to 
precipitate the product. 
 
(MEpy)3∙(BApy)3: White solid, yield 89 % (79.6 mg, 0.04 mmol).
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1
H NMR (400 MHz, CDCl3): δ = 13.59 (br., 6 H, NH∙∙∙N), 9.19 (br., 3 H, O∙∙∙H-N), 8.61 
(d, 
3
JH,H = 3.3 Hz, 6 H, CHPy MEN), 8.46 (d, 
3
JH,H = 3.1 Hz, 6 H, CHPy BAN), 8.03 (br., 3 
H, O∙∙∙H-N), 7.48 (d, 3JH,H = 7.7 Hz, 6 H, CHarCC), 7.29 (d, 
3
JH,H = 3.3 Hz, 6 H, CHPy 
MEC), 7.26 (d, 
3
JH,H = 7.7 Hz, 6 H, CHarCN), 7.00 (d, 
3
JH,H = 3.1 Hz, 6 H, CHPy BAC), 
6.74 (br., 6 H, NH2∙∙∙O), 4.69 (s, 6 H, CH2 ME), 3.28 (s, 6 H, CH2 BA), 2.14 (s, 6 H, 
CH2CBA), 1.33 [s, 27 H, C(CH3)3], 1.30 (m, 12 H, CH2 and CH2CH3), 0.90 (t, 
3
JH,H = 6.4 
Hz, 9 H, CH3) ppm.  
13
C NMR (100 MHz, CDCl3): δ = 174.67 (CO), 166.00 (CNHCH2), 165.67 (CNH2), 
163.58 (CNHC), 152.28 (HNCONH), 150.34 (CHPy BAN), 149.91 (CHPy MEN), 148.98 
(CPy ME), 146.21 (CarC), 144.02 (CPy BA), 136.55 (CarNH), 125.54 (CHarCN), 124.74 
(CHPy BAC), 122.35 (CHPy MEC), 120.75 (CHarCC), 57.73 (CBA), 43.97 (CH2 ME), 42.87 
(CH2 BA), 40.04 (CH2CBA), 34.46 [C(CH3)3], 31.60 [C(CH3)3], 27.12 (CH2), 22.73 
(CH2CH3), 13.80 (CH3) ppm.  
UV/Vis (CHCl3, 1.0 × 10
-5
 M): λmax (ε) = 265 nm (8.00 × 10
4
 M
-1
 cm
-1
).  
IR: ṽ = 3344 (br., NH), 2961 (br., CH aromatic), 1720 (s, NH), 1685 (s, C=O), 1602 (s, 
C···N), 1571 (s, C=N), 1520 (s, CN), 1411 (s, C···C) cm
-1
.  
D (CDCl3): 4.0 × 10
-10
 m
2
 s
-1
.  
C99H120N30O9∙H2O (1892.3): calcd. C 62.84, H 6.50, N 22.21; found C 62.18, H 6.36, N 
21.24. 
 
(MEpy)3∙(BApyRu)3 and (MEpy)3∙(BApyRh)3  
A mixture of BApyRu (50.0 mg, 0.09 mmol) or BApyRh (50.3 mg; 0.09 mmol) 
and MEpy (30.1 mg, 0.09 mmol) in dry chloroform (1 mL) was stirred at 25 °C for 30 
min. Then pentane was added to precipitate the product.  
(MEpy)3∙(BApyRu)3: Yellow solid, yield 89 % (71.3 mg, 0.03 mmol).
  
1
H NMR (400 MHz, CDCl3): δ = 14.26 (br., 6 H, NH∙∙∙N), 9.26 (br., 3 H, O∙∙∙H-N), 9.07 
(br., 3 H, CHPy MEN), 8.92 (br., 3 H, CHPy BAN), 8.60 (br., 3 H, CHPy ME’N), 8.47 (br., 3 
H, CHPy BA’N), 8.10 (br., 3 H, O∙∙∙H’-N), 7.48 (m, 6 H, CHarCC), 7.34 (m, 6 H, 
CHarCN), 7.29 (br., 6 H, CHPy MEC), 7.03 (br., 6 H, CHPy BAC), 6.84 (br., 3 H, NH2∙∙∙O), 
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6.02 (br., 3 H, NH2’∙∙∙O), 5.52 (br., 6 H, CHcym), 5.30 (br., 6 H, CHcym), 4.68 (br., 6 H, 
CH2 ME), 3.30 (br., 6 H, CH2 BA), 2.97 (m, 3 H, CH), 2.15 (br., 3 H, CH2CBA), 2.10 (br., 
3 H, CH2’CBA), 1.95 (m, 9 H, CH3Ccym), 1.36 [br., 27 H, C(CH3)3], 1.32 (m, 12 H, CH2 
and CH2CH3), 1.28 [m, 18 H, (CH3)2CH], 0.89 (t, 
3
JH,H = 6.6 Hz, 9 H, CH3) ppm.
  
13
C NMR (100 MHz, CDCl3): δ = 174.81 (CO), 165.84 (CNHCH2), 165.54 (CNH2), 
165.41(CNH2’), 163.43 (CNHC), 155.27 (CHPy BAN), 154.91 (CHPy MEN), 152.63 
(HNCONH), 151.53 (HNC’ONH), 150.36 (CHPy BA’N), 149.93 (CHPy ME’N), 148.88 
(CPy ME), 146.55 (CarC), 146.23 (Car’C), 143.96 (CPy BA), 136.65 (CarNH), 136.44 
(Car’NH), 125.92 (CHPy BAC), 125.53 (CHarCN), 124.71 (CHPy BA’C), 122.73 (CHPy 
MEC), 122.35 (CHPy ME’C), 120.77 (CHarCC), 120.63 (CHar’CC), 103.33 (CcymCH), 
97.36 (CcymCH3), 83.35 (CHcym), 81.93 (CHcym), 57.68 (CBA), 57.40 (CBA’), 43.97 (CH2 
ME), 43.37 (CH2 ME’), 43.35 (CH2 BA), 42.76 (CH2 BA’), 39.99 (CH2CBA), 34.50 
[C(CH3)3], 34.44 [C’(CH3)3], 31.67 [(CH3)3], 31.58 [C(C’H3)3], 30.84 (CH), 27.07 
(CH2), 26.69 (CH2’), 22.68 (CH2CH3), 22.50 [(CH3)2CH], 18.40 (CH3Ccym), 18.19 
(CH3’Ccym), 13.79 (CH3) ppm.  
UV/Vis (CHCl3, 1.0 × 10
-5
 M): λmax (ε) = 267 (8.55 × 10
4
), 413 nm (2.67 × 10
3
 M
-1
 cm
-
1
).  
IR: ṽ = 3326 (br., NH), 2961 (br., CH aromatic), 1725 (s, NH), 1698 (s, C=O), 1601 (s, 
C···N), 1570 (s, C=N), 1512 (s, CN), 1413 (s, C···C).  
D (CDCl3): 3.9 × 10
-10
 m
2
 s
-1
.  
C129H162Cl6N30O9Ru3∙3H2O (2846.9): calcd. C 54.43, H 5.95, N 14.76; found C 53.47, 
H 5.82, N 13.89. 
(MEpy)3∙(BApyRh)3: Orange solid, yield 89 % (71.5 mg, 0.03 mmol).
  
1
H NMR (400 MHz, CDCl3): δ = 14.17 (br., 6 H, NH∙∙∙N), 9.20 (br., 3 H, O∙∙∙H-N), 8.96 
(br., 3 H, CHPy MEN), 8.83 (br., 3 H, CHPy BAN), 8.61 (br., 3 H, CHPy ME’N), 8.46 (br., 3 
H, CHPy BA’N), 8.06 (br., 3 H, O∙∙∙H’-N), 7.46 (br., 6 H, CHarCC), 7.32 (br., 6 H, CHPy 
MEC), 7.29 (br., 6 H, CHarCN), 7.08 (br., 3 H, CHPy BAC), 7.01 (br., 3 H, CHPy BA’C), 
6.83 (br., 3 H, NH2∙∙∙O), 4.69 (br., 6 H, CH2 ME), 3.29 (br., 6 H, CH2 BA), 2.13 (br., 6 H, 
CH2CBA), 1.53 (m, 45 H, CH3CCp*), 1.33 [br., 27 H, C(CH3)3], 1.30 (m, 12 H, CH2 and 
CH2CH3), 0.89 (t, 
3
JH,H = 6.4 Hz, 9 H, CH3) ppm.
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13
C NMR (100 MHz, CDCl3): δ = 175.01 (CO), 165.53 (CNHCH2), 165.28 (CNH2), 
163.26 (CNHC), 153.73 (CHPy BAN), 153.33 (CHPy MEN), 152.90 (HNCONH), 151.55 
(HNC’ONH), 150.27 (CHPy BA’N), 149.56 (CHPy ME’N), 149.25 (CPy ME), 146.80 (CarC), 
146.31 (Car’C), 144.03 (CPy BA), 136.47 (CarNH), 136.30 (Car’NH), 126.56 (CHPy BAC), 
125.51 (CHarCN), 124.70 (CHPy BA’C), 123.73 (CHPy MEC), 122.44 (CHPy ME’C), 120.80 
(CHarCC), 120.66 (CHar’CC), 94.16 (CCp*), 57.62 (CBA), 57.45 (CBA’), 43.97 (CH2 ME), 
43.61 (CH2 ME’), 42.72 (CH2 BA), 41.06 (CH2 BA’), 39.95 (CH2CBA), 34.44 [C(CH3)3], 
31.57 [C(CH3)3], 27.04 (CH2), 26.82 (CH2’), 22.61 (CH2CH3), 13.78 (CH3), 8.99 
(CH3CCp*), 8.90 (CH3’CCp*) ppm.  
UV/Vis (CHCl3, 1.0 × 10
-5
 M): λmax (ε) = 265 (1.02 × 10
5
), 402 nm (8.59 × 10
3
 M
-1
 cm
-
1
).  
IR: ṽ = 3327 (br., NH), 2960 (br., CH aromatic), 1726 (s, NH), 1698 (s, C=O), 1601 (s, 
C···N), 1570 (s, C=N), 1512 (s, CN), 1413 (s, C···C) cm
-1
.  
D (CDCl3): 3.9 × 10
-10
 m
2
 s
-1
.  
C129H165Cl6N30O9Rh3∙3H2O (2855.4): calcd. C 54.26, H 6.04, N 14.72; found C 53.42, 
H 6.07, N 14.46. 
 
(MEpyRu)3∙(BApy)3 and (MEpyRh)3∙(BApy)3  
A mixture of BApy (30.0 mg, 0.11 mmol) and MEpyRu (71.4 mg, 0.11 mmol) 
or MEpyRh (71.8 mg, 0.11 mmol) in dry chloroform (1 mL) was stirred at 25 °C for 30 
min. Then pentane was added to precipitate the product. 
(MEpyRu)3∙(BApy)3: Yellow solid, yield 88 % (89.3 mg, 0.03 mmol).
  
1
H NMR (400 MHz, CDCl3): δ = 14.18 (br., 6 H, NH∙∙∙N), 9.20 (br., 3 H, O∙∙∙H-N), 9.07 
(br., 3 H, CHPy MEN), 8.92 (br., 3 H, CHPy BAN), 8.60 (br., 3 H, CHPy ME’N), 8.45 (br., 3 
H, CHPy BA’N), 8.10 (br., 3 H, O∙∙∙H’-N), 7.47 (m, 6 H, CHarCC), 7.33 (m, 
 
6 H, 
CHarCN), 7.28 (br., 6 H, CHPy MEC), 7.02 (br., 6 H, CHPy BAC), 6.85 (br., 3 H, NH2∙∙∙O), 
6.03 (br., 3 H, NH2’∙∙∙O), 5.50 (br., 6 H, CHcym), 5.30 (br., 6 H, CHcym), 4.68 (br., 6 H, 
CH2 ME), 3.30 (br., 6 H, CH2 BA), 2.96 (m, 3 H, CH), 2.11 (br., 6 H, CH2CBA), 1.96 (m, 9 
Chapter 6 Experimental 
128 
H, CH3Ccym), 1.35 [br., 27 H, C(CH3)3], 1.32 (m, 12 H, CH2 and CH2CH3), 1.28 [m, 18 
H, (CH3)2CH], 0.88 (t, 
3
JH,H = 6.4 Hz, 9 H, CH3) ppm.
  
13
C NMR (100 MHz, CDCl3): δ = 174.83 (CO), 165.73 (CNHCH2), 165.43 (CNH2), 
165.33 (C’NH2), 163.34 (CNHC), 155.23 (CHPy BAN), 154.87 (CHPy MEN), 152.69 
(HNCONH), 151.51 (HNC’ONH), 150.24 (CHPy BA’N), 149.76 (CHPy ME’N), 149.02 
(CPy ME), 146.56 (CarC), 146.23 (Car’C), 144.05 (CPy BA), 136.59 (CarNH), 136.39 
(Car’NH), 125.92 (CHPy BAC), 125.51 (CHarCN), 124.73 (CHPy BA’C), 122.76 (CHPy 
MEC), 122.37 (CHPy ME’C), 120.76 (CHarCC), 120.61 (CHar’CC), 103.30 (CcymCH), 
102.98 (Ccym’CH), 97.60 (CcymCH3), 97.36 (Ccym’CH3), 83.33 (CHcym), 81.93 (CHcym), 
57.63 (CBA), 57.36 (CBA’), 43.94 (CH2 ME), 43.35 (CH2 ME’), 43.34 (CH2 BA), 43.71 (CH2 
BA’), 39.97 (CH2CBA), 34.47 [C(CH3)3], 34.42 [C’(CH3)3], 31.64 [C(CH3)3], 31.55 
[C(CH3’)3], 30.81 (CH), 27.03 (CH2), 26.67 (CH2’), 22.65 (CH2CH3), 22.57 (CH2’CH3), 
22.47 [(CH3)2CH], 18.38 (CH3Ccym), 18.18 (CH3’Ccym), 13.78 (CH3) ppm.  
UV/Vis (CHCl3, 1.0 × 10
-5
 M): λmax (ε) = 267 (9.14 × 10
4
), 407 nm (2.55 × 10
3
 M
-1
 cm
-
1
).  
IR: ṽ = 3324 (br., NH), 2960 (br., CH aromatic), 1725 (s, NH), 1698 (s, C=O), 1614 (s, 
C···N), 1570 (s, C=N), 1512 (s, CN), 1414 (s, C···C) cm
-1
.  
D (CDCl3): 3.0 × 10
-10
 m
2
 s
-1
. 
C129H162Cl6N30O9Ru3∙CHCl3∙H2O (2930.2): calcd. C 53.29, H 5.68, N 14.34; found C 
52.46, H 5.83, N 13.85. 
(MEpyRh)3∙(BApy)3: orange solid, yield 88 % (89.5 mg, 0.03 mmol).
  
1
H NMR (400 MHz, CDCl3): δ = 14.15 (br., 6 H, NH∙∙∙N), 9.21 (br., 3 H, O∙∙∙H-N), 8.96 
(br., 3 H, CHPy MEN), 8.83 (br., 3 H, CHPy BAN), 8.61 (br., 3 H, CHPy ME’N), 8.46 (br., 3 
H, CHPy BA’N), 8.06 (br., 3 H, O∙∙∙H’-N), 7.47 (br., 6 H, CHarCC), 7.35 (br., 6 H, CHPy 
MEC), 7.31 (br., 6 H, CHarCN), 7.08 (br., 3 H, CHPy BAC), 7.02 (br., 3 H, CHPy BA’C), 
6.85 (br., 6 H, NH2∙∙∙O), 4.69 (br., 6 H, CH2 ME), 3.29 (br., 6 H, CH2 BA), 2.13 (br., 6 H, 
CH2CBA), 1.53 (m, 45 H, CH3CCp*), 1.34 [br., 27 H, C(CH3)3], 1.30 (m, 12 H, CH2 and 
CH2CH3), 0.89 (t, 
3
JH,H = 6.4 Hz, 9 H, CH3) ppm.
  
13
C NMR (100 MHz, CDCl3): δ = 174.87 (CO), 165.69 (CNHCH2), 165.39 (CNH2), 
163.32 (CNHC), 153.73 (CHPy BAN), 153.35 (CHPy MEN), 151.55 (HNCONH), 150.26 
Chapter 6 Experimental 
129 
(CHPy BA’N), 149.72 (CHPy ME’N), 149.05 (CPy ME), 146.82 (CarC), 146.25 (Car’C), 
144.05 (CPy BA), 136.54 (CarNH), 136.37 (Car’NH), 126.55 (CHPy BAC), 125.51 
(CHarCN), 124.70 (CHPy BA’C), 123.72 (CHPy MEC), 122.38 (CHPy ME’C), 120.77 
(CHarCC), 120.63 (CHar’CC), 94.18 (CCp*), 57.63 (CBA), 57.47 (CBA’), 43.95 (CH2 ME), 
43.62 (CH2 ME’), 42.72 (CH2 BA), 41.07 (CH2 BA’), 39.96 (CH2CBA), 34.43 [C(CH3)3], 
31.58 [C(CH3)3], 27.03 (CH2), 26.81 (CH2’), 22.60 (CH2CH3), 13.78 (CH3), 9.01 
(CH3CCp*), 8.90 (CH3’CCp*) ppm.  
UV/Vis (CHCl3, 1.0 × 10
-5
 M): λmax (ε) = 265 (9.65 × 10
4
), 403 nm (8.61 × 10
3
 M
-1
 cm
-
1
).  
IR: ṽ = 3329 (br., NH), 2960 (br., CH aromatic), 1726 (s, NH), 1698 (s, C=O), 1602 (s, 
C···N), 1570 (s, C=N), 1513 (s, CN), 1414 (s, C···C) cm
-1
.  
D (CDCl3): 3.7 × 10
-10
 m
2
 s
-1
.  
C129H165Cl6N30O9Rh3∙CHCl3∙H2O (2938.7): calcd. C 53.13, H 5.76, N 14.30; found C 
52.31, H 5.90, N 13.62. 
 
(MEpyRu)3∙(BApyRu)3 
Method 1: A mixture of BApy (39.4 mg, 0.14 mmol) and MEpy (50.0 mg, 0.14 
mmol) in dry chloroform (1.5 mL) was stirred at 25 °C. After 30 min, [Ru(cym)Cl2]2 
(87.6 mg, 0.14 mmol) was added, and the mixture was stirred at 25 °C for 16 h. Then 
the mixture was concentrated, and pentane was added to precipitate the product.  
Method 2: A mixture of (BApyRu) (44.4 mg, 0.08 mmol) and (MEpyRu) (50.0 
mg, 0.08 mmol) in dry chloroform (2 mL) was stirred at 25 °C for 30 min. Then pentane 
was added to precipitate the product.  
(MEpyRu)3∙(BApyRu)3: orange solid, yield 83 % (Method 1: 0.15 g, 0.04 mmol); 83 % 
(Method 2: 78.3 mg, 0.02 mmol).  
1
H NMR (400 MHz, CDCl3): δ = 14.23 (br., 6 H, NH∙∙∙N), 9.21 (br., 3 H, O∙∙∙H-N), 9.07 
(br., 6 H, CHPy MEN), 8.92 (br., 6 H, CHPy BAN), 8.09 (br., 3 H, O∙∙∙H’-N), 7.47 (d, 
3
JH,H 
= 7.5 Hz, 6 H, CHarCC), 7.31 (d, 
3
JH,H = 7.5 Hz, 6 H, CHarCN), 7.27 (br., 6 H, CHPy 
MEC), 7.01 (br., 6 H, CHPy BAC), 6.89 (br., 6 H, NH2∙∙∙O), 5.52 (br., 12 H, CHcym), 5.31 
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(br., 12 H, CHcym), 4.56 (br., 6 H, CH2 ME), 3.32 (br., 6 H, CH2 BA), 2.95 (m, 6 H, CH), 
2.09 (br., 6 H, CH2CBA), 1.99 (br., 9 H, CH3Ccym), 1.88 (br., 9 H, CH3’Ccym), 1.35 [br., 
27 H, C(CH3)3], 1.32 (m, 12 H, CH2 and CH2CH3), 1.26 [m, 36 H, (CH3)2CH], 0.88 (t, 
3
JH,H = 6.4 Hz, 9 H, CH3) ppm.  
13
C NMR (100 MHz, CDCl3): δ = 175.02 (CO), 165.47 (CNHCH2), 165.15 (CNH2), 
163.18 (CNHC), 155.25 (CHPy BAN), 154.86 (CHPy MEN), 153.06 (HNCONH), 151.45 
(CPy ME), 146.47 (CPy BA), 146.24 (CarC), 136.43 (CarNH), 125.87 (CHPy BAC), 125.50 
(CHarCN), 122.68 (CHPy MEC), 120.60 (CHarCC), 103.20 (CcymCH), 102.72 (Ccym’CH), 
97.67 (CcymCH3), 97.39 (Ccym’CH3), 83.66 (CHcym), 81.85 (CHcym), 57.37 (CBA), 43.27 
(CH2 ME), 41.35 (CH2CBA), 40.36 (CH2 BA), 34.44 [C(CH3)3], 31.59 [C(CH3)3], 30.78 
(CH), 26.62 (CH2), 22.46 (CH2CH3), 22.46 [(CH3)2CH], 18.37 (CH3Ccym), 18.11 
(CH3’Ccym), 13.73 (CH3) ppm.  
UV/Vis (CHCl3, 1.0 × 10
-5
 M): λmax (ε) = 266 (9.68 × 10
4
), 419 nm (4.31 × 10
3
 M
-1
 cm
-
1
). 
IR: ṽ = 3325 (br., NH), 2961 (br., CH aromatic), 1726 (s, NH), 1699 (s, C=O), 1615 (s, 
C···N), 1569 (s, C=N), 1512 (s, CN), 1414 (s, C···C) cm
-1
.  
D (CDCl3): 3.3 × 10
-10
 m
2
 s
-1
.  
C159H204Cl12N30O9Ru6 (3711.4): calcd. C 51.46, H 5.54, N 11.32; found C 50.54, H 5.70, 
N 11.43. 
 
(MEpyRh)3∙(BApyRu)3 and (MEpyRu)3∙(BApyRh)3  
Method 1: A mixture of BApyRu (83.2 mg, 0.14 mmol) or BApyRh (83.6 mg, 
0.14 mmol) and MEpy (50.0 mg, 0.14 mmol) in dry chloroform (3 mL) was stirred at 
25 °C. After 30 min, [Rh(Cp*)Cl2]2 (44.2 mg, 0.07 mmol) or [Ru(cym)Cl2]2 (43.8 mg, 
0.07 mmol) was added, and the mixture was stirred at 25 °C for 16 h. Then the mixture 
was concentrated, and pentane was added to precipitate the product.  
Method 2: A mixture of BApyRu (44.2 mg, 0.08 mmol) or BApyRh (44.6 mg, 
0.08 mmol) and MEpyRh (50.0 mg, 0.08 mmol) or MEpyRu (50.0 mg, 0.08 mmol) in 
dry chloroform (2 mL) was stirred at 25 °C for 30 min. Then pentane was added to 
precipitate the product.  
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(MEpyRh)3∙(BApyRu)3: Orange solid, yield 93 % (Method 1: 0.17 g, 0.04 mmol); 90 % 
(Method 2: 89.3 mg, 0.02 mmol).  
1
H NMR (400 MHz, CDCl3): δ = 14.20 (br., 6 H, NH∙∙∙N), 9.25 (br., 3 H, O∙∙∙H-N), 9.06 
(br., 6 H, CHPy MEN), 8.88 (br., 6 H, CHPy BAN), 8.10 (br., 3 H, O∙∙∙H’-N), 7.48 (br., 6 H, 
CHarCC), 7.34 (m, 6 H, CHPy MEC), 7.32 (m, 6 H, CHarCN), 7.10 (br., 6 H, CHPy BAC), 
7.00 (br., 3 H, NH2∙∙∙O), 6.93 (br., 3 H, NH2’∙∙∙O), 5.51 (br., 6 H, CHcym), 5.31 (br., 6 H, 
CHcym), 4.93 (br., 3 H, CH2 ME), 4.58 (br., 3 H, CH2’ME), 3.34 (br., 6 H, CH2 BA), 2.94 
(br., 3 H, CH), 2.09 (br., 6 H, CH2CBA), 1.94 (m., 9 H, CH3Ccym), 1.54 (m, 45 H, 
CH3CCp*), 1.35 [m, 27 H, C(CH3)3], 1.32 (m, 12 H, CH2 and CH2CH3), 1.26 [m, 18 H, 
(CH3)2CH], 0.89 (t, 
3
JH,H = 6.2 Hz, 9 H, CH3) ppm.  
13
C NMR (100 MHz, CDCl3): δ = 174.93 (CO), 165.60 (CNHCH2), 165.22 (CNH2), 
163.20 (CNHC), 155.27 (CHPy MEN), 154.90 (CHPy ME’N), 154.09 (HNCONH), 153.77 
(CHPy BAN), 153.48 (CHPy BA’N), 153.11 (CPy ME), 152.98 (CPy ME’), 151.53 (CPy BA), 
151.36 (CPy BA’), 146.50 (CarC), 146.29 (Car’C), 136.47 (CarNH), 126.52 (CHPy BAC), 
126.02 (CHPy BA’C), 125.51 (CHarCN), 123.60 (CHPy MEC), 122.77 (CHPy ME’C), 120.64 
(CHarCC), 103.17 (CcymCH), 97.39 (CcymCH3), 94.21 (CCp*), 83.48 (CHcym), 82.07 
(CHcym), 57.44 (CBA), 43.38 (CH2 ME), 41.67 (CH2CBA), 40.85 (CH2 BA), 34.46 
[C(CH3)3], 31.62 [C(CH3)3], 30.81 (CH), 26.61 (CH2), 22.55 (CH2CH3), 22.48 
[(CH3)2CH], 18.37 (CH3Ccym), 18.14 (CH3’Ccym), 13.78 (CH3), 9.09 (CH3CCp*), 8.95 
(CH3’CCp*) ppm.  
UV/Vis (CHCl3, 1.0 × 10
-5
 M): λmax (ε) = 265 (1.01 × 10
5
), 409 nm (9.97 × 10
3
 M
-1
 cm
-
1
).  
IR: ṽ = 3318 (br., NH), 2960 (br., CH aromatic), 1726 (s, NH), 1699 (s, C=O), 1614 (s, 
C···N), 1570 (s, C=N), 1512 (s, CN), 1417 (s, C···C) cm
-1
.  
D (CDCl3): 3.6 × 10
-10
 m
2
 s
-1
.  
C159H207Cl12N30O9Ru3Rh3∙3H2O (3774.0): calcd. C 50.60, H 5.69, N 11.13; found C 
49.77, H 5.74, N 10.87. 
(MEpyRu)3∙(BApyRh)3: Orange solid, yield 90 % (Method 1: 0.16 g, 0.04 mmol); 87 % 
(Method 2: 86.3 mg, 0.02 mmol).  
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1
H NMR (400 MHz, CDCl3): δ = 14.22 (br., 6 H, NH∙∙∙N), 9.25 (br., 3 H, O∙∙∙H-N), 9.08 
(br., 6 H, CHPy MEN), 8.86 (br., 6 H, CHPy BAN), 8.11 (br., 3 H, O∙∙∙H’-N), 7.48 (br., 6 H, 
CHarCC), 7.34 (m, 6 H, CHPy MEC), 7.28 (m, 6 H, CHarCN), 7.09 (br., 6 H, CHPy BAC), 
6.99 (br., 3 H, NH2∙∙∙O), 6.92 (br., 3 H, NH2’∙∙∙O), 5.52 (br., 6 H, CHcym), 5.33 (br., 6 H, 
CHcym), 4.96 (br., 3 H, CH2 ME), 4.58 (br., 3 H, CH2’ME), 3.34 (br., 6 H, CH2 BA), 2.96 
(br., 3 H, CH), 2.09 (br., 6 H, CH2CBA), 1.95 (br., 9 H, CH3Ccym), 1.54 (m, 45 H, 
CH3CCp*), 1.35 [m, 27 H, C(CH3)3], 1.32 (m, 12 H, CH2 and CH2CH3), 1.27 [m, 18 H, 
(CH3)2CH], 0.89 (t, 
3
JH,H = 6.4 Hz, 9 H, CH3) ppm.  
13
C NMR (100 MHz, CDCl3): δ = 174.91 (CO), 165.65 (CNHCH2), 165.30 (CNH2), 
163.23 (CNHC), 155.22 (CHPy MEN), 154.88 (CHPy ME’N), 154.29 (HNCONH), 153.73 
(CHPy BAN), 153.46 (CHPy BA’N), 153.22 (CPy ME), 152.84 (CPy ME’), 151.61 (CPy BA), 
151.39 (CPy BA’), 146.47 (CarC), 146.23 (Car’C), 136.50 (CarNH), 126.56 (CHPy BAC), 
126.00 (CHPy BA’C), 125.49 (CHarCN), 123.55 (CHPy MEC), 122.72 (CHPy ME’C), 120.61 
(CHarCC), 103.14 (CcymCH), 97.38 (CcymCH3), 94.20 (CCp*), 83.47 (CHcym), 81.81 
(CHcym), 57.44 (CBA), 43.37 (CH2 ME), 41.41 (CH2CBA), 40.51 (CH2 BA), 34.44 
[C(CH3)3], 31.59 [C(CH3)3], 30.79 (CH), 26.61 (CH2), 22.52 (CH2CH3), 22.47 
[(CH3)2CH], 18.33 (CH3Ccym), 18.12 (CH3’Ccym), 13.75 (CH3), 9.07 (CH3CCp*), 8.93 
(CH3’CCp*) ppm.  
UV/Vis (CHCl3, 1.0 × 10
-5
 M): λmax (ε) = 265 (9.77 × 10
4
), 406 nm (9.77 × 10
3
 M
-1
 cm
-
1
).  
IR: ṽ = 3325 (br., NH), 2960 (br., CH aromatic), 1726 (s, NH), 1699 (s, C=O), 1614 (s, 
C···N), 1570 (s, C=N), 1513 (s, CN), 1417 (s, C···C) cm
-1
.  
D (CDCl3): 3.0 × 10
-10
 m
2
 s
-1
.  
C159H207Cl12N30O9Ru3Rh3∙3H2O (3774.0): calcd. C 50.60, H 5.69, N 11.13; found C 
49.73, H 5.81, N 10.90. 
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6.2.3  Cationic hexanuclear metalla-assemblies 
[Rh2(Cp*)2(L
C
)Cl2] (Rh2L
C
) and [Ir2(Cp*)2(L
C
)Cl2] (Ir2L
C
)  
Sodium acetate (73.4 mg, 0.90 mmol) was added to a solution of 2,5-dihydroxy-
3-icosylcyclohexa-2,5-diene-1,4-dione (0.18 g, 0.43 mmol) in methanol (20 mL). After 
stirring for 1 h, [Rh(Cp*)Cl2]2 (0.25 g, 0.40 mmol) or [Ir(Cp*)Cl2]2 (0.31 g, 0.40 mmol) 
was added. The mixture was stirred at 25 °C for 16 h, and then the solvent was 
evaporated. The residue was washed with water to give the product. 
Rh2L
C
: Brown solid, yield 75 % (0.29 g, 0.30 mmol). 
1
H NMR (400 MHz, CDCl3): δ = 5.63 (s, 1 H, CHdobq), 2.35 (m, 2 H, CH2Cdobq), 1.71 (s, 
30 H, CH3CCp*), 1.41 (m, 2 H, CH2), 1.25 (m, 34 H, CH2), 0.87 (t, 
3
JH,H = 6.0 Hz, 3 H, 
CH3) ppm.  
13
C NMR (100 MHz, CDCl3): δ = 184.04 (COdobq), 181.37 (COdobq), 115.18 (Cdobq), 
101.10 (CHdobq), 92.70 (CCp*), 32.05 (CH2), 30.12 (CH2), 29.84 (CH2), 29.49 (CH2), 
28.44 (CH2), 22.82 (CH2), 22.49 (CH2Cdobq), 14.24 (CH3), 9.11 (CH3CCp*) ppm. 
UV/Vis (CH2Cl2, 1.0 × 10
-5
 M): λmax (ε) = 243 (3.74 × 10
4
), 308 nm (1.27 × 10
4
), 436 
nm (2.08 × 10
4
 M
-1
 cm
-1
).  
IR: ṽ = 2920 (s, CH aromatic), 1519 (s, C···O) cm-1.  
C46H72O4Cl2Rh2∙H2O (983.8): calcd. C 56.16, H 7.58; found C 55.95, H 7.33. 
ESI-MS: m/z = 929.2 [M - Cl]
+
.  
Ir2L
C
: Red-brown solid, yield 70 % (0.32 g, 0.28 mmol). 
1
H NMR (400 MHz, CDCl3): δ = 5.82 (s, 1 H, CHdobq), 2.42 (m, 2 H, CH2Cdobq), 1.71 (s, 
30 H, CH3CCp*), 1.45 (m, 2 H, CH2), 1.25 (m, 34 H, CH2), 0.87 (t, 
3
JH,H = 6.8 Hz, 3 H, 
CH3) ppm.  
13
C NMR (100 MHz, CDCl3): δ = 185.50 (COdobq), 182.90 (COdobq), 115.27 (Cdobq), 
100.92 (CHdobq), 84.23 (CCp*), 32.06 (CH2), 29.85 (CH2), 29.65 (CH2), 29.49 (CH2), 
28.18 (CH2), 22.82 (CH2), 22.44 (CH2Cdobq), 14.24 (CH3), 9.38 (CH3CCp*) ppm. 
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UV/Vis (CHCl3, 1.0 × 10
-5
 M): λmax (ε) = 230 (3.60 × 10
4
), 310 nm (1.54 × 10
4
), 460 nm 
(1.76 × 10
4
 M
-1
 cm
-1
).
 
IR: ṽ = 2920 (s, CH aromatic), 1523 (s, C···O) cm-1.  
C46H72O4Cl2Ir2 (1144.4): calcd. C 48.28, H 6.34; found C 49.27, H 6.59. 
ESI-MS: m/z = 1109.2 [M - Cl]
+
.  
 
N,N’-bis{4-[(5-methoxypyridin-3-yl)ethynyl]phenyl}melamine 
(MEbispy) 
3-ethynyl-5-methoxypyridine (0.40 g, 3.00 mmol), [PdCl2(PPh3)2] (0.10 g, 0.15 
mmol) and copper iodide (28.1 mg, 0.15 mmol) were added to a solution of N,N’-bis(4-
iodophenyl)melamine (0.78 g, 1.47 mmol) in dry tetrahydrofuran (20 mL). Then 
triethylamine (20 mL, 0.27 mol) was added progressively, and the mixture was stirred at 
60°C. After 24 h, the mixture was filtered and washed with H2O, THF, AcOEt and 
MeOH to give the product. 
MEbispy: Yellow solid, yield 68 % (0.54 g, 1.00 mmol). 
1
H NMR [400 MHz, (CD3)2SO]: δ = 9.45 (br., 2 H, NH), 8.33 (br., 2 H, CHPy), 8.31 (br., 
2 H, CHPy), 7.92 (d, 
3
JH,H = 7.8 Hz, 4 H, CHar), 7.55 (s, 2 H, CHPy), 7.49 (d, 
3
JH,H = 7.8 
Hz, 4 H, CHar), 6.80 (br., 2 H, NH2), 3.86 (s, 6 H, CH3O) ppm.  
13
C NMR [100 MHz, (CD3)2SO]: δ = 166.70 (CNH2), 164.19 (CNH), 155.05 
(CPyOCH3), 143.48 (CHPy), 141.23 (Car), 137.34 (CHPy), 131.76 (CHar), 121.69 (CHPy), 
120.23 (CPy), 119.43 (CHar), 114.00 (Car), 92.87 (C), 84.93 (C), 55.64 (CH3O) ppm. 
UV/Vis (THF, 1.0 × 10
-5
 M): λmax (ε) = 210 (5.29 × 10
4
), 329 nm (7.76 × 10
4
 M
-1
 cm
-1
). 
IR: ṽ = 3276 (br., NH), 2963 (br., CH aromatic), 2209 (s, C≡C), 1584 (s, C···N), 1498 
(s, C=N), 1432 (s, C···C) cm
-1
.  
C31H24N8O2∙CH3OH (572.6): calcd. C 67.12, H 4.93, N 19.57; found C 68.02, H 4.77, N 
19.51. 
ESI-MS: m/z = 541.1 [M + H]
+
. 
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(MEbispy)3∙(BA)3 
A mixture of MEbispy (0.15 g, 0.27 mmol) and BA (50.0 mg, 0.27 mmol) in dry 
chloroform (5 mL) was stirred at 25°C for 30 min. Then the mixture was filtered over 
celite, and washed with chloroform. The residue was concentrated, and pentane was 
added to precipitate the product. 
(MEbispy)3∙(BA)3: Light yellow solid, yield  50 % (98.4 mg, 0.05 mmol). 
1
H NMR (400 MHz, CDCl3): δ = 13.36 (br., 6 H, NH∙∙∙N), 9.53 (br., 6 H, O∙∙∙H-N), 8.41 
(s, 6 H, CHPy), 8.27 (s, 6 H, CHPy), 7.79 (br., 12 H, CHar), 7.56 (br., 12 H, CHar), 7.33 (s, 
6 H, CHPy), 7.04 (br., 6 H, NH2∙∙∙O), 3.88 (s, 18 H, CH3O), 2.18 (m, 12 H, CH2 BA), 1.01 
(m, 18 H, CH3 BA) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 175.97 (COBA), 166.35 (CNH2), 163.81 (CNH), 
155.24 (CPyOCH3), 153.30 (NHCONH), 144.66 (CHPy), 139.72 (Car), 137.23 (CHPy), 
132.41 (CHar), 122.38 (CHPy), 121.91 (CPy), 121.07 (CHar), 117.13 (Car), 92.84 (C), 
85.62 (C), 58.09 (CBA), 55.77 (CH3O), 32.26 (CH2 BA), 9.89 (CH3 BA)  ppm. 
UV/Vis (CH2Cl2, 1.0 × 10
-5
 M): λmax (ε) = 230 (1.21 × 10
5
), 323 nm (2.12 × 10
5
 M
-1
 cm
-
1
). 
IR: ṽ = 3298 (br., NH), 2973 (br., CH aromatic), 2204 (s, C≡C), 1715 (s, NH), 1562 (s, 
C···N), 1497 (s, C···O), 1456 (s, C=N), 1420 (s, C···C) cm
-1
.  
C117H108N30O15∙3H2O (2228.4): calcd. C 63.06, H 5.16, N 18.86; found C 63.49, H 5.08, 
N 18.03. 
 
MEbispyRu2L
C
 
A mixture of Ru2L
C
 (0.25 g, 0.26 mmol) and AgSO3CF3 (0.20 g, 0.78 mmol) in 
dry methanol (20 mL) was stirred at 25 °C for 2 h and filtered to remove AgCl. The 
solution of MEbispy (0.14 g, 0.26 mmol) in dry tetrahydrofuran (12 mL) was added to 
the residue. The mixture was stirred at 60 °C for 40 h, and then the solvent was 
evaporated. The residue was solubilized in dichloromethane, and diethyl ether was 
added to precipitate the product. 
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MEbispyRu2L
C
: Red-brown solid, yield 95 % (0.43 g, 0.25 mmol). 
1
H NMR (400 MHz, CD2Cl2): δ = 8.39 (br., 2 H, NH), 7.95 (s, 2 H, CHPy), 7.83 (s, 2 H, 
CHPy), 7.79 (s, 2 H, CHPy), 7.46 (br., 4 H, CHar), 7.42 (br., 4 H, CHar), 6.23 (br., 2 H, 
NH2), 5.84 (br., 4 H, CHcym), 5.70 (br., 4 H, CHcym), 5.64 (br., 1 H, CHdobq), 3.86 (s, 6 H, 
CH3O), 2.85 (m, 2 H, CH), 2.36 (m, 2 H, CH2Cdobq), 2.21 (s, 6 H, CH3Ccym), 1.36 [m, 12 
H, (CH3)2CH], 1.26 (m, 36 H, CH2), 0.87 (t, 
3
JH,H = 6.6 Hz, 3 H, CH3) ppm. 
13
C NMR (100 MHz, CD2Cl2): δ = 184.75 (CO), 182.31 (CO), 166.38 (CNH2), 161.87 
(CNH), 157.09 (CPyOCH3), 146.43 (CHPy), 141.41 (CHPy), 138.67 (Car), 132.42 (CHar), 
125.68 (CHPy), 123.44 (CHar), 122.74 (CPy), 119.56 (Car), 117.70, (Cdobq), 104.45 (Ccym), 
101.64 (CHdobq), 98.60 (Ccym), 95.21 (C), 83.79 (CHcym), 83.22 (C), 82.70 (CHcym), 
56.90 (CH3O), 32.31 (CH2), 31.81 (CH), 30.12 (CH2), 29.75 (CH2), 29.00 (CH2), 23.08 
(CH2), 22.27 [(CH3)2CH], 22.10 (CH2Cdobq), 18.39 (CH3Ccym), 14.29 (CH3) ppm. 
UV/Vis (CH2Cl2, 1.0 × 10
-5
 M): λmax (ε) = 228 (6.77 × 10
4
), 298 nm (4.91 × 10
4
), 496 
nm (1.35 × 10
4
 M
-1
 cm
-1
). 
IR: ṽ = 3287 (br., NH), 2924 (br., CH aromatic), 2219 (s, C≡C), 1580 (s, C···N), 1512 
(s, C···O), 1474 (s, C=N), 1415 (s, C···C), 1223 (s, CF3) cm
-1
.  
C79H94N8O12F6S2Ru2∙2CH2Cl2 (1897.8): calcd. C 51.26, H 5.21, N 5.90; found C 50.73, 
H 5.10, N 5.60. 
ESI-MS: m/z = 1579.0 [M – CF3SO3]
+
, 715.2 [M - 2 CF3SO3]
2+
. 
 
MEbispyRh2L
C
 and MEbispyIr2L
C
 
A mixture of Rh2L
C
 (0.25 g, 0.26 mmol) or Ir2L
C
 (0.30 g, 0.26 mmol) and 
AgSO3CF3 (0.20 g, 0.78 mmol) in dry methanol (20 mL) was stirred at 25 °C for 2 h 
and filtered to remove AgCl. The solution of MEbispy (0.14 g, 0.26 mmol) in dry 
tetrahydrofuran (12 mL) was added to the residue. The mixture was stirred at 60 °C for 
20 h, and then the solvent was evaporated. The residue was solubilized in 
dichloromethane, and diethyl ether was added to precipitate the product. 
MEbispyRh2L
C
: Green solid, yield 92 % (0.41 g, 0.24 mmol). 
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1
H NMR (400 MHz, CD3OD): δ = 8.05 (s, 2 H, CHPy), 7.95 (s, 2 H, CHPy), 7.70 (s, 2 H, 
CHPy), 7.57 (br., 4 H, CHar), 7.43 (br., 4 H, CHar), 5.59 (br., 1 H, CHdobq), 3.88 (s, 6 H, 
CH3O), 2.45 (m, 2 H, CH2Cdobq), 1.70 (s, 30 H, CH3CCp*), 1.28 (m, 36 H, CH2), 0.90 (t, 
3
JH,H = 6.2 Hz, 3 H, CH3) ppm. 
13
C NMR (100 MHz, CD3OD): δ = 185.05 (CO), 182.49 (CO), 164.07 (CNH2), 161.84 
(CNH), 158.81 (CPyOCH3), 145.72 (CHPy), 140.65 (CHPy), 135.79 (Car), 133.20 (CHar), 
126.59 (CHPy), 124.43 (CHar), 123.41 (CPy), 120.26 (Car), 117.02, (Cdobq), 102.29 
(CHdobq), 97.16 (CCp*), 95.55 (C), 84.38 (C), 57.08 (CH3O), 33.07 (CH2), 30.80 (CH2), 
30.50 (CH2), 23.72 (CH2), 22.81 (CH2Cdobq), 14.46 (CH3), 8.67 (CH3CCp*) ppm. 
UV/Vis (CH2Cl2, 1.0 × 10
-5
 M): λmax (ε) = 234 (8.08 × 10
4
), 339 nm (5.41 × 10
4
), 422 
nm (1.99 × 10
4
 M
-1
 cm
-1
).  
IR: ṽ = 3319 (br., NH), 2924 (br., CH aromatic), 2214 (s, C≡C), 1577 (s, C···N), 1511 
(s, C···O), 1483 (s, C=N), 1413 (s, C···C), 1223 (s, CF3) cm
-1
.  
C79H96N8O12F6S2Rh2∙4CH2Cl2 (2073.3): calcd. C 48.08, H 5.06, N 5.40; found C 48.49, 
H 5.04, N 5.40. 
ESI-MS: m/z = 1582.9 [M – CF3SO3]
+
, 717.3 [M - 2 CF3SO3]
2+
. 
MEbispyIr2L
C
: Red-brown solid, yield 90 % (0.45 g, 0.23 mmol). 
1
H NMR (400 MHz, CD3OD): δ = 8.07 (s, 2 H, CHPy), 7.95 (s, 2 H, CHPy), 7.72 (s, 2 H, 
CHPy), 7.51 (br., 4 H, CHar), 7.49 (br., 4 H, CHar), 5.80 (br., 1 H, CHdobq), 3.90 (s, 6 H, 
CH3O), 2.50 (m, 2 H, CH2Cdobq), 1.67 (s, 30 H, CH3CCp*), 1.28 (m, 36 H, CH2), 0.90 (t, 
3
JH,H = 6.2 Hz, 3 H, CH3) ppm. 
13
C NMR (100 MHz, CD3OD): δ = 186.79 (CO), 184.09 (CO), 163.02 (CNH2), 161.41 
(CNH), 159.32 (CPyOCH3), 146.09 (CHPy), 141.80 (CHPy), 139.71 (Car), 133.24 (CHar), 
127.10 (CHPy), 124.74 (CHar), 123.41 (CPy), 120.24 (Car), 117.08, (Cdobq), 101.47 
(CHdobq), 95.66 (C), 88.70 (CCp*), 84.00 (C), 57.25 (CH3O), 33.07 (CH2), 30.77 (CH2), 
30.47 (CH2), 23.72 (CH2), 22.83 (CH2Cdobq), 14.44 (CH3), 8.78 (CH3CCp*) ppm. 
UV/Vis (CH2Cl2, 1.0 × 10
-5
 M): λmax (ε) = 230 (7.34 × 10
4
), 296 (4.94 × 10
4
), 451 nm 
(1.33 × 10
4
 M
-1
 cm
-1
). 
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IR: ṽ = 3310 (br., NH), 2924 (br., CH aromatic), 2217 (s, C≡C), 1580 (s, C···N), 1515 
(s, C···O), 1459 (s, C=N), 1416 (s, C···C), 1223 (s, CF3) cm
-1
.  
C79H96N8O12F6S2Ir2∙4CH2Cl2 (2251.9): calcd. C 44.27, H 4.66, N 4.98; found C 43.42, 
H 4.47, N 4.94. 
ESI-MS: m/z = 1760.9 [M – CF3SO3]
+
, 807.3 [M - 2 CF3SO3]
2+
. 
 
MEbispyRu2L
A
 and MEbispyIr2L
B
 
A mixture of Ru2L
A
 (0.30 g, 0.38 mmol) or Ru2L
B
 (0.32 g, 0.38 mmol) and 
AgSO3CF3 (0.29 g, 1.13 mmol) in dry methanol (26 mL) was stirred at 25 °C for 2 h 
and filtered to remove AgCl. The solution of MEbispy (0.21 g, 0.38 mmol) in dry 
tetrahydrofuran (14 mL) was added to the residue. The mixture was stirred at 60 °C for 
16 h, and then the solvent was evaporated. The residue was solubilized in 
dichloromethane, and diethyl ether was added to precipitate the product. 
MEbispyRu2L
A
: Light green solid, yield 87 % (0.52 g, 0.33 mmol). 
1
H NMR (400 MHz, CD3OD): δ = 7.87 (br., 2 H, CHPy), 7.77 (br., 2 H, CHPy), 7.69 (br., 
2 H, CHPy), 7.57 (br., 4 H, CHar), 7.23 (br., 4 H, CHar), 5.94 (br., 4 H, CHcym), 5.53 (br., 
4 H, CHcym), 3.90 (s, 6 H, CH3O), 3.69 (m, 4 H, CH2N), 2.75 (m, 2 H, CH), 1.97 (m, 4 
H, CH2), 1.74 (s, 6 H, CH3Ccym) 1.53 (m, 12 H, CH2), 1.27 [m, 12 H, (CH3)2CH],  1.04 
(m, 6 H, CH3) ppm. 
13
C NMR (100 MHz, CD3OD): δ = 172.12 (CO), 162.82 (CNH2), 159.91 (CNH), 
157.55 (CPyOCH3), 148.48 (CHPy), 139.26 (CHPy), 135.73 (Car), 133.42 (CHar), 126.65 
(CHPy), 124.65 (CPy), 123.48 (C), 121.34 (CHar), 120.31 (C), 118.12 (Car), 104.40 
(Ccym), 100.49 (Ccym), 87.71 (CHcym), 80.44 (CHcym), 57.07 (CH3O), 54.12 (NCH2), 
33.02 (CH2), 32.53 (CH), 31.15 (CH2), 28.34 (CH2), 23.75 (CH2), 23.01 (CH2), 22.29 
[(CH3)2CH], 17.82 (CH3Ccym), 14.50 (CH3) ppm. 
UV/Vis (CH2Cl2, 1.0 × 10
-5
 M): λmax (ε) = 228 (5.21 × 10
4
), 350 nm (5.35 × 10
4
 M
-1
 cm
-
1
). 
IR: ṽ = 3310 (br., NH), 2931 (br., CH aromatic), 2214 (s, C≡C), 1595 (s, C···N), 1510 
(s, C···O), 1462 (s, C=N), 1416 (s, C···C), 1254 (s, CF3) cm
-1
.  
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C67H78N10O10F6S2Ru2∙2CH2Cl2 (1733.5): calcd. C 47.81, H 4.77, N 8.08; found C 47.14, 
H 4.69, N 7.66.  
ESI-MS: m/z = 1415.0 [M – CF3SO3]
+
, 633.4 [M - 2 CF3SO3]
2+
. 
MEbispyIr2L
B
: Light yellow solid, yield 86 % (0.53 g, 0.33 mmol). 
1
H NMR (400 MHz, CD3OD): δ = 7.90 (br., 2 H, CHPy), 7.79 (br., 2 H, CHPy), 7.73 (br., 
2 H, CHPy), 7.60 (br., 4 H, CHar), 7.24 (br., 4 H, CHar), 5.96 (br., 4 H, CHcym), 5.55 (br., 
4 H, CHcym), 3.93 (s, 6 H, CH3O), 3.68 (m, 4 H, CH2N), 2.78 (m, 2 H, CH), 2.01 (m, 4 
H, CH2), 1.76 (s, 6 H, CH3Ccym) 1.45 (m, 20 H, CH2), 1.30 [m, 12 H, (CH3)2CH],  0.99 
(m, 6 H, CH3) ppm. 
13
C NMR (100 MHz, CD3OD): δ = 172.36 (CO), 163.40 (CNH2), 161.62 (CNH), 
157.64 (CPyOCH3), 148.07 (CHPy), 140.25 (CHPy), 135.79 (Car), 133.59 (CHar), 126.65 
(CHPy), 124.75 (CPy), 123.48 (C), 121.23 (CHar), 120.31 (C), 117.34 (Car), 104.13 
(Ccym), 100.54 (Ccym), 87.53 (CHcym), 80.35 (CHcym), 57.11 (CH3O), 54.17 (NCH2), 
33.11 (CH2), 32.59 (CH), 31.27 (CH2), 30.82 (CH2), 30.54 (CH2), 28.77 (CH2), 23.82 
(CH2), 23.23 [(CH3)2CH], 17.83  (CH3Ccym), 14.50 (CH3) ppm. 
UV/Vis (CH2Cl2, 1.0 × 10
-5
 M): λmax (ε) = 229 (5.34 × 10
4
), 349 nm (5.63 × 10
4
 M
-1
 cm
-
1
). 
IR: ṽ = 3313 (br., NH), 2928 (br., CH aromatic), 2214 (s, C≡C), 1596 (s, C···N), 1510 
(s, C···O), 1465 (s, C=N), 1416 (s, C···C), 1255 (s, CF3) cm
-1
.  
C71H86N10O10F6S2Ru2∙2CH2Cl2 (1789.6): calcd. C 48.99, H 5.07, N 7.83; found C 48.57, 
H 5.01, N 7.58. 
ESI-MS: m/z = 1470.0 [M – CF3SO3]
+
, 660.8 [M - 2 CF3SO3]
2+
. 
 
(MEbispyRu2L
C
)3∙(BA)3 
A mixture of MEbispyRu2L
C
 (0.14 g, 0.08 mmol) and BA (14.9 mg, 0.08 mmol) 
in dry chloroform (3 mL) was stirred at 25°C for 48 h. Then the mixture was filtered 
over celite, and washed with chloroform. The residue was concentrated, and pentane 
was added to precipitate the product. 
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(MEbispyRu2L
C
)3∙(BA)3: Dark purple solid, yield  80 % (0.12 g, 0.02 mmol). 
1
H NMR (400 MHz, CD2Cl2): δ = 13.73 (br., 6 H, NH∙∙∙N), 9.71 (br., 6 H, O∙∙∙H-N), 
7.99 (s, 6 H, CHPy), 7.84 (br., 6 H, CHPy), 7.81 (br., 6 H, CHPy), 7.66 (br., 12 H, CHar), 
7.46 (br., 12 H, CHar), 7.24 (br., 6 H, NH2∙∙∙O), 5.87 (br., 12 H, CHcym), 5.73 (br., 12 H, 
CHcym), 5.57 (br., 3 H, CHdobq), 3.88 (s, 18 H, CH3O), 2.87 (m, 6 H, CH), 2.39 (m, 6 H, 
CH2Cdobq), 2.23 (s, 18 H, CH3Ccym), 2.15 (m, 12 H, CH2 BA), 1.38 [m, 36 H, (CH3)2CH], 
1.26 (m, 108 H, CH2), 0.99 (t, 
3
JH,H = 6.6 Hz, 18 H, CH3 BA), 0.86 (m, 9 H, CH3) ppm. 
13
C NMR (100 MHz, CD2Cl2): δ = 184.93 (CO), 182.45 (CO), 175.82 (COBA), 166.76 
(CNH2), 163.94 (CNH), 157.23 (CPyOCH3), 153.00 (NHCONH), 146.48 (CHPy), 141.43 
(CHPy), 140.33 (Car), 132.44 (CHar), 125.93 (CHPy), 123.69 (CPy), 123.08 (CHar), 119.85 
(Car), 116.71 (Cdobq), 104.99 (Ccym), 101.59 (CHdobq), 98.72 (Ccym), 95.70 (C), 83.86 
(CHcym), 83.37 (CHcym), 82.73 (C), 58.46 (CBA), 57.04 (CH3O), 32.54 (CH2 BA), 32.38 
(CH2 BA), 31.90 (CH), 30.19 (CH2), 29.82 (CH2), 23.14 (CH2), 22.46 [(CH3)2CH], 22.18 
(CH2Cdobq), 18.46 (CH3Ccym), 14.30 (CH3), 9.86 (CH3 BA)  ppm. 
UV/Vis (CH2Cl2, 1.0 × 10
-5
 M): λmax (ε) = 230 (2.32 × 10
5
), 297 (1.91 × 10
5
), 496 nm 
(5.10 × 10
4
 M
-1
 cm
-1
). 
IR: ṽ = 3290 (br., NH), 2924 (br., CH aromatic), 2216 (s, C≡C), 1715 (s, NH), 1580 (s, 
C···N), 1513 (s, C···O), 1453 (s, C=N), 1423 (s, C···C), 1241 (s, CF3) cm
-1
.  
C261H318N30O45F18S6Ru6 (5736.3): calcd. C 54.65, H 5.59, N 7.33; found C 53.87, H 
5.59, N 7.13. 
 
(MEbispyRh2L
C
)3∙(BA)3 and (MEbispyIr2L
C
)3∙(BA)3 
A mixture of MEbispyRh2L
C
 (0.14 g, 0.08 mmol) or MEbispyIr2L
C
 (0.15 g, 0.08 
mmol) and BA (15.0 mg, 0.08 mmol) in dry chloroform/dichloromethane (2 mL/1 mL) 
was stirred at 25°C for 24 h. Then the mixture was filtered over celite, and washed with 
chloroform. The residue was concentrated, and pentane was added to precipitate the 
product. 
(MEbispyRh2L
C
)3∙(BA)3: Green solid, yield  86 % (0.13 g, 0.02 mmol). 
Chapter 6 Experimental 
141 
1
H NMR (400 MHz, CD2Cl2): δ = 9.58 (br., 6 H, O∙∙∙H-N), 7.89 (br., 6 H, CHPy), 7.85 
(br., 6 H, CHPy), 7.73 (br., 6 H, CHPy), 7.58 (br., 12 H, CHar), 7.45 (br., 12 H, CHar), 
7.22 (br., 6 H, NH2∙∙∙O), 5.60 (br., 3 H, CHdobq), 3.88 (s, 18 H, CH3O), 2.37 (m, 6 H, 
CH2Cdobq), 2.04 (m, 12 H, CH2 BA), 1.67 (s, 90 H, CH3CCp*), 1.26 (m, 108 H, CH2), 0.90 
(m, 18 H, CH3 BA), 0.89 (m, 9 H, CH3) ppm. 
13
C NMR (100 MHz, CD2Cl2): δ = 184.31 (CO), 181.90 (CO), 173.61 (COBA), 168.61 
(CNH2), 164.03 (CNH), 157.68 (CPyOCH3), 150.79 (NHCONH), 144.89 (CHPy), 139.78 
(CHPy), 134.83 (Car), 132.35 (CHar), 130.91 (CHPy), 124.83 (CHar), 123.10 (CPy), 119.65 
(Car), 116.71 (Cdobq), 105.43 (CHdobq), 101.78 (C), 96.05 (CCp*), 82.92 (C), 58.35 (CBA), 
56.96 (CH3O), 32.34 (CH2 BA), 30.13 (CH2), 29.77 (CH2), 29.04 (CH2), 23.10 (CH2), 
22.31 (CH2Cdobq), 14.29 (CH3), 9.71 (CH3 BA), 9.05 (CH3CCp*) ppm. 
UV/Vis (CH2Cl2, 1.0 × 10
-5
 M): λmax (ε) = 234 (2.29 × 10
5
), 339 (1.57 × 10
5
), 422 nm 
(6.16 × 10
4
 M
-1
 cm
-1
). 
IR: ṽ = 3313 (br., NH), 2924 (br., CH aromatic), 2214 (s, C≡C), 1709 (s, NH), 1578 (s, 
C···N), 1512 (s, C···O), 1486 (s, C=N), 1413 (s, C···C), 1223 (s, CF3) cm
-1
.  
C261H324N30O45F18S6Rh6∙5CHCl3 (6350.2): calcd. C 50.31, H 5.22, N 6.62; found C 
49.51, H 5.35, N 6.23. 
(MEbispyIr2L
C
)3∙(BA)3: Red solid, yield  90 % (0.15 g, 0.02 mmol). 
1
H NMR (400 MHz, CD2Cl2): δ = 13.91 (br., 6 H, NH∙∙∙N), 8.95 (br., 6 H, O∙∙∙H-N), 
8.54 (br., 6 H, CHPy), 7.89 (br., 6 H, CHPy), 7.84 (br., 6 H, CHPy), 7.56 (br., 12 H, CHar), 
7.46 (br., 12 H, CHar), 6.61 (br., 6 H, NH2∙∙∙O), 5.83 (br., 3 H, CHdobq), 3.89 (s, 18 H, 
CH3O), 2.42 (m, 6 H, CH2Cdobq), 2.01 (m, 12 H, CH2 BA), 1.64 (s, 90 H, CH3CCp*), 1.26 
(m, 108 H, CH2), 0.90 (m, 18 H, CH3 BA), 0.88 (m, 9 H, CH3) ppm. 
13
C NMR (100 MHz, CD2Cl2): δ = 185.86 (CO), 183.62 (CO), 173.71 (COBA), 165.16 
(CNH2), 162.50 (CNH), 158.20 (CPyOCH3), 150.64 (NHCONH), 145.43 (CHPy), 140.66 
(CHPy), 139.46 (Car), 132.43 (CHar), 125.93 (CHPy), 123.37 (CHar), 122.76 (CPy), 119.57 
(Car), 117.26 (Cdobq), 101.62 (CHdobq), 96.06 (C), 87.66 (CCp*), 82.76 (C), 58.32 (CBA), 
57.13 (CH3O), 32.32 (CH2 BA), 30.11 (CH2), 29.75 (CH2), 28.85 (CH2), 23.08 (CH2), 
22.38 (CH2Cdobq), 14.28 (CH3), 9.66 (CH3 BA), 9.10 (CH3CCp*) ppm. 
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UV/Vis (CH2Cl2, 1.0 × 10
-5
 M): λmax (ε) = 232 (2.23 × 10
5
), 295 (1.60 × 10
5
), 451 nm 
(4.40 × 10
4
 M
-1
 cm
-1
). 
IR: ṽ = 3302 (br., NH), 2925 (br., CH aromatic), 2216 (s, C≡C), 1711 (s, NH), 1580 (s, 
C···N), 1515 (s, C···O), 1458 (s, C=N), 1417 (s, C···C), 1241 (s, CF3) cm
-1
.  
C261H324N30O45F18S6Ir6∙5CHCl3 (6886.1): calcd. C 46.40, H 4.82, N 6.10; found C 45.60, 
H 4.75, N 6.02. 
 
(MEbispyRu2L
A
)3∙(BA)3 and (MEbispyRu2L
B
)3∙(BA)3 
A mixture of MEbispyRu2L
A
 (0.13 g, 0.08 mmol) or MEbispyRu2L
B
 (0.13 g, 
0.08 mmol) and BA (15.0 mg, 0.08 mmol) in dry chloroform/dichloromethane (2 mL/1 
mL) was stirred at 25°C for 26 h. Then the mixture was filtered over celite, and washed 
with chloroform. The residue was concentrated, and pentane was added to precipitate 
the product. 
(MEbispyRu2L
A
)3∙(BA)3: Light yellow solid, yield  88 % (0.12 g, 0.02 mmol). 
1
H NMR (400 MHz, CD2Cl2): δ = 9.17 (br., 6 H, NH∙∙∙N), 8.71 (br., 6 H, O∙∙∙H-N), 7.65 
(br., 6 H, CHPy), 7.56 (br., 6 H, CHPy), 7.48 (br., 6 H, CHPy), 7.39 (br., 12 H, CHar), 7.20 
(br., 12 H, CHar), 6.46 (br., 6 H, NH2∙∙∙O), 5.76 (br., 12 H, CHcym), 5.48 (br., 12 H, 
CHcym), 3.89 (s, 18 H, CH3O), 3.70 (br., 12 H, NCH2), 2.72 (m, 6 H, CH), 2.02 (m, 12 H, 
CH2 BA), 1.80 (s, 18 H, CH3Ccym), 1.50 (m, 48 H, CH2), 1.27 [m, 36 H, (CH3)2CH], 1.03 
(m, 18 H, CH3), 0.91 (m, 18 H, CH3 BA) ppm. 
13
C NMR (100 MHz, CD2Cl2): δ = 173.17 (COBA), 170.94 (CO), 164.78 (CNH2), 
162.19 (CNH), 156.45 (CPyOCH3), 149.84 (NHCONH), 146.96 (CHPy), 138.38 (CHPy), 
136.25 (Car), 133.07 (CHar), 126.02 (CHPy), 124.16 (CPy), 122.83 (C), 120.75 (CHar), 
119.65 (C), 116.47 (Car), 103.46 (Ccym), 98.12 (Ccym), 84.96 (CHcym), 81.59 (CHcym), 
58.30 (CBA), 56.88 (CH3O), 53.28 (NCH2), 32.29 (CH2), 31.73 (CH), 30.53 (CH2 BA), 
27.50 (CH2), 23.10 (CH2), 22.72 [(CH3)2CH], 18.03 (CH3Ccym), 14.35 (CH3), 9.66 (CH3 
BA)  ppm. 
UV/Vis (CH2Cl2, 1.0 × 10
-5
 M): λmax (ε) = 230 (1.51 × 10
5
), 350 nm (1.80 × 10
5
 M
-1
 cm
-
1
). 
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IR: ṽ = 3310 (br., NH), 2966 (br., CH aromatic), 2214 (s, C≡C), 1708 (s, NH), 1597 (s, 
C···N), 1511 (s, C···O), 1459 (s, C=N), 1417 (s, C···C), 1254 (s, CF3) cm
-1
.  
C225H270N36O39F18S6Ru6∙3CHCl3 (5601.7): calcd. C 48.89, H 4.91, N 9.00; found C 
48.32, H 4.95, N 8.60. 
(MEbispyRu2L
B
)3∙(BA)3: Yellow solid, yield  86 % (0.12 g, 0.02 mmol). 
1
H NMR (400 MHz, CD2Cl2): δ = 9.35 (br., 6 H, NH∙∙∙N), 8.76 (br., 6 H, O∙∙∙H-N), 7.72 
(br., 6 H, CHPy), 7.62 (br., 6 H, CHPy), 7.47 (br., 6 H, CHPy), 7.29 (br., 12 H, CHar), 7.17 
(br., 12 H, CHar), 6.55 (br., 6 H, NH2∙∙∙O), 5.76 (br., 12 H, CHcym), 5.51 (br., 12 H, 
CHcym), 3.89 (s, 18 H, CH3O), 3.71 (br., 12 H, NCH2), 2.73 (m, 6 H, CH), 2.05 (m, 12 H, 
CH2 BA), 1.80 (s, 18 H, CH3Ccym), 1.41 (m, 72 H, CH2), 1.27 [m, 36 H, (CH3)2CH], 0.99 
(m, 18 H, CH3), 0.96 (m, 18 H, CH3 BA) ppm. 
13
C NMR (100 MHz, CD2Cl2): δ = 173.24 (COBA), 171.02 (CO), 163.85 (CNH2), 
162.48 (CNH), 156.33 (CPyOCH3), 150.60 (NHCONH), 147.29 (CHPy), 138.35 (CHPy), 
134.81 (Car), 133.07 (CHar), 126.07 (CHPy), 123.77 (CPy), 122.89 (C), 120.38 (CHar), 
119.70 (C), 116.51 (Car), 103.83 (Ccym), 98.25 (Ccym), 84.66 (CHcym), 81.58 (CHcym), 
58.24 (CBA), 57.01 (CH3O), 53.19 (NCH2), 32.37 (CH2), 31.74 (CH), 30.60 (CH2 BA), 
30.18 (CH2), 29.78 (CH2), 27.87 (CH2), 23.18 (CH2), 22.76 (CH2), 22.47 [(CH3)2CH], 
18.04 (CH3Ccym), 14.36 (CH3), 9.69 (CH3 BA)  ppm. 
UV/Vis (CH2Cl2, 1.0 × 10
-5
 M): λmax (ε) = 229 (1.56 × 10
5
), 351 nm (1.73 × 10
5
 M
-1
 cm
-
1
). 
IR: ṽ = 3307 (br., NH), 2929 (br., CH aromatic), 2214 (s, C≡C), 1711 (s, NH), 1596 (s, 
C···N), 1510 (s, C···O), 1456 (s, C=N), 1416 (s, C···C), 1254 (s, CF3) cm
-1
.  
C237H294N36O39F18S6Ru6∙2CHCl3 (5650.7): calcd. C 50.80, H 5.28, N 8.92; found C 
50,30 H 5.24, N 8.46. 
 
6.2.4  Crystal data 
A crystal of BApyRh was mounted on a Stoe Mark II-Image Plate Diffraction 
System, using Mo-Kα graphite-monochromated radiation, image plate distance 135 nm, 
2θ range 2.4-51.3°, Dmax - Dmin  = 16.029-0.836 Å. 
Chapter 6 Experimental 
144 
Empirical formula C24H32Cl2N3O3Rh1 
Formula mass [g mol
-1
] 584.33 
Crystal system monoclinic 
Space group P21/c 
Crystal size [nm] 0.18 × 0.17 × 0.14 
Crystal color and shape orange block 
a [Å] 16.3767(9) 
b [Å] 12.7685(6) 
c [Å] 25.0841(11) 
α [°] 90 
β [°] 103.962(4) 
γ [°] 90 
Cell volume [Å
3
] 5090.3(4) 
T [K] 203(2) 
Z 8 
Scan range [°] 1.80 < θ < 29.25 
ϱcalcd.  [g cm
-3
] 1.525 
μ [mm-1] 0.911 
Unique reflections 13485 
Reflections used [Ι > 2σ(Ι)] 6261 
Rint 0.1261 
Final R indices [Ι > 2σ(Ι)] [a] 0.0747, wR2 0.1610 
R indices (all data)
[b]
 0.1555, wR2 0.1878 
GOF
[c]
 0.927 
Max, min Δϱ/e [Å-3] 1.787, -1.718 
[a] R1 = Σ||Fo| – |Fc||/Σ|Fo|. [b] wR2 = {Σ[w(Fo
2
 – Fc
2
)
2
]/Σ[w(Fo
2
)
2
]}
1/2
. [c] GOF = 
{Σ[w(Fo
2
 – Fc
2
)
2
]/(n – p)}1/2, where n is the number of reflections and p is the total 
number of parameters refined. 
Table 7: Crystallographic data and structure refinement parameters for BApyRh 
 
The structure was solved by direct methods using the program SHELXS-97.
[252]
 
Refinement and all further calculations were carried out using SHELXL-97.
[252]
 The H 
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atoms were included in calculated positions and treated as riding atoms using the 
SHELXL default parameters. The non-H atoms were refined anisotropically, using 
weighted full-matrix least squares on F
2
. The electron densities higher than 1 e Å
–3
 were 
all located at less than 1 Å from the rhodium atoms. Crystallographic details are 
summarized in Table 1, and Figure 5 was drawn with ORTEP32.
[253]
 CCDC 1545897 
(for BApyRh) contains the supplementary crystallographic data for this paper. These 
data can be obtained free of charge from The Cambridge Crystallographic Data Centre. 
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